supplementary online content - jama network · symptomatic ae term surveys based on cancer type...

43
© 2015 American Medical Association. All rights reserved. Supplementary Online Content Dueck AC, Mendoza TR, Mitchell SA, et al. Validity and reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. Published online August 13, 2015. doi:10.1001/jamaoncol.2015.2639 eFigure 1. Participant Flow Diagram (N=1,100) eFigure 2. Distribution of PRO-CTCAE Item Scores at Visit 1 eFigure 3. Mean PRO-CTCAE Item Scores by Eastern Cooperative Oncology Group (ECOG) Performance Status Score, for PRO-CTCAE Frequency, Severity, and Interference Items at Visit 1 eTable 1. PRO-CTCAE Symptomatic AEs by Electronic Survey eTable 2. PRO-CTCAE Symptomatic AEs by Analysis eTable 3. Construct Validity of PRO-CTCAE Items (all anchors) eTable 4. Test-retest Reliability of 49 Preselected PRO-CTCAE Items (N=80) This supplementary material has been provided by the authors to give readers additional information about their work. Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Upload: others

Post on 28-Jun-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

© 2015 American Medical Association. All rights reserved.

Supplementary Online Content

Dueck AC, Mendoza TR, Mitchell SA, et al. Validity and reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. Published online August 13, 2015. doi:10.1001/jamaoncol.2015.2639

eFigure 1. Participant Flow Diagram (N=1,100) eFigure 2. Distribution of PRO-CTCAE Item Scores at Visit 1 eFigure 3. Mean PRO-CTCAE Item Scores by Eastern Cooperative Oncology Group (ECOG) Performance Status Score, for PRO-CTCAE Frequency, Severity, and Interference Items at Visit 1 eTable 1. PRO-CTCAE Symptomatic AEs by Electronic Survey eTable 2. PRO-CTCAE Symptomatic AEs by Analysis eTable 3. Construct Validity of PRO-CTCAE Items (all anchors) eTable 4. Test-retest Reliability of 49 Preselected PRO-CTCAE Items (N=80)

This supplementary material has been provided by the authors to give readers additional information about their work.

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 2: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

2

eFigure 1. Participant Flow Diagram (N=1,100)

1,100 patients enrolled

975 patients enrolled in the PRIMARY VALIDATION portion of the study

Group A: Patients receiving radiation therapy for ≥21 more

days (N=108)

Excluded from analysis Cancelled participation prior to

Visit 1 (N=7)

Available for analysis at Visit 1 (N=101)

Available for analysis at Visit 1b (next business day after Visit 1;

part of the TEST-RETEST RELIABILITY portion of the

study) (N=80)

Available for analysis at Visit 2 (one week after Visit 1) (N=89)

Visits 3, 4, and 5 (part of the RECALL portion of the study

[reported elsewhere], excluded from the current analysis)

Group B: Patients with 4 or 5 planned consecutive weekly

clinic visits (N=40)

Excluded from analysis Cancelled participation prior to

Visit 1 (N=3)

Available for analysis at Visit 1 (N=37)

Available for analysis at Visit 2 (one week after Visit 1) (N=35)

Visits 3, 4, and 5 (part of the RECALL portion of the study

[reported elsewhere], excluded from the current analysis)

Group C: Patients whose planned clinic visits precluded

participation in Group B (N=827)

Excluded from analysis Did not meet eligibility criteria

(N=2) Cancelled participation prior to

Visit 1 (N=23)

Available for analysis at Visit 1 (N=802)

Available for analysis at Visit 2 (one to six weeks after Visit 1)

(N=728)

125 patients enrolled in the MODE EQUIVALENCE portion of

the study (results reported elsewhere, excluded from the

current analysis)

N=940

N=852

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 3: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

3

eFigure 2. Distribution of PRO-CTCAE Item Scores at Visit 1†

Abbreviations: PRO-CTCAE, Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events; F, Frequency; S, Severity; I, Interference with usual or daily activities; A, Amount; P, Presence

†eFigure 2 includes items for the 20 “core” symptomatic AEs selected a priori based on high prevalence in prior National Cancer Institute sponsored clinical trials.

Response options: Frequency: 0=”Never”, 1=”Rarely”, 2=”Occasionally”, 3=”Frequently”, 4=”Almost constantly” Severity: 0=”None”, 1=”Mild”, 2=”Moderate”, 3=”Severe”, 4=”Very severe” Interference: 0=”Not at all”, 1=”A little bit”, 2=”Somewhat”, 3=”Quite a bit”, 4=” Very much” Presence: 0=”No”, 1=”Yes” Amount: 0=”Not at all”, 1=”A little bit”, 2=”Somewhat”, 3=”Quite a bit”, 4=” Very much”

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 4: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

4

eFigure 3. Mean PRO-CTCAE Item Scores by Eastern Cooperative Oncology Group (ECOG) Performance Status Score, for PRO-CTCAE Frequency, Severity, and Interference Items at Visit 1†

Abbreviations: PRO-CTCAE, Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events; ECOG, Eastern Cooperative Oncology Group; PS, Performance status; F, Frequency; S, Severity; I, Interference with usual or daily activities

†eFigure 3 includes frequency, severity, and interference items for the 20 “core” symptomatic AEs selected a priori based on high prevalence in prior National Cancer Institute sponsored clinical trials. Numerical data for ECOG PS comparisons appear in eTable 3 for all PRO-CTCAE items at both visits.

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 5: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

5

eTable 1. PRO-CTCAE Symptomatic AEs by Electronic Survey

PRO-CTCAE Symptomatic AE Term

Surveys Based on Cancer Type Survey for all

patients after 80% were

accrued Breast Survey

Lymphoma/ Myeloma

Survey

Prostate/ Bladder Survey

Lung Survey

Colorectal Survey

Head/Neck and

Esophageal Survey

Other Disease

Site Survey

Anxiety X X X X X X X

Arm/leg swelling X X X X X X X

Constipation X X X X X X X

Decreased appetite X X X X X X X

Dry mouth X X X X X X X

Fatigue X X X X X X X

Hair loss X X X X X X X

Headache X X X X X X X

Insomnia X X X X X X X

Loose stools X X X X X X X

Mouth or throat sores X X X X X X X

Nausea X X X X X X X Numbness/tingling in your hands or feet X X X X X X X

Pain X X X X X X X Problems with concentration X X X X X X X

Problems with tasting food/drink X X X X X X X

Rash X X X X X X X

Sad or unhappy feelings X X X X X X X

Shortness of breath X X X X X X X

Vomiting X X X X X X X

Aching joints X X X X

Aching muscles X X X

Acne X X X

Bed sores X X X

Bloating X X X

Blurry vision X X X

Body odor X X X Breast area enlargement or tenderness X X X

Bruise easily X X X Change in the color of fingernails/toenails X X X X

Cough X X X X

Decreased sexual interest X X X Difficulty getting or keeping an erection X X X

Difficulty swallowing X X X

Dizziness X X X

Dry skin X X X

Ejaculation problems X X X Feelings that nothing could cheer you up X X X X X X X

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 6: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

6

PRO-CTCAE Symptomatic AE Term

Surveys Based on Cancer Type Survey for all

patients after 80% were

accrued Breast Survey

Lymphoma/ Myeloma

Survey

Prostate/ Bladder Survey

Lung Survey

Colorectal Survey

Head/Neck and

Esophageal Survey

Other Disease

Site Survey

Flashing lights in eyes X X X

Frequent urination X X X

Hand-foot syndrome X X X X

Heartburn X X X

Hiccups X X X X

Hives X X X

Hoarse voice X X X

Hot flashes X X X X

Increased passing of gas X X X Increased skin sensitivity to sunlight X X X

Irregular menstrual periods X X X

Itchy skin X X X

Lose any fingernails/toenails X X X X Loss of control of bowel movements X X X

Loss of control of urine X X X Miss an expected menstrual period X X X

Nosebleeds X X X

Pain during vaginal sex X X X

Pain in the abdomen X X X Pain or burning with urination X X X

Pain/swelling/redness at IV X X X

Pounding/racing heartbeat X X X

Problems with memory X X X X Ridges/bumps on fingernails/toenails X X X X

Ringing in ears X X X

Shivering or shaking chills X X X

Skin burns from radiation X X X X X Skin cracking at the corners of your mouth X X X

Spots/lines/floaters) in eyes X X X

Stretch marks X X X

Sudden urges to urinate X X X Took too long to have an orgasm or climax X X X X

Unable to have an orgasm or climax X X X X

Unexpected decrease in sweating X X X

Unexpected or excessive sweating X X X X

Unusual darkening of the skin X X X X

Unusual vaginal discharge X X X

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 7: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

7

PRO-CTCAE Symptomatic AE Term

Surveys Based on Cancer Type Survey for all

patients after 80% were

accrued Breast Survey

Lymphoma/ Myeloma

Survey

Prostate/ Bladder Survey

Lung Survey

Colorectal Survey

Head/Neck and

Esophageal Survey

Other Disease

Site Survey

Urine color change X X X

Vaginal dryness X X X

Voice changes X X X

Watery eyes X X X

Wheezing X X X X

Abbreviations: PRO-CTCAE, Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events; AE, adverse event

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 8: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

8

eTable 2. PRO-CTCAE Symptomatic AEs by Analysis

PRO-CTCAE Symptomatic AE Term

Construct validity analyses

Test-retest

reliability Responsive-

ness

Convergent validity analyses Known-groups validity

analyses

Pearson correlation

with QLQ-C30 HRQOL

summary and functioning/ global scales

Pearson correlation with QLQ-

C30 symptom

scales

Comparison between

ECOG PS 0-1 vs 2-4 groups

Comparison between

groups based on cancer

type, treatment, or

other characteristic

Anxiety X X X X X

Arm/leg swelling X X X

Constipation X X X X X X

Decreased appetite X X X X X X

Dry mouth X X X X

Fatigue X X X X X X

Hair loss X X X X

Headache X X X

Insomnia X X X X X X

Loose stools X X X X X X

Mouth or throat sores X X X X X

Nausea X X X X X X Numbness/tingling in your hands or feet X X X X X

Pain X X X X X X Problems with concentration X X X X

Problems with tasting food/drink X X X

Rash X X X X

Sad or unhappy feelings X X X X X

Shortness of breath X X X X X X

Vomiting X X X X X X

Aching joints X X X

Aching muscles X X

Acne X X X

Bed sores X X

Bloating X X X

Blurry vision X X

Body odor X X Breast area enlargement or tenderness X X X

Bruise easily X X Change in the color of fingernails/toenails X X

Cough X X X X

Decreased sexual interest X X Difficulty getting or keeping an erection X X

Difficulty swallowing X X X

Dizziness X X

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 9: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

9

PRO-CTCAE Symptomatic AE Term

Construct validity analyses

Test-retest

reliability Responsive-

ness

Convergent validity analyses Known-groups validity

analyses

Pearson correlation

with QLQ-C30 HRQOL

summary and functioning/ global scales

Pearson correlation with QLQ-

C30 symptom

scales

Comparison between

ECOG PS 0-1 vs 2-4 groups

Comparison between

groups based on cancer

type, treatment, or

other characteristic

Dry skin X X

Ejaculation problems X X Feelings that nothing could cheer you up X X X X

Flashing lights in eyes X X

Frequent urination X X X

Hand-foot syndrome X X X

Heartburn X X X

Hiccups X X X X

Hives X X X

Hoarse voice X X X

Hot flashes X X X

Increased passing of gas X X X Increased skin sensitivity to sunlight X X

Irregular menstrual periods X X X

Itchy skin X X

Lose any fingernails/toenails X X Loss of control of bowel movements X X X

Loss of control of urine X X X Miss an expected menstrual period X X X

Nosebleeds X X X

Pain during vaginal sex X X X

Pain in the abdomen X X X Pain or burning with urination X X X

Pain/swelling/redness at IV X X X

Pounding/racing heartbeat X X

Problems with memory X X X Ridges/bumps on fingernails/toenails X X

Ringing in ears X X X

Shivering or shaking chills X X

Skin burns from radiation X X X X Skin cracking at the corners of your mouth X X X

Spots/lines/floaters) in eyes X X

Stretch marks X X X

Sudden urges to urinate X X X Took too long to have an orgasm or climax X X

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 10: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

10

PRO-CTCAE Symptomatic AE Term

Construct validity analyses

Test-retest

reliability Responsive-

ness

Convergent validity analyses Known-groups validity

analyses

Pearson correlation

with QLQ-C30 HRQOL

summary and functioning/ global scales

Pearson correlation with QLQ-

C30 symptom

scales

Comparison between

ECOG PS 0-1 vs 2-4 groups

Comparison between

groups based on cancer

type, treatment, or

other characteristic

Unable to have an orgasm or climax X X

Unexpected decrease in sweating X X

Unexpected or excessive sweating X X X

Unusual darkening of the skin X X X X

Unusual vaginal discharge X X X

Urine color change X X X

Vaginal dryness X X X

Voice changes X X X

Watery eyes X X

Wheezing X X X X

Abbreviations: PRO-CTCAE, Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events; EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire; HRQOL, Health-related quality of life; ECOG, Eastern Cooperative Oncology Group; PS, Performance status

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 11: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

11

eT

ab

le 3

. C

on

stru

ct V

alid

ity o

f P

RO

-CT

CA

E It

em

s (a

ll a

nch

ors

)

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eA

chin

g jo

ints

(F

)1

35

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.76

1.2

20

.62

.<

0.0

01

0.0

01

Ach

ing

join

ts (

F)

13

54

Cu

rre

ntly

re

ceiv

ing

ho

rmo

ne

the

rap

yO

the

r-0

.17

1.2

4-0

.13

.0

.32

0.6

5A

chin

g jo

ints

(F

)1

34

6P

hys

ica

l Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1A

chin

g jo

ints

(F

)1

34

6R

ole

Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1A

chin

g jo

ints

(F

)1

34

6E

mo

tion

al F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Ach

ing

join

ts (

F)

13

46

Co

gn

itive

Fu

nct

ion

ing

0.3

4<

0.0

01

<0

.00

1A

chin

g jo

ints

(F

)1

34

6S

oci

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Ach

ing

join

ts (

F)

13

46

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.32

<0

.00

1<

0.0

01

Ach

ing

join

ts (

F)

13

44

HR

QO

L S

um

ma

ry S

core

0.4

3<

0.0

01

<0

.00

1A

chin

g jo

ints

(F

)2

32

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.57

1.2

30

.47

.0

.01

0.0

4A

chin

g jo

ints

(F

)2

32

4C

urr

en

tly r

ece

ivin

g h

orm

on

e th

era

py

Oth

er

01

.24

0.

0.9

80

.98

Ach

ing

join

ts (

F)

23

11

Ph

ysic

al F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Ach

ing

join

ts (

F)

23

11

Ro

le F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Ach

ing

join

ts (

F)

23

12

Em

otio

na

l Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1A

chin

g jo

ints

(F

)2

31

2C

og

niti

ve F

un

ctio

nin

g0

.44

<0

.00

1<

0.0

01

Ach

ing

join

ts (

F)

23

11

So

cia

l Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1A

chin

g jo

ints

(F

)2

31

2G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

3<

0.0

01

<0

.00

1A

chin

g jo

ints

(F

)2

30

6H

RQ

OL

Su

mm

ary

Sco

re0

.48

<0

.00

1<

0.0

01

Ach

ing

join

ts (

S)

13

54

EC

OG

PS

2-4

EC

OG

PS

0-1

0.6

61

.01

0.6

6.

<0

.00

1<

0.0

01

Ach

ing

join

ts (

S)

13

54

Cu

rre

ntly

re

ceiv

ing

ho

rmo

ne

the

rap

yO

the

r-0

.08

1.0

3-0

.08

.0

.56

0.5

6A

chin

g jo

ints

(S

)1

34

6P

hys

ica

l Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1A

chin

g jo

ints

(S

)1

34

6R

ole

Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1A

chin

g jo

ints

(S

)1

34

6E

mo

tion

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Ach

ing

join

ts (

S)

13

46

Co

gn

itive

Fu

nct

ion

ing

0.3

4<

0.0

01

<0

.00

1A

chin

g jo

ints

(S

)1

34

6S

oci

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Ach

ing

join

ts (

S)

13

46

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.33

<0

.00

1<

0.0

01

Ach

ing

join

ts (

S)

13

44

HR

QO

L S

um

ma

ry S

core

0.4

7<

0.0

01

<0

.00

1A

chin

g jo

ints

(S

)2

32

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.47

0.9

70

.48

.0

.01

0.0

3A

chin

g jo

ints

(S

)2

32

4C

urr

en

tly r

ece

ivin

g h

orm

on

e th

era

py

Oth

er

-0.1

10

.98

-0.1

1.

0.4

40

.56

Ach

ing

join

ts (

S)

23

11

Ph

ysic

al F

un

ctio

nin

g0

.44

<0

.00

1<

0.0

01

Ach

ing

join

ts (

S)

23

11

Ro

le F

un

ctio

nin

g0

.35

<0

.00

1<

0.0

01

Ach

ing

join

ts (

S)

23

12

Em

otio

na

l Fu

nct

ion

ing

0.3

6<

0.0

01

<0

.00

1A

chin

g jo

ints

(S

)2

31

2C

og

niti

ve F

un

ctio

nin

g0

.41

<0

.00

1<

0.0

01

Ach

ing

join

ts (

S)

23

11

So

cia

l Fu

nct

ion

ing

0.3

6<

0.0

01

<0

.00

1A

chin

g jo

ints

(S

)2

31

2G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

5<

0.0

01

<0

.00

1A

chin

g jo

ints

(S

)2

30

6H

RQ

OL

Su

mm

ary

Sco

re0

.52

<0

.00

1<

0.0

01

Ach

ing

join

ts (

I)1

35

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.85

1.0

20

.84

.<

0.0

01

<0

.00

1A

chin

g jo

ints

(I)

13

54

Cu

rre

ntly

re

ceiv

ing

ho

rmo

ne

the

rap

yO

the

r-0

.09

1.0

5-0

.09

.0

.52

0.6

9A

chin

g jo

ints

(I)

13

46

Ph

ysic

al F

un

ctio

nin

g0

.46

<0

.00

1<

0.0

01

Ach

ing

join

ts (

I)1

34

6R

ole

Fu

nct

ion

ing

0.4

0<

0.0

01

<0

.00

1A

chin

g jo

ints

(I)

13

46

Em

otio

na

l Fu

nct

ion

ing

0.4

0<

0.0

01

<0

.00

1A

chin

g jo

ints

(I)

13

46

Co

gn

itive

Fu

nct

ion

ing

0.3

7<

0.0

01

<0

.00

1A

chin

g jo

ints

(I)

13

46

So

cia

l Fu

nct

ion

ing

0.4

4<

0.0

01

<0

.00

1A

chin

g jo

ints

(I)

13

46

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.41

<0

.00

1<

0.0

01

Ach

ing

join

ts (

I)1

34

4H

RQ

OL

Su

mm

ary

Sco

re0

.57

<0

.00

1<

0.0

01

Ach

ing

join

ts (

I)2

32

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.53

1.0

40

.51

.0

.00

70

.02

Ach

ing

join

ts (

I)2

32

4C

urr

en

tly r

ece

ivin

g h

orm

on

e th

era

py

Oth

er

-0.0

61

.05

-0.0

6.

0.6

90

.69

Ach

ing

join

ts (

I)2

31

1P

hys

ica

l Fu

nct

ion

ing

0.4

5<

0.0

01

<0

.00

1A

chin

g jo

ints

(I)

23

11

Ro

le F

un

ctio

nin

g0

.40

<0

.00

1<

0.0

01

Ach

ing

join

ts (

I)2

31

2E

mo

tion

al F

un

ctio

nin

g0

.41

<0

.00

1<

0.0

01

Ach

ing

join

ts (

I)2

31

2C

og

niti

ve F

un

ctio

nin

g0

.41

<0

.00

1<

0.0

01

Ach

ing

join

ts (

I)2

31

1S

oci

al F

un

ctio

nin

g0

.42

<0

.00

1<

0.0

01

Ach

ing

join

ts (

I)2

31

2G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

6<

0.0

01

<0

.00

1A

chin

g jo

ints

(I)

23

06

HR

QO

L S

um

ma

ry S

core

0.5

6<

0.0

01

<0

.00

1A

chin

g m

usc

les

(F)

12

27

EC

OG

PS

2-4

EC

OG

PS

0-1

0.5

31

.13

0.4

7.

0.0

20

.03

Ach

ing

mu

scle

s (F

)1

22

6P

hys

ica

l Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1A

chin

g m

usc

les

(F)

12

26

Ro

le F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (F

)1

22

6E

mo

tion

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (F

)1

22

6C

og

niti

ve F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (F

)1

22

6S

oci

al F

un

ctio

nin

g0

.32

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (F

)1

22

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

8<

0.0

01

<0

.00

1A

chin

g m

usc

les

(F)

12

24

HR

QO

L S

um

ma

ry S

core

0.4

0<

0.0

01

<0

.00

1A

chin

g m

usc

les

(F)

22

01

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

71

.13

0.2

4.

0.2

60

.26

Ach

ing

mu

scle

s (F

)2

19

9P

hys

ica

l Fu

nct

ion

ing

0.3

7<

0.0

01

<0

.00

1A

chin

g m

usc

les

(F)

21

99

Ro

le F

un

ctio

nin

g0

.34

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (F

)2

19

8E

mo

tion

al F

un

ctio

nin

g0

.20

0.0

04

0.0

1A

chin

g m

usc

les

(F)

21

98

Co

gn

itive

Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1A

chin

g m

usc

les

(F)

21

97

So

cia

l Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1A

chin

g m

usc

les

(F)

21

98

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.32

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (F

)2

19

5H

RQ

OL

Su

mm

ary

Sco

re0

.46

<0

.00

1<

0.0

01

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 12: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

12

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eA

chin

g m

usc

les

(S)

12

27

EC

OG

PS

2-4

EC

OG

PS

0-1

0.4

81

.01

0.4

8.

0.0

10

.03

Ach

ing

mu

scle

s (S

)1

22

6P

hys

ica

l Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1A

chin

g m

usc

les

(S)

12

26

Ro

le F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (S

)1

22

6E

mo

tion

al F

un

ctio

nin

g0

.21

0.0

01

0.0

05

Ach

ing

mu

scle

s (S

)1

22

6C

og

niti

ve F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (S

)1

22

6S

oci

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (S

)1

22

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

7<

0.0

01

<0

.00

1A

chin

g m

usc

les

(S)

12

24

HR

QO

L S

um

ma

ry S

core

0.4

0<

0.0

01

<0

.00

1A

chin

g m

usc

les

(S)

22

01

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

90

.98

0.1

9.

0.3

70

.37

Ach

ing

mu

scle

s (S

)2

19

9P

hys

ica

l Fu

nct

ion

ing

0.4

0<

0.0

01

<0

.00

1A

chin

g m

usc

les

(S)

21

99

Ro

le F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (S

)2

19

8E

mo

tion

al F

un

ctio

nin

g0

.20

0.0

04

0.0

1A

chin

g m

usc

les

(S)

21

98

Co

gn

itive

Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1A

chin

g m

usc

les

(S)

21

97

So

cia

l Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1A

chin

g m

usc

les

(S)

21

98

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.31

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (S

)2

19

5H

RQ

OL

Su

mm

ary

Sco

re0

.47

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (I

)1

22

7E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.71

1.0

90

.65

.<

0.0

01

0.0

01

Ach

ing

mu

scle

s (I

)1

22

6P

hys

ica

l Fu

nct

ion

ing

0.3

9<

0.0

01

<0

.00

1A

chin

g m

usc

les

(I)

12

26

Ro

le F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (I

)1

22

6E

mo

tion

al F

un

ctio

nin

g0

.32

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (I

)1

22

6C

og

niti

ve F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (I

)1

22

6S

oci

al F

un

ctio

nin

g0

.40

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (I

)1

22

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

2<

0.0

01

<0

.00

1A

chin

g m

usc

les

(I)

12

24

HR

QO

L S

um

ma

ry S

core

0.4

9<

0.0

01

<0

.00

1A

chin

g m

usc

les

(I)

22

01

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

21

.05

0.3

1.

0.1

40

.14

Ach

ing

mu

scle

s (I

)2

19

9P

hys

ica

l Fu

nct

ion

ing

0.4

2<

0.0

01

<0

.00

1A

chin

g m

usc

les

(I)

21

99

Ro

le F

un

ctio

nin

g0

.42

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (I

)2

19

8E

mo

tion

al F

un

ctio

nin

g0

.25

<0

.00

10

.00

1A

chin

g m

usc

les

(I)

21

98

Co

gn

itive

Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1A

chin

g m

usc

les

(I)

21

97

So

cia

l Fu

nct

ion

ing

0.3

7<

0.0

01

<0

.00

1A

chin

g m

usc

les

(I)

21

98

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.28

<0

.00

1<

0.0

01

Ach

ing

mu

scle

s (I

)2

19

5H

RQ

OL

Su

mm

ary

Sco

re0

.50

<0

.00

1<

0.0

01

Acn

e (

S)

14

09

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.0

40

.66

-0.0

6.

0.6

60

.82

Acn

e (

S)

14

09

Ep

ide

rma

l gro

wth

fact

or

rece

pto

r in

hib

itor

in p

rior

2 w

ee

ksO

the

r0

.41

0.6

50

.63

.0

.00

50

.09

Acn

e (

S)

13

94

Ph

ysic

al F

un

ctio

nin

g-0

.03

0.5

80

.82

Acn

e (

S)

13

94

Ro

le F

un

ctio

nin

g0

.06

0.2

60

.82

Acn

e (

S)

13

94

Em

otio

na

l Fu

nct

ion

ing

0.0

20

.69

0.8

2A

cne

(S

)1

39

4C

og

niti

ve F

un

ctio

nin

g-0

.01

0.7

90

.82

Acn

e (

S)

13

94

So

cia

l Fu

nct

ion

ing

0.0

70

.14

0.8

2A

cne

(S

)1

39

4G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

40

.47

0.8

2A

cne

(S

)1

39

1H

RQ

OL

Su

mm

ary

Sco

re0

.02

0.7

0.8

2A

cne

(S

)2

37

2E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.14

0.6

8-0

.20

.0

.22

0.8

2A

cne

(S

)2

37

2E

pid

erm

al g

row

th fa

cto

r re

cep

tor

inh

ibito

r in

prio

r 2

we

eks

Oth

er

0.4

50

.67

0.6

7.

0.0

04

0.0

8A

cne

(S

)2

35

6P

hys

ica

l Fu

nct

ion

ing

0.0

30

.52

0.8

2A

cne

(S

)2

35

6R

ole

Fu

nct

ion

ing

0.1

00

.05

0.8

1A

cne

(S

)2

35

6E

mo

tion

al F

un

ctio

nin

g-0

.04

0.5

0.8

2A

cne

(S

)2

35

6C

og

niti

ve F

un

ctio

nin

g0

.03

0.5

60

.82

Acn

e (

S)

23

56

So

cia

l Fu

nct

ion

ing

0.0

80

.13

0.8

2A

cne

(S

)2

35

6G

lob

al H

ea

lth S

tatu

s/Q

oL

-0.0

10

.82

0.8

2A

cne

(S

)2

35

2H

RQ

OL

Su

mm

ary

Sco

re0

.04

0.4

90

.82

An

xie

ty (

F)

18

37

EC

OG

PS

2-4

EC

OG

PS

0-1

0.4

01

.07

0.3

8.

<0

.00

1<

0.0

01

An

xie

ty (

F)

18

37

Cu

rre

ntly

taki

ng

an

xie

ty m

ed

Oth

er

0.7

91

.02

0.7

7.

<0

.00

1<

0.0

01

An

xie

ty (

F)

18

21

Ph

ysic

al F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

An

xie

ty (

F)

18

21

Ro

le F

un

ctio

nin

g0

.36

<0

.00

1<

0.0

01

An

xie

ty (

F)

18

18

Em

otio

na

l Fu

nct

ion

ing

0.7

0<

0.0

01

<0

.00

1A

nxi

ety

(F

)1

81

8C

og

niti

ve F

un

ctio

nin

g0

.42

<0

.00

1<

0.0

01

An

xie

ty (

F)

18

18

So

cia

l Fu

nct

ion

ing

0.4

1<

0.0

01

<0

.00

1A

nxi

ety

(F

)1

81

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

0<

0.0

01

<0

.00

1A

nxi

ety

(F

)1

81

6H

RQ

OL

Su

mm

ary

Sco

re0

.50

<0

.00

1<

0.0

01

An

xie

ty (

F)

27

78

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

61

.07

0.3

4.

<0

.00

1<

0.0

01

An

xie

ty (

F)

27

78

Cu

rre

ntly

taki

ng

an

xie

ty m

ed

Oth

er

0.7

81

.02

0.7

7.

<0

.00

1<

0.0

01

An

xie

ty (

F)

27

56

Ph

ysic

al F

un

ctio

nin

g0

.32

<0

.00

1<

0.0

01

An

xie

ty (

F)

27

56

Ro

le F

un

ctio

nin

g0

.32

<0

.00

1<

0.0

01

An

xie

ty (

F)

27

54

Em

otio

na

l Fu

nct

ion

ing

0.7

2<

0.0

01

<0

.00

1A

nxi

ety

(F

)2

75

4C

og

niti

ve F

un

ctio

nin

g0

.43

<0

.00

1<

0.0

01

An

xie

ty (

F)

27

53

So

cia

l Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1A

nxi

ety

(F

)2

75

4G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

5<

0.0

01

<0

.00

1A

nxi

ety

(F

)2

74

7H

RQ

OL

Su

mm

ary

Sco

re0

.49

<0

.00

1<

0.0

01

An

xie

ty (

S)

18

37

EC

OG

PS

2-4

EC

OG

PS

0-1

0.4

30

.96

0.4

5.

<0

.00

1<

0.0

01

An

xie

ty (

S)

18

37

Cu

rre

ntly

taki

ng

an

xie

ty m

ed

Oth

er

0.6

50

.93

0.7

0.

<0

.00

1<

0.0

01

An

xie

ty (

S)

18

21

Ph

ysic

al F

un

ctio

nin

g0

.30

<0

.00

1<

0.0

01

An

xie

ty (

S)

18

21

Ro

le F

un

ctio

nin

g0

.36

<0

.00

1<

0.0

01

An

xie

ty (

S)

18

18

Em

otio

na

l Fu

nct

ion

ing

0.7

0<

0.0

01

<0

.00

1

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 13: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

13

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eA

nxi

ety

(S

)1

81

8C

og

niti

ve F

un

ctio

nin

g0

.44

<0

.00

1<

0.0

01

An

xie

ty (

S)

18

18

So

cia

l Fu

nct

ion

ing

0.4

2<

0.0

01

<0

.00

1A

nxi

ety

(S

)1

81

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

2<

0.0

01

<0

.00

1A

nxi

ety

(S

)1

81

6H

RQ

OL

Su

mm

ary

Sco

re0

.51

<0

.00

1<

0.0

01

An

xie

ty (

S)

27

78

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

50

.92

0.3

8.

<0

.00

1<

0.0

01

An

xie

ty (

S)

27

78

Cu

rre

ntly

taki

ng

an

xie

ty m

ed

Oth

er

0.6

60

.89

0.7

5.

<0

.00

1<

0.0

01

An

xie

ty (

S)

27

56

Ph

ysic

al F

un

ctio

nin

g0

.34

<0

.00

1<

0.0

01

An

xie

ty (

S)

27

56

Ro

le F

un

ctio

nin

g0

.33

<0

.00

1<

0.0

01

An

xie

ty (

S)

27

54

Em

otio

na

l Fu

nct

ion

ing

0.7

0<

0.0

01

<0

.00

1A

nxi

ety

(S

)2

75

4C

og

niti

ve F

un

ctio

nin

g0

.43

<0

.00

1<

0.0

01

An

xie

ty (

S)

27

53

So

cia

l Fu

nct

ion

ing

0.3

7<

0.0

01

<0

.00

1A

nxi

ety

(S

)2

75

4G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

8<

0.0

01

<0

.00

1A

nxi

ety

(S

)2

74

7H

RQ

OL

Su

mm

ary

Sco

re0

.52

<0

.00

1<

0.0

01

An

xie

ty (

I)1

83

7E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.48

1.0

30

.46

.<

0.0

01

<0

.00

1A

nxi

ety

(I)

18

37

Cu

rre

ntly

taki

ng

an

xie

ty m

ed

Oth

er

0.6

31

.01

0.6

3.

<0

.00

1<

0.0

01

An

xie

ty (

I)1

82

1P

hys

ica

l Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1A

nxi

ety

(I)

18

21

Ro

le F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

An

xie

ty (

I)1

81

8E

mo

tion

al F

un

ctio

nin

g0

.64

<0

.00

1<

0.0

01

An

xie

ty (

I)1

81

8C

og

niti

ve F

un

ctio

nin

g0

.42

<0

.00

1<

0.0

01

An

xie

ty (

I)1

81

8S

oci

al F

un

ctio

nin

g0

.49

<0

.00

1<

0.0

01

An

xie

ty (

I)1

81

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

3<

0.0

01

<0

.00

1A

nxi

ety

(I)

18

16

HR

QO

L S

um

ma

ry S

core

0.5

1<

0.0

01

<0

.00

1A

nxi

ety

(I)

27

78

EC

OG

PS

2-4

EC

OG

PS

0-1

0.4

60

.97

0.4

7.

<0

.00

1<

0.0

01

An

xie

ty (

I)2

77

8C

urr

en

tly ta

kin

g a

nxi

ety

me

dO

the

r0

.59

0.9

50

.62

.<

0.0

01

<0

.00

1A

nxi

ety

(I)

27

56

Ph

ysic

al F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

An

xie

ty (

I)2

75

6R

ole

Fu

nct

ion

ing

0.3

9<

0.0

01

<0

.00

1A

nxi

ety

(I)

27

54

Em

otio

na

l Fu

nct

ion

ing

0.6

5<

0.0

01

<0

.00

1A

nxi

ety

(I)

27

54

Co

gn

itive

Fu

nct

ion

ing

0.4

3<

0.0

01

<0

.00

1A

nxi

ety

(I)

27

53

So

cia

l Fu

nct

ion

ing

0.4

1<

0.0

01

<0

.00

1A

nxi

ety

(I)

27

54

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.36

<0

.00

1<

0.0

01

An

xie

ty (

I)2

74

7H

RQ

OL

Su

mm

ary

Sco

re0

.51

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(F

)1

82

7E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.24

1.1

00

.22

.0

.02

0.0

2A

rm/le

g s

we

llin

g (

F)

18

11

Ph

ysic

al F

un

ctio

nin

g0

.23

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(F

)1

81

1R

ole

Fu

nct

ion

ing

0.1

9<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

F)

18

08

Em

otio

na

l Fu

nct

ion

ing

0.1

6<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

F)

18

08

Co

gn

itive

Fu

nct

ion

ing

0.2

0<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

F)

18

08

So

cia

l Fu

nct

ion

ing

0.1

3<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

F)

18

08

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.19

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(F

)1

80

7H

RQ

OL

Su

mm

ary

Sco

re0

.24

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(F

)2

76

3E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.28

1.0

70

.26

.0

.01

0.0

2A

rm/le

g s

we

llin

g (

F)

27

41

Ph

ysic

al F

un

ctio

nin

g0

.22

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(F

)2

74

1R

ole

Fu

nct

ion

ing

0.1

7<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

F)

27

39

Em

otio

na

l Fu

nct

ion

ing

0.1

9<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

F)

27

39

Co

gn

itive

Fu

nct

ion

ing

0.1

4<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

F)

27

38

So

cia

l Fu

nct

ion

ing

0.1

10

.00

30

.01

Arm

/leg

sw

elli

ng

(F

)2

73

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

7<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

F)

27

32

HR

QO

L S

um

ma

ry S

core

0.2

0<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

S)

18

28

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

30

.87

0.2

6.

0.0

04

0.0

06

Arm

/leg

sw

elli

ng

(S

)1

81

2P

hys

ica

l Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

S)

18

12

Ro

le F

un

ctio

nin

g0

.18

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(S

)1

80

9E

mo

tion

al F

un

ctio

nin

g0

.19

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(S

)1

80

9C

og

niti

ve F

un

ctio

nin

g0

.20

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(S

)1

80

9S

oci

al F

un

ctio

nin

g0

.13

<0

.00

10

.00

1A

rm/le

g s

we

llin

g (

S)

18

09

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.21

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(S

)1

80

7H

RQ

OL

Su

mm

ary

Sco

re0

.26

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(S

)2

76

3E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.27

0.8

20

.33

.<

0.0

01

0.0

03

Arm

/leg

sw

elli

ng

(S

)2

74

1P

hys

ica

l Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

S)

27

41

Ro

le F

un

ctio

nin

g0

.17

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(S

)2

73

9E

mo

tion

al F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(S

)2

73

9C

og

niti

ve F

un

ctio

nin

g0

.13

<0

.00

10

.00

1A

rm/le

g s

we

llin

g (

S)

27

38

So

cia

l Fu

nct

ion

ing

0.1

00

.00

60

.00

6A

rm/le

g s

we

llin

g (

S)

27

39

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.17

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(S

)2

73

2H

RQ

OL

Su

mm

ary

Sco

re0

.20

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(I)

18

28

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

40

.84

0.2

9.

0.0

02

0.0

03

Arm

/leg

sw

elli

ng

(I)

18

12

Ph

ysic

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(I)

18

12

Ro

le F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(I)

18

09

Em

otio

na

l Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

I)1

80

9C

og

niti

ve F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(I)

18

09

So

cia

l Fu

nct

ion

ing

0.1

9<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

I)1

80

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

2<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

I)1

80

7H

RQ

OL

Su

mm

ary

Sco

re0

.29

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(I)

27

63

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

80

.77

0.2

4.

0.0

20

.02

Arm

/leg

sw

elli

ng

(I)

27

41

Ph

ysic

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 14: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

14

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eA

rm/le

g s

we

llin

g (

I)2

74

1R

ole

Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

I)2

73

9E

mo

tion

al F

un

ctio

nin

g0

.22

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(I)

27

39

Co

gn

itive

Fu

nct

ion

ing

0.1

6<

0.0

01

<0

.00

1A

rm/le

g s

we

llin

g (

I)2

73

8S

oci

al F

un

ctio

nin

g0

.17

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(I)

27

39

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.15

<0

.00

1<

0.0

01

Arm

/leg

sw

elli

ng

(I)

27

32

HR

QO

L S

um

ma

ry S

core

0.2

6<

0.0

01

<0

.00

1B

ed

so

res

(P)

13

29

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

1%

0.0

1.

0.9

50

.98

Be

d s

ore

s (P

)1

32

1P

hys

ica

l Fu

nct

ion

ing

0.1

20

.04

0.5

4B

ed

so

res

(P)

13

21

Ro

le F

un

ctio

nin

g0

.14

0.0

10

.17

Be

d s

ore

s (P

)1

32

1E

mo

tion

al F

un

ctio

nin

g0

.10

0.0

70

.79

Be

d s

ore

s (P

)1

32

1C

og

niti

ve F

un

ctio

nin

g0

.02

0.7

70

.98

Be

d s

ore

s (P

)1

32

1S

oci

al F

un

ctio

nin

g0

.09

0.1

20

.98

Be

d s

ore

s (P

)1

32

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

90

.09

0.9

8B

ed

so

res

(P)

13

18

HR

QO

L S

um

ma

ry S

core

0.1

40

.01

0.2

Be

d s

ore

s (P

)2

29

2E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.21

%-0

.01

.0

.93

0.9

8B

ed

so

res

(P)

22

87

Ph

ysic

al F

un

ctio

nin

g0

.05

0.4

50

.98

Be

d s

ore

s (P

)2

28

7R

ole

Fu

nct

ion

ing

0.0

00

.98

0.9

8B

ed

so

res

(P)

22

85

Em

otio

na

l Fu

nct

ion

ing

-0.0

10

.92

0.9

8B

ed

so

res

(P)

22

85

Co

gn

itive

Fu

nct

ion

ing

-0.0

10

.83

0.9

8B

ed

so

res

(P)

22

85

So

cia

l Fu

nct

ion

ing

-0.1

10

.06

0.7

5B

ed

so

res

(P)

22

85

Glo

ba

l He

alth

Sta

tus/

Qo

L-0

.09

0.1

20

.98

Be

d s

ore

s (P

)2

28

4H

RQ

OL

Su

mm

ary

Sco

re-0

.02

0.6

80

.98

Blo

atin

g (

F)

13

32

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

01

.07

0.0

9.

0.5

10

.91

Blo

atin

g (

F)

12

40

Ga

stro

inte

stin

al

Lu

ng

/He

ad

/Ne

ck0

.43

0.9

90

.44

.0

.00

50

.02

Blo

atin

g (

F)

13

24

Ph

ysic

al F

un

ctio

nin

g0

.23

<0

.00

1<

0.0

01

Blo

atin

g (

F)

13

24

Ro

le F

un

ctio

nin

g0

.26

<0

.00

1<

0.0

01

Blo

atin

g (

F)

13

23

Em

otio

na

l Fu

nct

ion

ing

0.2

0<

0.0

01

0.0

02

Blo

atin

g (

F)

13

23

Co

gn

itive

Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1B

loa

ting

(F

)1

32

3S

oci

al F

un

ctio

nin

g0

.21

<0

.00

10

.00

2B

loa

ting

(F

)1

32

3G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

40

.01

0.0

6B

loa

ting

(F

)1

32

0H

RQ

OL

Su

mm

ary

Sco

re0

.31

<0

.00

1<

0.0

01

Blo

atin

g (

F)

22

92

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.0

21

.01

-0.0

2.

0.9

10

.91

Blo

atin

g (

F)

22

12

Ga

stro

inte

stin

al

Lu

ng

/He

ad

/Ne

ck0

.24

0.9

80

.25

.0

.13

0.3

9B

loa

ting

(F

)2

28

7P

hys

ica

l Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1B

loa

ting

(F

)2

28

7R

ole

Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1B

loa

ting

(F

)2

28

5E

mo

tion

al F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Blo

atin

g (

F)

22

85

Co

gn

itive

Fu

nct

ion

ing

0.1

9<

0.0

01

0.0

06

Blo

atin

g (

F)

22

85

So

cia

l Fu

nct

ion

ing

0.2

5<

0.0

01

<0

.00

1B

loa

ting

(F

)2

28

5G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

0<

0.0

01

0.0

06

Blo

atin

g (

F)

22

84

HR

QO

L S

um

ma

ry S

core

0.3

5<

0.0

01

<0

.00

1B

loa

ting

(S

)1

33

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.12

0.8

90

.14

.0

.32

0.6

2B

loa

ting

(S

)1

24

0G

ast

roin

test

ina

lL

un

g/H

ea

d/N

eck

0.3

90

.84

0.4

6.

0.0

03

0.0

1B

loa

ting

(S

)1

32

4P

hys

ica

l Fu

nct

ion

ing

0.2

2<

0.0

01

<0

.00

1B

loa

ting

(S

)1

32

4R

ole

Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1B

loa

ting

(S

)1

32

3E

mo

tion

al F

un

ctio

nin

g0

.21

<0

.00

10

.00

2B

loa

ting

(S

)1

32

3C

og

niti

ve F

un

ctio

nin

g0

.22

<0

.00

1<

0.0

01

Blo

atin

g (

S)

13

23

So

cia

l Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1B

loa

ting

(S

)1

32

3G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

70

.00

20

.01

Blo

atin

g (

S)

13

20

HR

QO

L S

um

ma

ry S

core

0.3

3<

0.0

01

<0

.00

1B

loa

ting

(S

)2

29

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.07

0.8

40

.08

.0

.62

0.6

2B

loa

ting

(S

)2

21

2G

ast

roin

test

ina

lL

un

g/H

ea

d/N

eck

0.2

00

.84

0.2

4.

0.1

40

.42

Blo

atin

g (

S)

22

87

Ph

ysic

al F

un

ctio

nin

g0

.21

<0

.00

10

.00

3B

loa

ting

(S

)2

28

7R

ole

Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1B

loa

ting

(S

)2

28

5E

mo

tion

al F

un

ctio

nin

g0

.23

<0

.00

1<

0.0

01

Blo

atin

g (

S)

22

85

Co

gn

itive

Fu

nct

ion

ing

0.1

70

.00

40

.02

Blo

atin

g (

S)

22

85

So

cia

l Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1B

loa

ting

(S

)2

28

5G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

0<

0.0

01

0.0

04

Blo

atin

g (

S)

22

84

HR

QO

L S

um

ma

ry S

core

0.2

9<

0.0

01

<0

.00

1B

lurr

y vi

sio

n (

S)

12

70

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

10

.84

0.2

5.

0.1

60

.27

Blu

rry

visi

on

(S

)1

26

7P

hys

ica

l Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1B

lurr

y vi

sio

n (

S)

12

67

Ro

le F

un

ctio

nin

g0

.20

<0

.00

10

.00

5B

lurr

y vi

sio

n (

S)

12

63

Em

otio

na

l Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1B

lurr

y vi

sio

n (

S)

12

63

Co

gn

itive

Fu

nct

ion

ing

0.4

5<

0.0

01

<0

.00

1B

lurr

y vi

sio

n (

S)

12

63

So

cia

l Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1B

lurr

y vi

sio

n (

S)

12

63

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.25

<0

.00

1<

0.0

01

Blu

rry

visi

on

(S

)1

26

1H

RQ

OL

Su

mm

ary

Sco

re0

.39

<0

.00

1<

0.0

01

Blu

rry

visi

on

(S

)2

23

9E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.16

0.7

40

.22

.0

.27

0.2

7B

lurr

y vi

sio

n (

S)

22

37

Ph

ysic

al F

un

ctio

nin

g0

.24

<0

.00

10

.00

2B

lurr

y vi

sio

n (

S)

22

37

Ro

le F

un

ctio

nin

g0

.19

0.0

04

0.0

2B

lurr

y vi

sio

n (

S)

22

37

Em

otio

na

l Fu

nct

ion

ing

0.2

3<

0.0

01

0.0

03

Blu

rry

visi

on

(S

)2

23

7C

og

niti

ve F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Blu

rry

visi

on

(S

)2

23

7S

oci

al F

un

ctio

nin

g0

.14

0.0

30

.12

Blu

rry

visi

on

(S

)2

23

7G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

30

.04

60

.14

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 15: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

15

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eB

lurr

y vi

sio

n (

S)

22

37

HR

QO

L S

um

ma

ry S

core

0.3

2<

0.0

01

<0

.00

1B

lurr

y vi

sio

n (

I)1

27

0E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.29

0.8

30

.36

.0

.04

80

.14

Blu

rry

visi

on

(I)

12

67

Ph

ysic

al F

un

ctio

nin

g0

.26

<0

.00

1<

0.0

01

Blu

rry

visi

on

(I)

12

67

Ro

le F

un

ctio

nin

g0

.18

0.0

03

0.0

2B

lurr

y vi

sio

n (

I)1

26

3E

mo

tion

al F

un

ctio

nin

g0

.23

<0

.00

10

.00

2B

lurr

y vi

sio

n (

I)1

26

3C

og

niti

ve F

un

ctio

nin

g0

.41

<0

.00

1<

0.0

01

Blu

rry

visi

on

(I)

12

63

So

cia

l Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1B

lurr

y vi

sio

n (

I)1

26

3G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

90

.00

20

.01

Blu

rry

visi

on

(I)

12

61

HR

QO

L S

um

ma

ry S

core

0.3

5<

0.0

01

<0

.00

1B

lurr

y vi

sio

n (

I)2

23

9E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.09

0.6

90

.13

.0

.51

0.5

1B

lurr

y vi

sio

n (

I)2

23

7P

hys

ica

l Fu

nct

ion

ing

0.1

90

.00

30

.02

Blu

rry

visi

on

(I)

22

37

Ro

le F

un

ctio

nin

g0

.16

0.0

10

.04

6B

lurr

y vi

sio

n (

I)2

23

7E

mo

tion

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Blu

rry

visi

on

(I)

22

37

Co

gn

itive

Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1B

lurr

y vi

sio

n (

I)2

23

7S

oci

al F

un

ctio

nin

g0

.17

0.0

10

.04

6B

lurr

y vi

sio

n (

I)2

23

7G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

10

.09

0.1

9B

lurr

y vi

sio

n (

I)2

23

7H

RQ

OL

Su

mm

ary

Sco

re0

.30

<0

.00

1<

0.0

01

Bo

dy

od

or

(S)

12

00

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

60

.45

0.3

5.

0.0

50

.62

Bo

dy

od

or

(S)

11

99

Ph

ysic

al F

un

ctio

nin

g0

.20

0.0

05

0.0

7B

od

y o

do

r (S

)1

19

9R

ole

Fu

nct

ion

ing

0.1

30

.08

0.8

3B

od

y o

do

r (S

)1

19

9E

mo

tion

al F

un

ctio

nin

g0

.09

0.2

10

.91

Bo

dy

od

or

(S)

11

99

Co

gn

itive

Fu

nct

ion

ing

0.0

90

.23

0.9

1B

od

y o

do

r (S

)1

19

9S

oci

al F

un

ctio

nin

g0

.16

0.0

20

.34

Bo

dy

od

or

(S)

11

99

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.14

0.0

46

0.5

9B

od

y o

do

r (S

)1

19

7H

RQ

OL

Su

mm

ary

Sco

re0

.23

<0

.00

10

.02

Bo

dy

od

or

(S)

21

76

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.0

10

.30

-0.0

2.

0.9

10

.91

Bo

dy

od

or

(S)

21

75

Ph

ysic

al F

un

ctio

nin

g0

.09

0.2

30

.91

Bo

dy

od

or

(S)

21

75

Ro

le F

un

ctio

nin

g0

.09

0.2

30

.91

Bo

dy

od

or

(S)

21

75

Em

otio

na

l Fu

nct

ion

ing

0.0

30

.65

0.9

1B

od

y o

do

r (S

)2

17

5C

og

niti

ve F

un

ctio

nin

g-0

.01

0.9

0.9

1B

od

y o

do

r (S

)2

17

5S

oci

al F

un

ctio

nin

g0

.09

0.2

50

.91

Bo

dy

od

or

(S)

21

75

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.09

0.2

50

.91

Bo

dy

od

or

(S)

21

75

HR

QO

L S

um

ma

ry S

core

0.1

00

.18

0.9

1B

rea

st a

rea

en

larg

em

en

t or

ten

de

rne

ss (

S)

12

41

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.2

20

.64

-0.3

4.

0.0

80

.92

Bre

ast

are

a e

nla

rge

me

nt o

r te

nd

ern

ess

(S

)1

12

7P

rost

ate

Ga

stro

inte

stin

al

0.3

00

.58

0.5

1.

0.0

05

0.0

9B

rea

st a

rea

en

larg

em

en

t or

ten

de

rne

ss (

S)

12

40

Ph

ysic

al F

un

ctio

nin

g-0

.01

0.8

20

.92

Bre

ast

are

a e

nla

rge

me

nt o

r te

nd

ern

ess

(S

)1

24

0R

ole

Fu

nct

ion

ing

-0.0

80

.22

0.9

2B

rea

st a

rea

en

larg

em

en

t or

ten

de

rne

ss (

S)

12

40

Em

otio

na

l Fu

nct

ion

ing

0.0

50

.45

0.9

2B

rea

st a

rea

en

larg

em

en

t or

ten

de

rne

ss (

S)

12

40

Co

gn

itive

Fu

nct

ion

ing

0.0

70

.30

.92

Bre

ast

are

a e

nla

rge

me

nt o

r te

nd

ern

ess

(S

)1

24

0S

oci

al F

un

ctio

nin

g-0

.03

0.6

0.9

2B

rea

st a

rea

en

larg

em

en

t or

ten

de

rne

ss (

S)

12

40

Glo

ba

l He

alth

Sta

tus/

Qo

L-0

.05

0.4

70

.92

Bre

ast

are

a e

nla

rge

me

nt o

r te

nd

ern

ess

(S

)1

23

8H

RQ

OL

Su

mm

ary

Sco

re-0

.04

0.5

30

.92

Bre

ast

are

a e

nla

rge

me

nt o

r te

nd

ern

ess

(S

)2

21

3E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.18

0.6

0-0

.29

.0

.20

.92

Bre

ast

are

a e

nla

rge

me

nt o

r te

nd

ern

ess

(S

)2

11

5P

rost

ate

Ga

stro

inte

stin

al

0.1

10

.40

0.2

7.

0.1

50

.92

Bre

ast

are

a e

nla

rge

me

nt o

r te

nd

ern

ess

(S

)2

21

1P

hys

ica

l Fu

nct

ion

ing

-0.0

30

.62

0.9

2B

rea

st a

rea

en

larg

em

en

t or

ten

de

rne

ss (

S)

22

11

Ro

le F

un

ctio

nin

g-0

.12

0.0

70

.92

Bre

ast

are

a e

nla

rge

me

nt o

r te

nd

ern

ess

(S

)2

21

0E

mo

tion

al F

un

ctio

nin

g0

.14

0.0

40

.63

Bre

ast

are

a e

nla

rge

me

nt o

r te

nd

ern

ess

(S

)2

21

0C

og

niti

ve F

un

ctio

nin

g0

.18

0.0

08

0.1

4B

rea

st a

rea

en

larg

em

en

t or

ten

de

rne

ss (

S)

22

09

So

cia

l Fu

nct

ion

ing

-0.0

30

.66

0.9

2B

rea

st a

rea

en

larg

em

en

t or

ten

de

rne

ss (

S)

22

10

Glo

ba

l He

alth

Sta

tus/

Qo

L-0

.01

0.9

20

.92

Bre

ast

are

a e

nla

rge

me

nt o

r te

nd

ern

ess

(S

)2

20

7H

RQ

OL

Su

mm

ary

Sco

re-0

.01

0.9

10

.92

Bru

ise

ea

sily

(P

)1

31

6E

CO

G P

S 2

-4E

CO

G P

S 0

-11

7.5

1%

0.3

6.

0.0

08

0.1

2B

ruis

e e

asi

ly (

P)

13

08

Ph

ysic

al F

un

ctio

nin

g0

.04

0.4

80

.57

Bru

ise

ea

sily

(P

)1

30

8R

ole

Fu

nct

ion

ing

0.0

70

.21

0.5

7B

ruis

e e

asi

ly (

P)

13

08

Em

otio

na

l Fu

nct

ion

ing

0.1

20

.04

0.5

7B

ruis

e e

asi

ly (

P)

13

08

Co

gn

itive

Fu

nct

ion

ing

0.1

70

.00

30

.06

Bru

ise

ea

sily

(P

)1

30

8S

oci

al F

un

ctio

nin

g0

.03

0.5

50

.57

Bru

ise

ea

sily

(P

)1

30

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

50

.41

0.5

7B

ruis

e e

asi

ly (

P)

13

05

HR

QO

L S

um

ma

ry S

core

0.0

90

.12

0.5

7B

ruis

e e

asi

ly (

P)

22

78

EC

OG

PS

2-4

EC

OG

PS

0-1

9.0

8%

0.1

9.

0.2

10

.57

Bru

ise

ea

sily

(P

)2

27

3P

hys

ica

l Fu

nct

ion

ing

0.0

80

.19

0.5

7B

ruis

e e

asi

ly (

P)

22

73

Ro

le F

un

ctio

nin

g0

.08

0.1

90

.57

Bru

ise

ea

sily

(P

)2

27

1E

mo

tion

al F

un

ctio

nin

g0

.11

0.0

60

.57

Bru

ise

ea

sily

(P

)2

27

1C

og

niti

ve F

un

ctio

nin

g0

.09

0.1

50

.57

Bru

ise

ea

sily

(P

)2

27

1S

oci

al F

un

ctio

nin

g0

.03

0.5

70

.57

Bru

ise

ea

sily

(P

)2

27

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

60

.31

0.5

7B

ruis

e e

asi

ly (

P)

22

70

HR

QO

L S

um

ma

ry S

core

0.1

00

.09

0.5

7C

ha

ng

e in

the

co

lor

of f

ing

ern

ails

/toe

na

ils (

P)

14

83

EC

OG

PS

2-4

EC

OG

PS

0-1

-6.8

1%

-0.1

9.

0.2

0.7

1C

ha

ng

e in

the

co

lor

of f

ing

ern

ails

/toe

na

ils (

P)

14

68

Ph

ysic

al F

un

ctio

nin

g0

.07

0.1

30

.71

Ch

an

ge

in th

e c

olo

r o

f fin

ge

rna

ils/to

en

ails

(P

)1

46

8R

ole

Fu

nct

ion

ing

0.0

50

.28

0.7

1C

ha

ng

e in

the

co

lor

of f

ing

ern

ails

/toe

na

ils (

P)

14

68

Em

otio

na

l Fu

nct

ion

ing

0.0

20

.71

0.7

1C

ha

ng

e in

the

co

lor

of f

ing

ern

ails

/toe

na

ils (

P)

14

68

Co

gn

itive

Fu

nct

ion

ing

0.1

20

.00

80

.14

Ch

an

ge

in th

e c

olo

r o

f fin

ge

rna

ils/to

en

ails

(P

)1

46

8S

oci

al F

un

ctio

nin

g0

.11

0.0

20

.34

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 16: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

16

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eC

ha

ng

e in

the

co

lor

of f

ing

ern

ails

/toe

na

ils (

P)

14

68

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.08

0.0

90

.71

Ch

an

ge

in th

e c

olo

r o

f fin

ge

rna

ils/to

en

ails

(P

)1

46

5H

RQ

OL

Su

mm

ary

Sco

re0

.10

0.0

40

.51

Ch

an

ge

in th

e c

olo

r o

f fin

ge

rna

ils/to

en

ails

(P

)2

44

1E

CO

G P

S 2

-4E

CO

G P

S 0

-1-6

.96

%-0

.19

.0

.26

0.7

1C

ha

ng

e in

the

co

lor

of f

ing

ern

ails

/toe

na

ils (

P)

24

24

Ph

ysic

al F

un

ctio

nin

g0

.09

0.0

60

.71

Ch

an

ge

in th

e c

olo

r o

f fin

ge

rna

ils/to

en

ails

(P

)2

42

4R

ole

Fu

nct

ion

ing

0.0

30

.51

0.7

1C

ha

ng

e in

the

co

lor

of f

ing

ern

ails

/toe

na

ils (

P)

24

23

Em

otio

na

l Fu

nct

ion

ing

0.0

20

.66

0.7

1C

ha

ng

e in

the

co

lor

of f

ing

ern

ails

/toe

na

ils (

P)

24

23

Co

gn

itive

Fu

nct

ion

ing

0.0

90

.07

0.7

1C

ha

ng

e in

the

co

lor

of f

ing

ern

ails

/toe

na

ils (

P)

24

22

So

cia

l Fu

nct

ion

ing

0.0

70

.15

0.7

1C

ha

ng

e in

the

co

lor

of f

ing

ern

ails

/toe

na

ils (

P)

24

23

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.10

0.0

40

.51

Ch

an

ge

in th

e c

olo

r o

f fin

ge

rna

ils/to

en

ails

(P

)2

41

6H

RQ

OL

Su

mm

ary

Sco

re0

.07

0.1

40

.71

Co

nst

ipa

tion

(S

)1

84

7E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.47

1.1

10

.42

.<

0.0

01

<0

.00

1C

on

stip

atio

n (

S)

18

47

La

xativ

e in

prio

r w

ee

kO

the

r1

.03

1.0

21

.01

.<

0.0

01

<0

.00

1C

on

stip

atio

n (

S)

18

47

Op

ioid

[na

rco

tic] p

ain

me

d in

prio

r w

ee

kO

the

r0

.57

1.0

90

.52

.<

0.0

01

<0

.00

1C

on

stip

atio

n (

S)

18

47

Su

rge

ry in

prio

r 2

we

eks

Oth

er

0.5

61

.12

0.5

0.

0.0

05

0.0

1C

on

stip

atio

n (

S)

18

31

Ph

ysic

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Co

nst

ipa

tion

(S

)1

83

1R

ole

Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1C

on

stip

atio

n (

S)

18

27

Em

otio

na

l Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1C

on

stip

atio

n (

S)

18

27

Co

gn

itive

Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1C

on

stip

atio

n (

S)

18

27

So

cia

l Fu

nct

ion

ing

0.2

5<

0.0

01

<0

.00

1C

on

stip

atio

n (

S)

18

27

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.25

<0

.00

1<

0.0

01

Co

nst

ipa

tion

(S

)1

82

5H

RQ

OL

Su

mm

ary

Sco

re0

.42

<0

.00

1<

0.0

01

Co

nst

ipa

tion

(S

)1

83

0C

on

stip

atio

n0

.76

<0

.00

1<

0.0

01

Co

nst

ipa

tion

(S

)2

78

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.31

1.1

20

.28

.0

.00

40

.01

Co

nst

ipa

tion

(S

)2

78

2L

axa

tive

in p

rior

we

ek

Oth

er

1.0

21

.02

0.9

9.

<0

.00

1<

0.0

01

Co

nst

ipa

tion

(S

)2

78

2O

pio

id [n

arc

otic

] pa

in m

ed

in p

rior

we

ek

Oth

er

0.5

11

.10

0.4

6.

<0

.00

1<

0.0

01

Co

nst

ipa

tion

(S

)2

78

2S

urg

ery

in p

rior

2 w

ee

ksO

the

r0

.36

1.1

30

.32

.0

.13

0.1

3C

on

stip

atio

n (

S)

27

60

Ph

ysic

al F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Co

nst

ipa

tion

(S

)2

76

0R

ole

Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1C

on

stip

atio

n (

S)

27

58

Em

otio

na

l Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1C

on

stip

atio

n (

S)

27

58

Co

gn

itive

Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1C

on

stip

atio

n (

S)

27

57

So

cia

l Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1C

on

stip

atio

n (

S)

27

58

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.30

<0

.00

1<

0.0

01

Co

nst

ipa

tion

(S

)2

75

1H

RQ

OL

Su

mm

ary

Sco

re0

.46

<0

.00

1<

0.0

01

Co

nst

ipa

tion

(S

)2

76

0C

on

stip

atio

n0

.80

<0

.00

1<

0.0

01

Co

ug

h (

S)

14

55

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

60

.90

0.4

0.

0.0

03

0.0

1C

ou

gh

(S

)1

45

5C

urr

en

tly u

sin

g a

n in

ha

ler

Oth

er

0.6

50

.88

0.7

4.

<0

.00

1<

0.0

01

Co

ug

h (

S)

13

64

Lu

ng

/He

ad

/Ne

ckP

rost

ate

/Bla

dd

er

0.4

00

.91

0.4

4.

<0

.00

10

.00

2C

ou

gh

(S

)1

44

5P

hys

ica

l Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1C

ou

gh

(S

)1

44

5R

ole

Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1C

ou

gh

(S

)1

44

2E

mo

tion

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Co

ug

h (

S)

14

42

Co

gn

itive

Fu

nct

ion

ing

0.2

1<

0.0

01

<0

.00

1C

ou

gh

(S

)1

44

2S

oci

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Co

ug

h (

S)

14

42

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.25

<0

.00

1<

0.0

01

Co

ug

h (

S)

14

39

HR

QO

L S

um

ma

ry S

core

0.3

6<

0.0

01

<0

.00

1C

ou

gh

(S

)2

40

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.19

0.8

70

.22

.0

.15

0.1

5C

ou

gh

(S

)2

40

8C

urr

en

tly u

sin

g a

n in

ha

ler

Oth

er

0.4

50

.85

0.5

3.

<0

.00

10

.00

1C

ou

gh

(S

)2

32

7L

un

g/H

ea

d/N

eck

Pro

sta

te/B

lad

de

r0

.29

0.8

60

.34

.0

.00

80

.03

Co

ug

h (

S)

24

01

Ph

ysic

al F

un

ctio

nin

g0

.27

<0

.00

1<

0.0

01

Co

ug

h (

S)

24

01

Ro

le F

un

ctio

nin

g0

.26

<0

.00

1<

0.0

01

Co

ug

h (

S)

23

98

Em

otio

na

l Fu

nct

ion

ing

0.1

20

.01

0.0

3C

ou

gh

(S

)2

39

8C

og

niti

ve F

un

ctio

nin

g0

.15

0.0

03

0.0

1C

ou

gh

(S

)2

39

7S

oci

al F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

Co

ug

h (

S)

23

98

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.19

<0

.00

10

.00

1C

ou

gh

(S

)2

39

4H

RQ

OL

Su

mm

ary

Sco

re0

.33

<0

.00

1<

0.0

01

Co

ug

h (

I)1

45

5E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.31

0.8

60

.36

.0

.00

70

.00

7C

ou

gh

(I)

14

55

Cu

rre

ntly

usi

ng

an

inh

ale

rO

the

r0

.38

0.8

60

.44

.<

0.0

01

0.0

06

Co

ug

h (

I)1

36

4L

un

g/H

ea

d/N

eck

Pro

sta

te/B

lad

de

r0

.33

0.8

70

.38

.0

.00

20

.00

7C

ou

gh

(I)

14

45

Ph

ysic

al F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Co

ug

h (

I)1

44

5R

ole

Fu

nct

ion

ing

0.2

0<

0.0

01

<0

.00

1C

ou

gh

(I)

14

42

Em

otio

na

l Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1C

ou

gh

(I)

14

42

Co

gn

itive

Fu

nct

ion

ing

0.1

6<

0.0

01

0.0

06

Co

ug

h (

I)1

44

2S

oci

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Co

ug

h (

I)1

44

2G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

50

.00

10

.00

7C

ou

gh

(I)

14

39

HR

QO

L S

um

ma

ry S

core

0.3

0<

0.0

01

<0

.00

1C

ou

gh

(I)

24

08

EC

OG

PS

2-4

EC

OG

PS

0-1

0.4

30

.86

0.5

0.

<0

.00

10

.00

6C

ou

gh

(I)

24

08

Cu

rre

ntly

usi

ng

an

inh

ale

rO

the

r0

.33

0.8

60

.38

.0

.00

70

.00

7C

ou

gh

(I)

23

27

Lu

ng

/He

ad

/Ne

ckP

rost

ate

/Bla

dd

er

0.3

80

.85

0.4

4.

<0

.00

10

.00

6C

ou

gh

(I)

24

01

Ph

ysic

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Co

ug

h (

I)2

40

1R

ole

Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1C

ou

gh

(I)

23

98

Em

otio

na

l Fu

nct

ion

ing

0.1

8<

0.0

01

0.0

03

Co

ug

h (

I)2

39

8C

og

niti

ve F

un

ctio

nin

g0

.14

0.0

07

0.0

07

Co

ug

h (

I)2

39

7S

oci

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Co

ug

h (

I)2

39

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

7<

0.0

01

0.0

06

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 17: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

17

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eC

ou

gh

(I)

23

94

HR

QO

L S

um

ma

ry S

core

0.3

6<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(S

)1

84

1E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.69

1.1

20

.61

.<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(S

)1

84

1C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

0.4

21

.13

0.3

7.

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

S)

18

25

Ph

ysic

al F

un

ctio

nin

g0

.37

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

S)

18

25

Ro

le F

un

ctio

nin

g0

.41

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

S)

18

22

Em

otio

na

l Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(S

)1

82

2C

og

niti

ve F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

S)

18

22

So

cia

l Fu

nct

ion

ing

0.4

1<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(S

)1

82

2G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

8<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(S

)1

82

0H

RQ

OL

Su

mm

ary

Sco

re0

.58

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

S)

18

25

Ap

pe

tite

Lo

ss0

.79

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

S)

27

78

EC

OG

PS

2-4

EC

OG

PS

0-1

0.6

11

.12

0.5

4.

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

S)

27

78

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.21

1.1

40

.18

.0

.01

0.0

1D

ecr

ea

sed

ap

pe

tite

(S

)2

75

6P

hys

ica

l Fu

nct

ion

ing

0.4

1<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(S

)2

75

6R

ole

Fu

nct

ion

ing

0.4

2<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(S

)2

75

4E

mo

tion

al F

un

ctio

nin

g0

.33

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

S)

27

54

Co

gn

itive

Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(S

)2

75

3S

oci

al F

un

ctio

nin

g0

.45

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

S)

27

54

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.41

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

S)

27

47

HR

QO

L S

um

ma

ry S

core

0.6

2<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(S

)2

75

5A

pp

etit

e L

oss

0.8

2<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(I)

18

40

EC

OG

PS

2-4

EC

OG

PS

0-1

0.5

81

.09

0.5

3.

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

I)1

84

0C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

0.4

21

.09

0.3

8.

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

I)1

82

4P

hys

ica

l Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(I)

18

24

Ro

le F

un

ctio

nin

g0

.41

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

I)1

82

1E

mo

tion

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

I)1

82

1C

og

niti

ve F

un

ctio

nin

g0

.26

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

I)1

82

1S

oci

al F

un

ctio

nin

g0

.44

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

I)1

82

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

6<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(I)

18

19

HR

QO

L S

um

ma

ry S

core

0.5

6<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(I)

18

24

Ap

pe

tite

Lo

ss0

.69

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

I)2

77

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.57

1.0

80

.52

.<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(I)

27

78

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.08

1.1

00

.07

.0

.33

0.3

3D

ecr

ea

sed

ap

pe

tite

(I)

27

56

Ph

ysic

al F

un

ctio

nin

g0

.44

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

I)2

75

6R

ole

Fu

nct

ion

ing

0.4

4<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(I)

27

54

Em

otio

na

l Fu

nct

ion

ing

0.3

4<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(I)

27

54

Co

gn

itive

Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(I)

27

53

So

cia

l Fu

nct

ion

ing

0.4

5<

0.0

01

<0

.00

1D

ecr

ea

sed

ap

pe

tite

(I)

27

54

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.39

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

I)2

74

7H

RQ

OL

Su

mm

ary

Sco

re0

.57

<0

.00

1<

0.0

01

De

cre

ase

d a

pp

etit

e (

I)2

75

5A

pp

etit

e L

oss

0.6

8<

0.0

01

<0

.00

1D

ecr

ea

sed

se

xua

l in

tere

st (

S)

13

21

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

01

.46

0.0

7.

0.7

40

.95

De

cre

ase

d s

exu

al i

nte

rest

(S

)1

31

3P

hys

ica

l Fu

nct

ion

ing

0.1

60

.00

50

.04

De

cre

ase

d s

exu

al i

nte

rest

(S

)1

31

3R

ole

Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1D

ecr

ea

sed

se

xua

l in

tere

st (

S)

13

13

Em

otio

na

l Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1D

ecr

ea

sed

se

xua

l in

tere

st (

S)

13

13

Co

gn

itive

Fu

nct

ion

ing

0.2

0<

0.0

01

0.0

05

De

cre

ase

d s

exu

al i

nte

rest

(S

)1

31

3S

oci

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

De

cre

ase

d s

exu

al i

nte

rest

(S

)1

31

3G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

2<

0.0

01

0.0

01

De

cre

ase

d s

exu

al i

nte

rest

(S

)1

31

1H

RQ

OL

Su

mm

ary

Sco

re0

.32

<0

.00

1<

0.0

01

De

cre

ase

d s

exu

al i

nte

rest

(S

)2

29

5E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.02

1.4

00

.01

.0

.95

0.9

5D

ecr

ea

sed

se

xua

l in

tere

st (

S)

22

82

Ph

ysic

al F

un

ctio

nin

g0

.14

0.0

20

.11

De

cre

ase

d s

exu

al i

nte

rest

(S

)2

28

2R

ole

Fu

nct

ion

ing

0.1

30

.03

0.1

3D

ecr

ea

sed

se

xua

l in

tere

st (

S)

22

83

Em

otio

na

l Fu

nct

ion

ing

0.0

50

.42

0.9

5D

ecr

ea

sed

se

xua

l in

tere

st (

S)

22

83

Co

gn

itive

Fu

nct

ion

ing

0.1

10

.06

0.2

6D

ecr

ea

sed

se

xua

l in

tere

st (

S)

22

82

So

cia

l Fu

nct

ion

ing

0.1

90

.00

20

.01

De

cre

ase

d s

exu

al i

nte

rest

(S

)2

28

3G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

0<

0.0

01

0.0

06

De

cre

ase

d s

exu

al i

nte

rest

(S

)2

27

7H

RQ

OL

Su

mm

ary

Sco

re0

.21

<0

.00

10

.00

5D

iffic

ulty

ge

ttin

g o

r ke

ep

ing

an

ere

ctio

n (

S)

14

5E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.15

1.5

40

.10

.0

.84

0.8

8D

iffic

ulty

ge

ttin

g o

r ke

ep

ing

an

ere

ctio

n (

S)

14

5P

hys

ica

l Fu

nct

ion

ing

0.1

40

.36

0.8

8D

iffic

ulty

ge

ttin

g o

r ke

ep

ing

an

ere

ctio

n (

S)

14

5R

ole

Fu

nct

ion

ing

0.2

00

.19

0.8

8D

iffic

ulty

ge

ttin

g o

r ke

ep

ing

an

ere

ctio

n (

S)

14

5E

mo

tion

al F

un

ctio

nin

g0

.20

0.1

90

.88

Diff

icu

lty g

etti

ng

or

kee

pin

g a

n e

rect

ion

(S

)1

45

Co

gn

itive

Fu

nct

ion

ing

0.1

90

.21

0.8

8D

iffic

ulty

ge

ttin

g o

r ke

ep

ing

an

ere

ctio

n (

S)

14

5S

oci

al F

un

ctio

nin

g0

.30

0.0

40

.7D

iffic

ulty

ge

ttin

g o

r ke

ep

ing

an

ere

ctio

n (

S)

14

5G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

70

.26

0.8

8D

iffic

ulty

ge

ttin

g o

r ke

ep

ing

an

ere

ctio

n (

S)

14

5H

RQ

OL

Su

mm

ary

Sco

re0

.22

0.1

40

.88

Diff

icu

lty g

etti

ng

or

kee

pin

g a

n e

rect

ion

(S

)2

40

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.2

71

.44

-0.1

9.

0.7

60

.88

Diff

icu

lty g

etti

ng

or

kee

pin

g a

n e

rect

ion

(S

)2

40

Ph

ysic

al F

un

ctio

nin

g0

.22

0.1

70

.88

Diff

icu

lty g

etti

ng

or

kee

pin

g a

n e

rect

ion

(S

)2

40

Ro

le F

un

ctio

nin

g0

.29

0.0

70

.88

Diff

icu

lty g

etti

ng

or

kee

pin

g a

n e

rect

ion

(S

)2

39

Em

otio

na

l Fu

nct

ion

ing

-0.0

40

.79

0.8

8D

iffic

ulty

ge

ttin

g o

r ke

ep

ing

an

ere

ctio

n (

S)

23

9C

og

niti

ve F

un

ctio

nin

g0

.18

0.2

70

.88

Diff

icu

lty g

etti

ng

or

kee

pin

g a

n e

rect

ion

(S

)2

39

So

cia

l Fu

nct

ion

ing

0.2

50

.13

0.8

8D

iffic

ulty

ge

ttin

g o

r ke

ep

ing

an

ere

ctio

n (

S)

23

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

30

.88

0.8

8D

iffic

ulty

ge

ttin

g o

r ke

ep

ing

an

ere

ctio

n (

S)

23

9H

RQ

OL

Su

mm

ary

Sco

re0

.19

0.2

40

.88

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 18: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

18

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eD

iffic

ulty

sw

allo

win

g (

S)

12

54

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

91

.01

0.1

9.

0.2

80

.55

Diff

icu

lty s

wa

llow

ing

(S

)1

25

4H

ea

d/N

eck

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

Oth

er

0.6

10

.97

0.6

3.

<0

.00

1<

0.0

01

Diff

icu

lty s

wa

llow

ing

(S

)1

25

0P

hys

ica

l Fu

nct

ion

ing

0.1

40

.03

0.1

3D

iffic

ulty

sw

allo

win

g (

S)

12

50

Ro

le F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Diff

icu

lty s

wa

llow

ing

(S

)1

24

7E

mo

tion

al F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Diff

icu

lty s

wa

llow

ing

(S

)1

24

7C

og

niti

ve F

un

ctio

nin

g0

.18

0.0

05

0.0

3D

iffic

ulty

sw

allo

win

g (

S)

12

47

So

cia

l Fu

nct

ion

ing

0.2

4<

0.0

01

0.0

01

Diff

icu

lty s

wa

llow

ing

(S

)1

24

7G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

2<

0.0

01

<0

.00

1D

iffic

ulty

sw

allo

win

g (

S)

12

45

HR

QO

L S

um

ma

ry S

core

0.3

6<

0.0

01

<0

.00

1D

iffic

ulty

sw

allo

win

g (

S)

22

23

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

11

.02

0.0

1.

0.9

50

.95

Diff

icu

lty s

wa

llow

ing

(S

)2

22

3H

ea

d/N

eck

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

Oth

er

0.8

60

.93

0.9

3.

<0

.00

1<

0.0

01

Diff

icu

lty s

wa

llow

ing

(S

)2

22

1P

hys

ica

l Fu

nct

ion

ing

0.1

60

.02

0.0

8D

iffic

ulty

sw

allo

win

g (

S)

22

21

Ro

le F

un

ctio

nin

g0

.30

<0

.00

1<

0.0

01

Diff

icu

lty s

wa

llow

ing

(S

)2

22

1E

mo

tion

al F

un

ctio

nin

g0

.23

<0

.00

10

.00

4D

iffic

ulty

sw

allo

win

g (

S)

22

21

Co

gn

itive

Fu

nct

ion

ing

0.1

30

.06

0.1

7D

iffic

ulty

sw

allo

win

g (

S)

22

21

So

cia

l Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1D

iffic

ulty

sw

allo

win

g (

S)

22

21

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.32

<0

.00

1<

0.0

01

Diff

icu

lty s

wa

llow

ing

(S

)2

22

1H

RQ

OL

Su

mm

ary

Sco

re0

.37

<0

.00

1<

0.0

01

Diz

zin

ess

(S

)1

41

1E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.40

0.7

10

.56

.<

0.0

01

<0

.00

1D

izzi

ne

ss (

S)

13

96

Ph

ysic

al F

un

ctio

nin

g0

.36

<0

.00

1<

0.0

01

Diz

zin

ess

(S

)1

39

6R

ole

Fu

nct

ion

ing

0.3

7<

0.0

01

<0

.00

1D

izzi

ne

ss (

S)

13

96

Em

otio

na

l Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1D

izzi

ne

ss (

S)

13

96

Co

gn

itive

Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1D

izzi

ne

ss (

S)

13

96

So

cia

l Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1D

izzi

ne

ss (

S)

13

96

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.34

<0

.00

1<

0.0

01

Diz

zin

ess

(S

)1

39

3H

RQ

OL

Su

mm

ary

Sco

re0

.49

<0

.00

1<

0.0

01

Diz

zin

ess

(S

)2

37

3E

CO

G P

S 2

-4E

CO

G P

S 0

-10

0.6

90

.0

.98

0.9

8D

izzi

ne

ss (

S)

23

57

Ph

ysic

al F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Diz

zin

ess

(S

)2

35

7R

ole

Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1D

izzi

ne

ss (

S)

23

57

Em

otio

na

l Fu

nct

ion

ing

0.3

7<

0.0

01

<0

.00

1D

izzi

ne

ss (

S)

23

57

Co

gn

itive

Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1D

izzi

ne

ss (

S)

23

57

So

cia

l Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1D

izzi

ne

ss (

S)

23

57

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.27

<0

.00

1<

0.0

01

Diz

zin

ess

(S

)2

35

3H

RQ

OL

Su

mm

ary

Sco

re0

.44

<0

.00

1<

0.0

01

Diz

zin

ess

(I)

14

11

EC

OG

PS

2-4

EC

OG

PS

0-1

0.4

10

.73

0.5

5.

<0

.00

1<

0.0

01

Diz

zin

ess

(I)

13

96

Ph

ysic

al F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Diz

zin

ess

(I)

13

96

Ro

le F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Diz

zin

ess

(I)

13

96

Em

otio

na

l Fu

nct

ion

ing

0.3

9<

0.0

01

<0

.00

1D

izzi

ne

ss (

I)1

39

6C

og

niti

ve F

un

ctio

nin

g0

.30

<0

.00

1<

0.0

01

Diz

zin

ess

(I)

13

96

So

cia

l Fu

nct

ion

ing

0.3

8<

0.0

01

<0

.00

1D

izzi

ne

ss (

I)1

39

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

1<

0.0

01

<0

.00

1D

izzi

ne

ss (

I)1

39

3H

RQ

OL

Su

mm

ary

Sco

re0

.49

<0

.00

1<

0.0

01

Diz

zin

ess

(I)

23

73

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.0

20

.73

-0.0

3.

0.8

50

.85

Diz

zin

ess

(I)

23

57

Ph

ysic

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Diz

zin

ess

(I)

23

57

Ro

le F

un

ctio

nin

g0

.37

<0

.00

1<

0.0

01

Diz

zin

ess

(I)

23

57

Em

otio

na

l Fu

nct

ion

ing

0.3

9<

0.0

01

<0

.00

1D

izzi

ne

ss (

I)2

35

7C

og

niti

ve F

un

ctio

nin

g0

.32

<0

.00

1<

0.0

01

Diz

zin

ess

(I)

23

57

So

cia

l Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1D

izzi

ne

ss (

I)2

35

7G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

6<

0.0

01

<0

.00

1D

izzi

ne

ss (

I)2

35

3H

RQ

OL

Su

mm

ary

Sco

re0

.46

<0

.00

1<

0.0

01

Dry

mo

uth

(S

)1

84

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.66

1.0

30

.64

.<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

18

42

He

ad

/Ne

ck w

ith r

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r0

.46

1.0

50

.44

.<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

18

26

Ph

ysic

al F

un

ctio

nin

g0

.36

<0

.00

1<

0.0

01

Dry

mo

uth

(S

)1

82

6R

ole

Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

18

23

Em

otio

na

l Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

18

23

Co

gn

itive

Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

18

23

So

cia

l Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

18

23

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.30

<0

.00

1<

0.0

01

Dry

mo

uth

(S

)1

82

1H

RQ

OL

Su

mm

ary

Sco

re0

.47

<0

.00

1<

0.0

01

Dry

mo

uth

(S

)2

78

0E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.49

1.0

30

.47

.<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

27

80

He

ad

/Ne

ck w

ith r

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r0

.69

1.0

10

.68

.<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

27

58

Ph

ysic

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Dry

mo

uth

(S

)2

75

8R

ole

Fu

nct

ion

ing

0.3

4<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

27

56

Em

otio

na

l Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

27

56

Co

gn

itive

Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

27

55

So

cia

l Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1D

ry m

ou

th (

S)

27

56

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.36

<0

.00

1<

0.0

01

Dry

mo

uth

(S

)2

74

9H

RQ

OL

Su

mm

ary

Sco

re0

.47

<0

.00

1<

0.0

01

Dry

ski

n (

S)

14

11

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

10

.91

0.0

1.

0.9

30

.93

Dry

ski

n (

S)

13

96

Ph

ysic

al F

un

ctio

nin

g0

.22

<0

.00

1<

0.0

01

Dry

ski

n (

S)

13

96

Ro

le F

un

ctio

nin

g0

.18

<0

.00

10

.00

2D

ry s

kin

(S

)1

39

6E

mo

tion

al F

un

ctio

nin

g0

.15

0.0

02

0.0

06

Dry

ski

n (

S)

13

96

Co

gn

itive

Fu

nct

ion

ing

0.1

8<

0.0

01

0.0

01

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 19: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

19

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eD

ry s

kin

(S

)1

39

6S

oci

al F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

Dry

ski

n (

S)

13

96

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.22

<0

.00

1<

0.0

01

Dry

ski

n (

S)

13

93

HR

QO

L S

um

ma

ry S

core

0.2

5<

0.0

01

<0

.00

1D

ry s

kin

(S

)2

37

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.13

0.9

10

.14

.0

.38

0.7

7D

ry s

kin

(S

)2

35

8P

hys

ica

l Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1D

ry s

kin

(S

)2

35

8R

ole

Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1D

ry s

kin

(S

)2

35

8E

mo

tion

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Dry

ski

n (

S)

23

58

Co

gn

itive

Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1D

ry s

kin

(S

)2

35

8S

oci

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Dry

ski

n (

S)

23

58

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.26

<0

.00

1<

0.0

01

Dry

ski

n (

S)

23

54

HR

QO

L S

um

ma

ry S

core

0.3

7<

0.0

01

<0

.00

1E

jacu

latio

n p

rob

lem

s (F

)1

75

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.7

71

.68

-0.4

6.

0.2

90

.96

Eja

cula

tion

pro

ble

ms

(F)

17

5P

hys

ica

l Fu

nct

ion

ing

0.2

00

.08

0.9

6E

jacu

latio

n p

rob

lem

s (F

)1

75

Ro

le F

un

ctio

nin

g0

.26

0.0

20

.35

Eja

cula

tion

pro

ble

ms

(F)

17

5E

mo

tion

al F

un

ctio

nin

g0

.09

0.4

50

.96

Eja

cula

tion

pro

ble

ms

(F)

17

5C

og

niti

ve F

un

ctio

nin

g-0

.01

0.9

60

.96

Eja

cula

tion

pro

ble

ms

(F)

17

5S

oci

al F

un

ctio

nin

g0

.18

0.1

30

.96

Eja

cula

tion

pro

ble

ms

(F)

17

5G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

10

.34

0.9

6E

jacu

latio

n p

rob

lem

s (F

)1

75

HR

QO

L S

um

ma

ry S

core

0.1

40

.24

0.9

6E

jacu

latio

n p

rob

lem

s (F

)2

61

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.9

81

.59

-0.6

2.

0.1

90

.96

Eja

cula

tion

pro

ble

ms

(F)

26

1P

hys

ica

l Fu

nct

ion

ing

0.2

70

.04

0.5

4E

jacu

latio

n p

rob

lem

s (F

)2

61

Ro

le F

un

ctio

nin

g0

.26

0.0

46

0.6

4E

jacu

latio

n p

rob

lem

s (F

)2

60

Em

otio

na

l Fu

nct

ion

ing

0.1

10

.42

0.9

6E

jacu

latio

n p

rob

lem

s (F

)2

60

Co

gn

itive

Fu

nct

ion

ing

0.1

00

.44

0.9

6E

jacu

latio

n p

rob

lem

s (F

)2

60

So

cia

l Fu

nct

ion

ing

0.1

60

.22

0.9

6E

jacu

latio

n p

rob

lem

s (F

)2

60

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.08

0.5

30

.96

Eja

cula

tion

pro

ble

ms

(F)

25

9H

RQ

OL

Su

mm

ary

Sco

re0

.22

0.1

0.9

6F

atig

ue

(S

)1

87

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.76

1.0

30

.74

.<

0.0

01

<0

.00

1F

atig

ue

(S

)1

87

8C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

0.1

71

.06

0.1

6.

0.0

20

.1F

atig

ue

(S

)1

87

8C

urr

en

tly ta

kin

g a

nxi

ety

me

dO

the

r0

.38

1.0

50

.36

.<

0.0

01

<0

.00

1F

atig

ue

(S

)1

87

8R

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r0

.02

1.0

70

.02

.0

.81

0.8

9F

atig

ue

(S

)1

87

8S

lee

p a

id in

prio

r w

ee

kO

the

r0

.39

1.0

50

.37

.<

0.0

01

<0

.00

1F

atig

ue

(S

)1

87

8S

urg

ery

in p

rior

2 w

ee

ksO

the

r-0

.03

1.0

7-0

.02

.0

.89

0.8

9F

atig

ue

(S

)1

86

1P

hys

ica

l Fu

nct

ion

ing

0.5

9<

0.0

01

<0

.00

1F

atig

ue

(S

)1

86

1R

ole

Fu

nct

ion

ing

0.6

0<

0.0

01

<0

.00

1F

atig

ue

(S

)1

85

8E

mo

tion

al F

un

ctio

nin

g0

.46

<0

.00

1<

0.0

01

Fa

tigu

e (

S)

18

58

Co

gn

itive

Fu

nct

ion

ing

0.4

6<

0.0

01

<0

.00

1F

atig

ue

(S

)1

85

8S

oci

al F

un

ctio

nin

g0

.53

<0

.00

1<

0.0

01

Fa

tigu

e (

S)

18

58

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.56

<0

.00

1<

0.0

01

Fa

tigu

e (

S)

18

55

HR

QO

L S

um

ma

ry S

core

0.7

2<

0.0

01

<0

.00

1F

atig

ue

(S

)1

86

1F

atig

ue

0.7

6<

0.0

01

<0

.00

1F

atig

ue

(S

)2

81

3E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.63

1.0

00

.63

.<

0.0

01

<0

.00

1F

atig

ue

(S

)2

81

3C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

0.0

81

.02

0.0

8.

0.2

80

.89

Fa

tigu

e (

S)

28

13

Cu

rre

ntly

taki

ng

an

xie

ty m

ed

Oth

er

0.2

51

.02

0.2

4.

0.0

03

0.0

2F

atig

ue

(S

)2

81

3R

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r0

.02

1.0

30

.02

.0

.81

0.8

9F

atig

ue

(S

)2

81

3S

lee

p a

id in

prio

r w

ee

kO

the

r0

.48

1.0

10

.47

.<

0.0

01

<0

.00

1F

atig

ue

(S

)2

81

3S

urg

ery

in p

rior

2 w

ee

ksO

the

r0

.31

1.0

20

.30

.0

.15

0.7

6F

atig

ue

(S

)2

79

0P

hys

ica

l Fu

nct

ion

ing

0.6

0<

0.0

01

<0

.00

1F

atig

ue

(S

)2

79

0R

ole

Fu

nct

ion

ing

0.5

9<

0.0

01

<0

.00

1F

atig

ue

(S

)2

78

8E

mo

tion

al F

un

ctio

nin

g0

.43

<0

.00

1<

0.0

01

Fa

tigu

e (

S)

27

88

Co

gn

itive

Fu

nct

ion

ing

0.4

4<

0.0

01

<0

.00

1F

atig

ue

(S

)2

78

7S

oci

al F

un

ctio

nin

g0

.53

<0

.00

1<

0.0

01

Fa

tigu

e (

S)

27

88

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.55

<0

.00

1<

0.0

01

Fa

tigu

e (

S)

27

81

HR

QO

L S

um

ma

ry S

core

0.6

9<

0.0

01

<0

.00

1F

atig

ue

(S

)2

79

0F

atig

ue

0.7

3<

0.0

01

<0

.00

1F

atig

ue

(I)

18

75

EC

OG

PS

2-4

EC

OG

PS

0-1

0.8

31

.18

0.7

1.

<0

.00

1<

0.0

01

Fa

tigu

e (

I)1

87

5C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

0.2

01

.22

0.1

7.

0.0

10

.09

Fa

tigu

e (

I)1

87

5C

urr

en

tly ta

kin

g a

nxi

ety

me

dO

the

r0

.50

1.2

00

.42

.<

0.0

01

<0

.00

1F

atig

ue

(I)

18

75

Ra

dia

tion

the

rap

y in

prio

r 2

we

eks

Oth

er

0.1

01

.22

0.0

8.

0.2

40

.73

Fa

tigu

e (

I)1

87

5S

lee

p a

id in

prio

r w

ee

kO

the

r0

.47

1.2

10

.39

.<

0.0

01

<0

.00

1F

atig

ue

(I)

18

75

Su

rge

ry in

prio

r 2

we

eks

Oth

er

-0.0

51

.22

-0.0

4.

0.8

20

.82

Fa

tigu

e (

I)1

85

8P

hys

ica

l Fu

nct

ion

ing

0.6

1<

0.0

01

<0

.00

1F

atig

ue

(I)

18

58

Ro

le F

un

ctio

nin

g0

.65

<0

.00

1<

0.0

01

Fa

tigu

e (

I)1

85

5E

mo

tion

al F

un

ctio

nin

g0

.46

<0

.00

1<

0.0

01

Fa

tigu

e (

I)1

85

5C

og

niti

ve F

un

ctio

nin

g0

.44

<0

.00

1<

0.0

01

Fa

tigu

e (

I)1

85

5S

oci

al F

un

ctio

nin

g0

.61

<0

.00

1<

0.0

01

Fa

tigu

e (

I)1

85

5G

lob

al H

ea

lth S

tatu

s/Q

oL

0.5

5<

0.0

01

<0

.00

1F

atig

ue

(I)

18

52

HR

QO

L S

um

ma

ry S

core

0.7

4<

0.0

01

<0

.00

1F

atig

ue

(I)

18

58

Fa

tigu

e0

.74

<0

.00

1<

0.0

01

Fa

tigu

e (

I)2

81

3E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.69

1.1

60

.60

.<

0.0

01

<0

.00

1F

atig

ue

(I)

28

13

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.04

1.1

90

.03

.0

.66

0.8

2F

atig

ue

(I)

28

13

Cu

rre

ntly

taki

ng

an

xie

ty m

ed

Oth

er

0.4

21

.18

0.3

6.

<0

.00

1<

0.0

01

Fa

tigu

e (

I)2

81

3R

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r0

.16

1.1

90

.14

.0

.04

90

.24

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 20: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

20

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eF

atig

ue

(I)

28

13

Sle

ep

aid

in p

rior

we

ek

Oth

er

0.6

51

.16

0.5

6.

<0

.00

1<

0.0

01

Fa

tigu

e (

I)2

81

3S

urg

ery

in p

rior

2 w

ee

ksO

the

r0

.38

1.1

90

.32

.0

.13

0.5

4F

atig

ue

(I)

27

90

Ph

ysic

al F

un

ctio

nin

g0

.59

<0

.00

1<

0.0

01

Fa

tigu

e (

I)2

79

0R

ole

Fu

nct

ion

ing

0.6

3<

0.0

01

<0

.00

1F

atig

ue

(I)

27

88

Em

otio

na

l Fu

nct

ion

ing

0.4

3<

0.0

01

<0

.00

1F

atig

ue

(I)

27

88

Co

gn

itive

Fu

nct

ion

ing

0.4

4<

0.0

01

<0

.00

1F

atig

ue

(I)

27

87

So

cia

l Fu

nct

ion

ing

0.5

9<

0.0

01

<0

.00

1F

atig

ue

(I)

27

88

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.52

<0

.00

1<

0.0

01

Fa

tigu

e (

I)2

78

1H

RQ

OL

Su

mm

ary

Sco

re0

.70

<0

.00

1<

0.0

01

Fa

tigu

e (

I)2

79

0F

atig

ue

0.7

1<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

F)

18

15

EC

OG

PS

2-4

EC

OG

PS

0-1

0.5

20

.94

0.5

5.

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(F

)1

81

5C

urr

en

tly ta

kin

g d

ep

ress

ion

me

dO

the

r0

.49

0.9

50

.52

.<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

F)

17

99

Ph

ysic

al F

un

ctio

nin

g0

.30

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(F

)1

79

9R

ole

Fu

nct

ion

ing

0.3

6<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

F)

17

96

Em

otio

na

l Fu

nct

ion

ing

0.5

7<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

F)

17

96

Co

gn

itive

Fu

nct

ion

ing

0.3

8<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

F)

17

96

So

cia

l Fu

nct

ion

ing

0.3

8<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

F)

17

96

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.38

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(F

)1

79

4H

RQ

OL

Su

mm

ary

Sco

re0

.45

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(F

)2

74

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.51

0.9

40

.54

.<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

F)

27

48

Cu

rre

ntly

taki

ng

de

pre

ssio

n m

ed

Oth

er

0.5

80

.94

0.6

1.

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(F

)2

72

6P

hys

ica

l Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

F)

27

26

Ro

le F

un

ctio

nin

g0

.36

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(F

)2

72

4E

mo

tion

al F

un

ctio

nin

g0

.61

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(F

)2

72

4C

og

niti

ve F

un

ctio

nin

g0

.43

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(F

)2

72

3S

oci

al F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(F

)2

72

4G

lob

al H

ea

lth S

tatu

s/Q

oL

0.4

3<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

F)

27

17

HR

QO

L S

um

ma

ry S

core

0.5

0<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

S)

18

15

EC

OG

PS

2-4

EC

OG

PS

0-1

0.4

40

.86

0.5

2.

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(S

)1

81

5C

urr

en

tly ta

kin

g d

ep

ress

ion

me

dO

the

r0

.45

0.8

60

.52

.<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

S)

17

99

Ph

ysic

al F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(S

)1

79

9R

ole

Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

S)

17

96

Em

otio

na

l Fu

nct

ion

ing

0.5

7<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

S)

17

96

Co

gn

itive

Fu

nct

ion

ing

0.3

6<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

S)

17

96

So

cia

l Fu

nct

ion

ing

0.3

7<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

S)

17

96

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.35

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(S

)1

79

4H

RQ

OL

Su

mm

ary

Sco

re0

.44

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(S

)2

74

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.47

0.8

00

.59

.<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

S)

27

48

Cu

rre

ntly

taki

ng

de

pre

ssio

n m

ed

Oth

er

0.5

10

.79

0.6

5.

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(S

)2

72

6P

hys

ica

l Fu

nct

ion

ing

0.3

7<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

S)

27

26

Ro

le F

un

ctio

nin

g0

.35

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(S

)2

72

4E

mo

tion

al F

un

ctio

nin

g0

.59

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(S

)2

72

4C

og

niti

ve F

un

ctio

nin

g0

.41

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(S

)2

72

3S

oci

al F

un

ctio

nin

g0

.37

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(S

)2

72

4G

lob

al H

ea

lth S

tatu

s/Q

oL

0.4

0<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

S)

27

17

HR

QO

L S

um

ma

ry S

core

0.5

0<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)1

81

5E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.37

0.8

60

.43

.<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)1

81

5C

urr

en

tly ta

kin

g d

ep

ress

ion

me

dO

the

r0

.42

0.8

60

.49

.<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)1

79

9P

hys

ica

l Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)1

79

9R

ole

Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)1

79

6E

mo

tion

al F

un

ctio

nin

g0

.54

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(I)

17

96

Co

gn

itive

Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)1

79

6S

oci

al F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(I)

17

96

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.35

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(I)

17

94

HR

QO

L S

um

ma

ry S

core

0.4

2<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)2

74

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.50

0.8

20

.61

.<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)2

74

8C

urr

en

tly ta

kin

g d

ep

ress

ion

me

dO

the

r0

.52

0.8

20

.64

.<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)2

72

6P

hys

ica

l Fu

nct

ion

ing

0.3

9<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)2

72

6R

ole

Fu

nct

ion

ing

0.4

0<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)2

72

4E

mo

tion

al F

un

ctio

nin

g0

.59

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(I)

27

24

Co

gn

itive

Fu

nct

ion

ing

0.4

1<

0.0

01

<0

.00

1F

ee

ling

s th

at n

oth

ing

co

uld

ch

ee

r yo

u u

p (

I)2

72

3S

oci

al F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(I)

27

24

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.37

<0

.00

1<

0.0

01

Fe

elin

gs

tha

t no

thin

g c

ou

ld c

he

er

you

up

(I)

27

17

HR

QO

L S

um

ma

ry S

core

0.5

1<

0.0

01

<0

.00

1F

lash

ing

lig

hts

in e

yes

(P)

12

69

EC

OG

PS

2-4

EC

OG

PS

0-1

-1.1

1%

-0.0

4.

0.8

30

.91

Fla

shin

g li

gh

ts in

eye

s (P

)1

26

6P

hys

ica

l Fu

nct

ion

ing

0.0

50

.41

0.9

1F

lash

ing

lig

hts

in e

yes

(P)

12

66

Ro

le F

un

ctio

nin

g0

.03

0.6

0.9

1F

lash

ing

lig

hts

in e

yes

(P)

12

62

Em

otio

na

l Fu

nct

ion

ing

0.0

80

.21

0.9

1F

lash

ing

lig

hts

in e

yes

(P)

12

62

Co

gn

itive

Fu

nct

ion

ing

0.1

40

.03

0.3

5F

lash

ing

lig

hts

in e

yes

(P)

12

62

So

cia

l Fu

nct

ion

ing

-0.0

40

.48

0.9

1F

lash

ing

lig

hts

in e

yes

(P)

12

62

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.01

0.9

10

.91

Fla

shin

g li

gh

ts in

eye

s (P

)1

26

0H

RQ

OL

Su

mm

ary

Sco

re0

.05

0.3

90

.91

Fla

shin

g li

gh

ts in

eye

s (P

)2

23

6E

CO

G P

S 2

-4E

CO

G P

S 0

-11

9.8

6%

0.5

4.

<0

.00

10

.01

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 21: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

21

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eF

lash

ing

lig

hts

in e

yes

(P)

22

34

Ph

ysic

al F

un

ctio

nin

g0

.11

0.0

90

.91

Fla

shin

g li

gh

ts in

eye

s (P

)2

23

4R

ole

Fu

nct

ion

ing

0.0

50

.41

0.9

1F

lash

ing

lig

hts

in e

yes

(P)

22

34

Em

otio

na

l Fu

nct

ion

ing

0.1

50

.02

0.3

Fla

shin

g li

gh

ts in

eye

s (P

)2

23

4C

og

niti

ve F

un

ctio

nin

g0

.18

0.0

07

0.1

Fla

shin

g li

gh

ts in

eye

s (P

)2

23

4S

oci

al F

un

ctio

nin

g0

.13

0.0

60

.67

Fla

shin

g li

gh

ts in

eye

s (P

)2

23

4G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

10

.87

0.9

1F

lash

ing

lig

hts

in e

yes

(P)

22

34

HR

QO

L S

um

ma

ry S

core

0.0

80

.23

0.9

1F

req

ue

nt u

rina

tion

(F

)1

22

3E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.13

1.2

60

.10

.0

.60

.6F

req

ue

nt u

rina

tion

(F

)1

56

Pro

sta

te/B

lad

de

r w

ith r

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksH

em

ato

log

ic1

.08

1.1

70

.92

.0

.00

20

.03

Fre

qu

en

t urin

atio

n (

F)

12

22

Ph

ysic

al F

un

ctio

nin

g0

.07

0.2

70

.6F

req

ue

nt u

rina

tion

(F

)1

22

2R

ole

Fu

nct

ion

ing

0.0

90

.16

0.6

Fre

qu

en

t urin

atio

n (

F)

12

22

Em

otio

na

l Fu

nct

ion

ing

0.1

40

.03

0.3

1F

req

ue

nt u

rina

tion

(F

)1

22

2C

og

niti

ve F

un

ctio

nin

g0

.07

0.3

10

.6F

req

ue

nt u

rina

tion

(F

)1

22

2S

oci

al F

un

ctio

nin

g0

.16

0.0

20

.16

Fre

qu

en

t urin

atio

n (

F)

12

22

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.16

0.0

20

.16

Fre

qu

en

t urin

atio

n (

F)

12

20

HR

QO

L S

um

ma

ry S

core

0.1

70

.01

0.1

3F

req

ue

nt u

rina

tion

(F

)2

19

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.23

1.2

10

.19

.0

.37

0.6

Fre

qu

en

t urin

atio

n (

F)

24

9P

rost

ate

/Bla

dd

er

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

He

ma

tolo

gic

1.2

01

.16

1.0

3.

0.0

01

0.0

2F

req

ue

nt u

rina

tion

(F

)2

19

2P

hys

ica

l Fu

nct

ion

ing

0.1

30

.07

0.5

6F

req

ue

nt u

rina

tion

(F

)2

19

2R

ole

Fu

nct

ion

ing

0.1

20

.09

0.6

Fre

qu

en

t urin

atio

n (

F)

21

91

Em

otio

na

l Fu

nct

ion

ing

0.2

10

.00

40

.06

Fre

qu

en

t urin

atio

n (

F)

21

91

Co

gn

itive

Fu

nct

ion

ing

0.1

80

.01

0.1

6F

req

ue

nt u

rina

tion

(F

)2

19

0S

oci

al F

un

ctio

nin

g0

.11

0.1

40

.6F

req

ue

nt u

rina

tion

(F

)2

19

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

90

.00

90

.13

Fre

qu

en

t urin

atio

n (

F)

21

88

HR

QO

L S

um

ma

ry S

core

0.2

20

.00

30

.04

Fre

qu

en

t urin

atio

n (

I)1

22

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.18

1.1

60

.15

.0

.43

0.4

3F

req

ue

nt u

rina

tion

(I)

15

5P

rost

ate

/Bla

dd

er

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

He

ma

tolo

gic

0.6

21

.21

0.5

1.

0.0

70

.22

Fre

qu

en

t urin

atio

n (

I)1

22

1P

hys

ica

l Fu

nct

ion

ing

0.2

20

.00

10

.02

Fre

qu

en

t urin

atio

n (

I)1

22

1R

ole

Fu

nct

ion

ing

0.1

80

.00

80

.08

Fre

qu

en

t urin

atio

n (

I)1

22

1E

mo

tion

al F

un

ctio

nin

g0

.20

0.0

03

0.0

3F

req

ue

nt u

rina

tion

(I)

12

21

Co

gn

itive

Fu

nct

ion

ing

0.1

20

.07

0.2

2F

req

ue

nt u

rina

tion

(I)

12

21

So

cia

l Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1F

req

ue

nt u

rina

tion

(I)

12

21

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.15

0.0

20

.15

Fre

qu

en

t urin

atio

n (

I)1

21

9H

RQ

OL

Su

mm

ary

Sco

re0

.31

<0

.00

1<

0.0

01

Fre

qu

en

t urin

atio

n (

I)2

19

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.24

1.0

50

.23

.0

.28

0.4

3F

req

ue

nt u

rina

tion

(I)

24

9P

rost

ate

/Bla

dd

er

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

He

ma

tolo

gic

0.8

60

.92

0.9

4.

0.0

03

0.0

3F

req

ue

nt u

rina

tion

(I)

21

92

Ph

ysic

al F

un

ctio

nin

g0

.14

0.0

47

0.2

2F

req

ue

nt u

rina

tion

(I)

21

92

Ro

le F

un

ctio

nin

g0

.16

0.0

20

.15

Fre

qu

en

t urin

atio

n (

I)2

19

1E

mo

tion

al F

un

ctio

nin

g0

.26

<0

.00

10

.00

4F

req

ue

nt u

rina

tion

(I)

21

91

Co

gn

itive

Fu

nct

ion

ing

0.1

60

.03

0.1

5F

req

ue

nt u

rina

tion

(I)

21

90

So

cia

l Fu

nct

ion

ing

0.2

00

.00

60

.07

Fre

qu

en

t urin

atio

n (

I)2

19

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

90

.01

0.0

9F

req

ue

nt u

rina

tion

(I)

21

88

HR

QO

L S

um

ma

ry S

core

0.2

30

.00

10

.02

Ha

ir lo

ss (

A)

18

15

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

71

.50

0.0

5.

0.5

80

.84

Ha

ir lo

ss (

A)

18

15

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.45

1.4

80

.31

.<

0.0

01

<0

.00

1H

air

loss

(A

)1

79

9P

hys

ica

l Fu

nct

ion

ing

0.1

10

.00

10

.01

Ha

ir lo

ss (

A)

17

99

Ro

le F

un

ctio

nin

g0

.14

<0

.00

1<

0.0

01

Ha

ir lo

ss (

A)

17

96

Em

otio

na

l Fu

nct

ion

ing

0.1

00

.00

30

.03

Ha

ir lo

ss (

A)

17

96

Co

gn

itive

Fu

nct

ion

ing

0.1

8<

0.0

01

<0

.00

1H

air

loss

(A

)1

79

6S

oci

al F

un

ctio

nin

g0

.17

<0

.00

1<

0.0

01

Ha

ir lo

ss (

A)

17

96

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.10

0.0

06

0.0

4H

air

loss

(A

)1

79

4H

RQ

OL

Su

mm

ary

Sco

re0

.17

<0

.00

1<

0.0

01

Ha

ir lo

ss (

A)

27

48

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.0

31

.45

-0.0

2.

0.8

40

.84

Ha

ir lo

ss (

A)

27

48

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.41

1.4

30

.29

.<

0.0

01

0.0

01

Ha

ir lo

ss (

A)

27

26

Ph

ysic

al F

un

ctio

nin

g0

.10

0.0

05

0.0

4H

air

loss

(A

)2

72

6R

ole

Fu

nct

ion

ing

0.1

10

.00

30

.03

Ha

ir lo

ss (

A)

27

24

Em

otio

na

l Fu

nct

ion

ing

0.0

80

.03

0.0

9H

air

loss

(A

)2

72

4C

og

niti

ve F

un

ctio

nin

g0

.08

0.0

30

.09

Ha

ir lo

ss (

A)

27

23

So

cia

l Fu

nct

ion

ing

0.0

90

.01

0.0

7H

air

loss

(A

)2

72

4G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

90

.02

0.0

9H

air

loss

(A

)2

71

7H

RQ

OL

Su

mm

ary

Sco

re0

.15

<0

.00

10

.00

1H

an

d-f

oo

t syn

dro

me

(S

)1

45

6E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.02

0.6

2-0

.03

.0

.82

0.9

5H

an

d-f

oo

t syn

dro

me

(S

)1

45

6H

an

d-f

oo

t syn

dro

me

-ind

uci

ng

ch

em

oth

era

py

[foo

tno

te 1

] in

prio

r 2

we

eks

Oth

er

0.2

40

.62

0.3

9.

0.0

20

.26

Ha

nd

-fo

ot s

ynd

rom

e (

S)

14

41

Ph

ysic

al F

un

ctio

nin

g0

.08

0.0

90

.95

Ha

nd

-fo

ot s

ynd

rom

e (

S)

14

41

Ro

le F

un

ctio

nin

g0

.06

0.2

50

.95

Ha

nd

-fo

ot s

ynd

rom

e (

S)

14

41

Em

otio

na

l Fu

nct

ion

ing

0.0

00

.95

0.9

5H

an

d-f

oo

t syn

dro

me

(S

)1

44

1C

og

niti

ve F

un

ctio

nin

g0

.04

0.4

0.9

5H

an

d-f

oo

t syn

dro

me

(S

)1

44

1S

oci

al F

un

ctio

nin

g0

.05

0.3

20

.95

Ha

nd

-fo

ot s

ynd

rom

e (

S)

14

41

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.08

0.1

10

.95

Ha

nd

-fo

ot s

ynd

rom

e (

S)

14

38

HR

QO

L S

um

ma

ry S

core

0.0

90

.07

0.8

Ha

nd

-fo

ot s

ynd

rom

e (

S)

24

16

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

20

.67

0.0

3.

0.8

20

.95

Ha

nd

-fo

ot s

ynd

rom

e (

S)

24

16

Ha

nd

-fo

ot s

ynd

rom

e-in

du

cin

g c

he

mo

the

rap

y [fo

otn

ote

1] i

n p

rior

2 w

ee

ksO

the

r0

.25

0.6

60

.37

.0

.03

0.4

7H

an

d-f

oo

t syn

dro

me

(S

)2

40

0P

hys

ica

l Fu

nct

ion

ing

0.1

30

.01

0.1

8

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 22: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

22

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eH

an

d-f

oo

t syn

dro

me

(S

)2

40

0R

ole

Fu

nct

ion

ing

0.0

60

.26

0.9

5H

an

d-f

oo

t syn

dro

me

(S

)2

40

0E

mo

tion

al F

un

ctio

nin

g0

.12

0.0

20

.26

Ha

nd

-fo

ot s

ynd

rom

e (

S)

24

00

Co

gn

itive

Fu

nct

ion

ing

0.1

00

.04

0.4

7H

an

d-f

oo

t syn

dro

me

(S

)2

40

0S

oci

al F

un

ctio

nin

g0

.04

0.4

40

.95

Ha

nd

-fo

ot s

ynd

rom

e (

S)

24

00

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.08

0.1

0.9

5H

an

d-f

oo

t syn

dro

me

(S

)2

39

6H

RQ

OL

Su

mm

ary

Sco

re0

.13

0.0

10

.2H

ea

da

che

(F

)1

83

7E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.18

0.9

40

.19

.0

.04

0.0

7H

ea

da

che

(F

)1

82

1P

hys

ica

l Fu

nct

ion

ing

0.1

3<

0.0

01

0.0

01

He

ad

ach

e (

F)

18

21

Ro

le F

un

ctio

nin

g0

.18

<0

.00

1<

0.0

01

He

ad

ach

e (

F)

18

18

Em

otio

na

l Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1H

ea

da

che

(F

)1

81

8C

og

niti

ve F

un

ctio

nin

g0

.23

<0

.00

1<

0.0

01

He

ad

ach

e (

F)

18

18

So

cia

l Fu

nct

ion

ing

0.1

7<

0.0

01

<0

.00

1H

ea

da

che

(F

)1

81

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

8<

0.0

01

<0

.00

1H

ea

da

che

(F

)1

81

6H

RQ

OL

Su

mm

ary

Sco

re0

.29

<0

.00

1<

0.0

01

He

ad

ach

e (

F)

27

72

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

40

.91

0.1

5.

0.1

30

.13

He

ad

ach

e (

F)

27

50

Ph

ysic

al F

un

ctio

nin

g0

.11

0.0

03

0.0

1H

ea

da

che

(F

)2

75

0R

ole

Fu

nct

ion

ing

0.1

6<

0.0

01

<0

.00

1H

ea

da

che

(F

)2

74

8E

mo

tion

al F

un

ctio

nin

g0

.18

<0

.00

1<

0.0

01

He

ad

ach

e (

F)

27

48

Co

gn

itive

Fu

nct

ion

ing

0.1

9<

0.0

01

<0

.00

1H

ea

da

che

(F

)2

74

7S

oci

al F

un

ctio

nin

g0

.13

<0

.00

10

.00

2H

ea

da

che

(F

)2

74

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

7<

0.0

01

<0

.00

1H

ea

da

che

(F

)2

74

1H

RQ

OL

Su

mm

ary

Sco

re0

.26

<0

.00

1<

0.0

01

He

ad

ach

e (

S)

18

36

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

00

.87

0.2

3.

0.0

10

.02

He

ad

ach

e (

S)

18

20

Ph

ysic

al F

un

ctio

nin

g0

.15

<0

.00

1<

0.0

01

He

ad

ach

e (

S)

18

20

Ro

le F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

He

ad

ach

e (

S)

18

17

Em

otio

na

l Fu

nct

ion

ing

0.2

2<

0.0

01

<0

.00

1H

ea

da

che

(S

)1

81

7C

og

niti

ve F

un

ctio

nin

g0

.22

<0

.00

1<

0.0

01

He

ad

ach

e (

S)

18

17

So

cia

l Fu

nct

ion

ing

0.2

0<

0.0

01

<0

.00

1H

ea

da

che

(S

)1

81

7G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

0<

0.0

01

<0

.00

1H

ea

da

che

(S

)1

81

5H

RQ

OL

Su

mm

ary

Sco

re0

.31

<0

.00

1<

0.0

01

He

ad

ach

e (

S)

27

72

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

80

.85

0.2

1.

0.0

30

.03

He

ad

ach

e (

S)

27

50

Ph

ysic

al F

un

ctio

nin

g0

.11

0.0

02

0.0

07

He

ad

ach

e (

S)

27

50

Ro

le F

un

ctio

nin

g0

.18

<0

.00

1<

0.0

01

He

ad

ach

e (

S)

27

48

Em

otio

na

l Fu

nct

ion

ing

0.2

0<

0.0

01

<0

.00

1H

ea

da

che

(S

)2

74

8C

og

niti

ve F

un

ctio

nin

g0

.19

<0

.00

1<

0.0

01

He

ad

ach

e (

S)

27

47

So

cia

l Fu

nct

ion

ing

0.1

7<

0.0

01

<0

.00

1H

ea

da

che

(S

)2

74

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

8<

0.0

01

<0

.00

1H

ea

da

che

(S

)2

74

1H

RQ

OL

Su

mm

ary

Sco

re0

.29

<0

.00

1<

0.0

01

He

ad

ach

e (

I)1

83

6E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.22

0.8

30

.27

.0

.00

30

.00

6H

ea

da

che

(I)

18

20

Ph

ysic

al F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

He

ad

ach

e (

I)1

82

0R

ole

Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1H

ea

da

che

(I)

18

17

Em

otio

na

l Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1H

ea

da

che

(I)

18

17

Co

gn

itive

Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1H

ea

da

che

(I)

18

17

So

cia

l Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1H

ea

da

che

(I)

18

17

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.25

<0

.00

1<

0.0

01

He

ad

ach

e (

I)1

81

5H

RQ

OL

Su

mm

ary

Sco

re0

.39

<0

.00

1<

0.0

01

He

ad

ach

e (

I)2

77

1E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.13

0.8

00

.16

.0

.11

0.1

1H

ea

da

che

(I)

27

49

Ph

ysic

al F

un

ctio

nin

g0

.17

<0

.00

1<

0.0

01

He

ad

ach

e (

I)2

74

9R

ole

Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1H

ea

da

che

(I)

27

47

Em

otio

na

l Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1H

ea

da

che

(I)

27

47

Co

gn

itive

Fu

nct

ion

ing

0.2

2<

0.0

01

<0

.00

1H

ea

da

che

(I)

27

46

So

cia

l Fu

nct

ion

ing

0.2

2<

0.0

01

<0

.00

1H

ea

da

che

(I)

27

47

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.20

<0

.00

1<

0.0

01

He

ad

ach

e (

I)2

74

0H

RQ

OL

Su

mm

ary

Sco

re0

.32

<0

.00

1<

0.0

01

He

art

bu

rn (

F)

12

52

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

91

.10

0.1

7.

0.3

30

.33

He

art

bu

rn (

F)

12

52

An

taci

d in

prio

r w

ee

kO

the

r0

.65

1.0

50

.62

.<

0.0

01

<0

.00

1H

ea

rtb

urn

(F

)1

24

9P

hys

ica

l Fu

nct

ion

ing

0.1

70

.00

80

.04

He

art

bu

rn (

F)

12

49

Ro

le F

un

ctio

nin

g0

.15

0.0

20

.08

He

art

bu

rn (

F)

12

46

Em

otio

na

l Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1H

ea

rtb

urn

(F

)1

24

6C

og

niti

ve F

un

ctio

nin

g0

.22

<0

.00

10

.00

5H

ea

rtb

urn

(F

)1

24

6S

oci

al F

un

ctio

nin

g0

.18

0.0

06

0.0

4H

ea

rtb

urn

(F

)1

24

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

6<

0.0

01

<0

.00

1H

ea

rtb

urn

(F

)1

24

4H

RQ

OL

Su

mm

ary

Sco

re0

.32

<0

.00

1<

0.0

01

He

art

bu

rn (

F)

22

22

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

71

.04

0.3

5.

0.0

60

.17

He

art

bu

rn (

F)

22

22

An

taci

d in

prio

r w

ee

kO

the

r0

.75

0.9

80

.76

.<

0.0

01

<0

.00

1H

ea

rtb

urn

(F

)2

22

0P

hys

ica

l Fu

nct

ion

ing

0.2

00

.00

30

.02

He

art

bu

rn (

F)

22

20

Ro

le F

un

ctio

nin

g0

.20

0.0

03

0.0

2H

ea

rtb

urn

(F

)2

22

0E

mo

tion

al F

un

ctio

nin

g0

.22

0.0

01

0.0

1H

ea

rtb

urn

(F

)2

22

0C

og

niti

ve F

un

ctio

nin

g0

.12

0.0

80

.17

He

art

bu

rn (

F)

22

20

So

cia

l Fu

nct

ion

ing

0.1

80

.00

80

.04

He

art

bu

rn (

F)

22

20

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.26

<0

.00

10

.00

1H

ea

rtb

urn

(F

)2

22

0H

RQ

OL

Su

mm

ary

Sco

re0

.35

<0

.00

1<

0.0

01

He

art

bu

rn (

S)

12

52

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

81

.00

0.2

8.

0.1

10

.13

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 23: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

23

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eH

ea

rtb

urn

(S

)1

25

2A

nta

cid

in p

rior

we

ek

Oth

er

0.6

70

.95

0.7

0.

<0

.00

1<

0.0

01

He

art

bu

rn (

S)

12

49

Ph

ysic

al F

un

ctio

nin

g0

.20

0.0

02

0.0

2H

ea

rtb

urn

(S

)1

24

9R

ole

Fu

nct

ion

ing

0.1

80

.00

40

.03

He

art

bu

rn (

S)

12

46

Em

otio

na

l Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1H

ea

rtb

urn

(S

)1

24

6C

og

niti

ve F

un

ctio

nin

g0

.27

<0

.00

1<

0.0

01

He

art

bu

rn (

S)

12

46

So

cia

l Fu

nct

ion

ing

0.1

90

.00

30

.03

He

art

bu

rn (

S)

12

46

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.29

<0

.00

1<

0.0

01

He

art

bu

rn (

S)

12

44

HR

QO

L S

um

ma

ry S

core

0.3

6<

0.0

01

<0

.00

1H

ea

rtb

urn

(S

)2

22

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.28

0.9

30

.30

.0

.11

0.1

3H

ea

rtb

urn

(S

)2

22

2A

nta

cid

in p

rior

we

ek

Oth

er

0.6

60

.87

0.7

5.

<0

.00

1<

0.0

01

He

art

bu

rn (

S)

22

20

Ph

ysic

al F

un

ctio

nin

g0

.16

0.0

20

.06

He

art

bu

rn (

S)

22

20

Ro

le F

un

ctio

nin

g0

.19

0.0

05

0.0

4H

ea

rtb

urn

(S

)2

22

0E

mo

tion

al F

un

ctio

nin

g0

.17

0.0

10

.06

He

art

bu

rn (

S)

22

20

Co

gn

itive

Fu

nct

ion

ing

0.1

00

.13

0.1

3H

ea

rtb

urn

(S

)2

22

0S

oci

al F

un

ctio

nin

g0

.18

0.0

07

0.0

4H

ea

rtb

urn

(S

)2

22

0G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

4<

0.0

01

0.0

05

He

art

bu

rn (

S)

22

20

HR

QO

L S

um

ma

ry S

core

0.3

2<

0.0

01

<0

.00

1H

iccu

ps

(F)

14

28

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

70

.85

0.3

2.

0.0

10

.1H

iccu

ps

(F)

14

28

Cu

rre

ntly

taki

ng

na

use

a m

ed

Oth

er

0.2

90

.85

0.3

4.

<0

.00

10

.00

9H

iccu

ps

(F)

14

28

Lu

ng

/He

ad

/Ne

ck/G

ast

roin

test

ina

lO

the

r0

.22

0.8

50

.26

.0

.03

0.1

2H

iccu

ps

(F)

14

18

Ph

ysic

al F

un

ctio

nin

g0

.16

<0

.00

10

.00

9H

iccu

ps

(F)

14

18

Ro

le F

un

ctio

nin

g0

.17

<0

.00

10

.00

7H

iccu

ps

(F)

14

15

Em

otio

na

l Fu

nct

ion

ing

0.1

9<

0.0

01

0.0

01

Hic

cup

s (F

)1

41

5C

og

niti

ve F

un

ctio

nin

g0

.20

<0

.00

1<

0.0

01

Hic

cup

s (F

)1

41

5S

oci

al F

un

ctio

nin

g0

.18

<0

.00

10

.00

4H

iccu

ps

(F)

14

15

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.18

<0

.00

10

.00

3H

iccu

ps

(F)

14

12

HR

QO

L S

um

ma

ry S

core

0.2

7<

0.0

01

<0

.00

1H

iccu

ps

(F)

23

81

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

80

.77

0.1

1.

0.4

60

.46

Hic

cup

s (F

)2

38

1C

urr

en

tly ta

kin

g n

au

sea

me

dO

the

r0

.24

0.7

70

.31

.0

.00

40

.03

Hic

cup

s (F

)2

38

1L

un

g/H

ea

d/N

eck

/Ga

stro

inte

stin

al

Oth

er

0.1

10

.77

0.1

4.

0.2

60

.46

Hic

cup

s (F

)2

37

5P

hys

ica

l Fu

nct

ion

ing

0.0

50

.32

0.4

6H

iccu

ps

(F)

23

75

Ro

le F

un

ctio

nin

g0

.15

0.0

03

0.0

3H

iccu

ps

(F)

23

73

Em

otio

na

l Fu

nct

ion

ing

0.1

20

.02

0.1

Hic

cup

s (F

)2

37

3C

og

niti

ve F

un

ctio

nin

g0

.11

0.0

30

.12

Hic

cup

s (F

)2

37

3S

oci

al F

un

ctio

nin

g0

.17

0.0

01

0.0

1H

iccu

ps

(F)

23

73

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.17

<0

.00

10

.00

9H

iccu

ps

(F)

23

72

HR

QO

L S

um

ma

ry S

core

0.1

9<

0.0

01

0.0

04

Hic

cup

s (S

)1

42

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.14

0.7

30

.20

.0

.13

0.5

1H

iccu

ps

(S)

14

28

Cu

rre

ntly

taki

ng

na

use

a m

ed

Oth

er

0.2

40

.72

0.3

4.

<0

.00

10

.01

Hic

cup

s (S

)1

42

8L

un

g/H

ea

d/N

eck

/Ga

stro

inte

stin

al

Oth

er

0.1

90

.73

0.2

6.

0.0

30

.16

Hic

cup

s (S

)1

41

8P

hys

ica

l Fu

nct

ion

ing

0.1

30

.00

70

.04

9H

iccu

ps

(S)

14

18

Ro

le F

un

ctio

nin

g0

.16

0.0

01

0.0

1H

iccu

ps

(S)

14

15

Em

otio

na

l Fu

nct

ion

ing

0.1

8<

0.0

01

0.0

02

Hic

cup

s (S

)1

41

5C

og

niti

ve F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

Hic

cup

s (S

)1

41

5S

oci

al F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

Hic

cup

s (S

)1

41

5G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

60

.00

10

.01

Hic

cup

s (S

)1

41

2H

RQ

OL

Su

mm

ary

Sco

re0

.26

<0

.00

1<

0.0

01

Hic

cup

s (S

)2

38

1E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.06

0.7

20

.09

.0

.55

0.5

5H

iccu

ps

(S)

23

81

Cu

rre

ntly

taki

ng

na

use

a m

ed

Oth

er

0.2

50

.71

0.3

5.

0.0

01

0.0

1H

iccu

ps

(S)

23

81

Lu

ng

/He

ad

/Ne

ck/G

ast

roin

test

ina

lO

the

r0

.12

0.7

10

.17

.0

.19

0.5

3H

iccu

ps

(S)

23

75

Ph

ysic

al F

un

ctio

nin

g0

.06

0.2

60

.53

Hic

cup

s (S

)2

37

5R

ole

Fu

nct

ion

ing

0.1

8<

0.0

01

0.0

06

Hic

cup

s (S

)2

37

3E

mo

tion

al F

un

ctio

nin

g0

.14

0.0

06

0.0

4H

iccu

ps

(S)

23

73

Co

gn

itive

Fu

nct

ion

ing

0.1

10

.03

0.1

7H

iccu

ps

(S)

23

73

So

cia

l Fu

nct

ion

ing

0.2

1<

0.0

01

<0

.00

1H

iccu

ps

(S)

23

73

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.21

<0

.00

1<

0.0

01

Hic

cup

s (S

)2

37

2H

RQ

OL

Su

mm

ary

Sco

re0

.22

<0

.00

1<

0.0

01

Hiv

es

(P)

14

09

EC

OG

PS

2-4

EC

OG

PS

0-1

-1.3

5%

-0.0

5.

0.7

50

.92

Hiv

es

(P)

14

09

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r2

.17

%0

.07

.0

.47

0.9

2H

ive

s (P

)1

40

9S

kin

-re

act

ion

ch

em

oth

era

py

[foo

tno

te 2

] in

prio

r 2

we

eks

Oth

er

6.0

7%

0.2

0.

0.0

45

0.9

Hiv

es

(P)

13

94

Ph

ysic

al F

un

ctio

nin

g0

.03

0.5

40

.92

Hiv

es

(P)

13

94

Ro

le F

un

ctio

nin

g0

.00

0.9

20

.92

Hiv

es

(P)

13

94

Em

otio

na

l Fu

nct

ion

ing

0.0

30

.58

0.9

2H

ive

s (P

)1

39

4C

og

niti

ve F

un

ctio

nin

g0

.09

0.0

80

.92

Hiv

es

(P)

13

94

So

cia

l Fu

nct

ion

ing

0.0

30

.61

0.9

2H

ive

s (P

)1

39

4G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

10

.77

0.9

2H

ive

s (P

)1

39

1H

RQ

OL

Su

mm

ary

Sco

re0

.03

0.5

50

.92

Hiv

es

(P)

23

72

EC

OG

PS

2-4

EC

OG

PS

0-1

-2.4

5%

-0.0

9.

0.6

0.9

2H

ive

s (P

)2

37

2C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

-0.5

3%

-0.0

2.

0.8

60

.92

Hiv

es

(P)

23

72

Ski

n-r

ea

ctio

n c

he

mo

the

rap

y [fo

otn

ote

2] i

n p

rior

2 w

ee

ksO

the

r1

.90

%0

.06

.0

.55

0.9

2H

ive

s (P

)2

35

6P

hys

ica

l Fu

nct

ion

ing

-0.0

10

.87

0.9

2H

ive

s (P

)2

35

6R

ole

Fu

nct

ion

ing

-0.0

10

.91

0.9

2H

ive

s (P

)2

35

6E

mo

tion

al F

un

ctio

nin

g-0

.01

0.8

40

.92

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 24: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

24

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eH

ive

s (P

)2

35

6C

og

niti

ve F

un

ctio

nin

g0

.03

0.5

40

.92

Hiv

es

(P)

23

56

So

cia

l Fu

nct

ion

ing

0.0

80

.15

0.9

2H

ive

s (P

)2

35

6G

lob

al H

ea

lth S

tatu

s/Q

oL

-0.0

30

.59

0.9

2H

ive

s (P

)2

35

2H

RQ

OL

Su

mm

ary

Sco

re-0

.02

0.7

30

.92

Ho

ars

e v

oic

e (

S)

12

53

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

40

.97

0.0

4.

0.8

20

.82

Ho

ars

e v

oic

e (

S)

12

53

He

ad

/Ne

ck w

ith r

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r0

.28

0.9

60

.29

.0

.02

0.1

Ho

ars

e v

oic

e (

S)

12

50

Ph

ysic

al F

un

ctio

nin

g0

.16

0.0

10

.08

Ho

ars

e v

oic

e (

S)

12

50

Ro

le F

un

ctio

nin

g0

.21

<0

.00

10

.00

7H

oa

rse

vo

ice

(S

)1

24

7E

mo

tion

al F

un

ctio

nin

g0

.27

<0

.00

1<

0.0

01

Ho

ars

e v

oic

e (

S)

12

47

Co

gn

itive

Fu

nct

ion

ing

0.2

3<

0.0

01

0.0

03

Ho

ars

e v

oic

e (

S)

12

47

So

cia

l Fu

nct

ion

ing

0.2

00

.00

20

.02

Ho

ars

e v

oic

e (

S)

12

47

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.24

<0

.00

10

.00

2H

oa

rse

vo

ice

(S

)1

24

5H

RQ

OL

Su

mm

ary

Sco

re0

.34

<0

.00

1<

0.0

01

Ho

ars

e v

oic

e (

S)

22

22

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

61

.02

0.0

6.

0.7

50

.82

Ho

ars

e v

oic

e (

S)

22

22

He

ad

/Ne

ck w

ith r

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r0

.42

1.0

00

.42

.0

.00

20

.02

Ho

ars

e v

oic

e (

S)

22

20

Ph

ysic

al F

un

ctio

nin

g0

.19

0.0

05

0.0

4H

oa

rse

vo

ice

(S

)2

22

0R

ole

Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1H

oa

rse

vo

ice

(S

)2

22

0E

mo

tion

al F

un

ctio

nin

g0

.16

0.0

20

.09

Ho

ars

e v

oic

e (

S)

22

20

Co

gn

itive

Fu

nct

ion

ing

0.0

30

.62

0.8

2H

oa

rse

vo

ice

(S

)2

22

0S

oci

al F

un

ctio

nin

g0

.25

<0

.00

10

.00

3H

oa

rse

vo

ice

(S

)2

22

0G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

80

.00

70

.05

Ho

ars

e v

oic

e (

S)

22

20

HR

QO

L S

um

ma

ry S

core

0.3

4<

0.0

01

<0

.00

1H

ot f

lash

es

(F)

13

69

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.1

41

.11

-0.1

3.

0.4

60

.46

Ho

t fla

she

s (F

)1

29

2B

rea

st/P

rost

ate

Ga

stro

inte

stin

al

0.4

91

.14

0.4

3.

0.0

04

0.0

6H

ot f

lash

es

(F)

13

69

Cu

rre

ntly

re

ceiv

ing

ho

rmo

ne

the

rap

yO

the

r0

.62

1.0

80

.58

.<

0.0

01

<0

.00

1H

ot f

lash

es

(F)

13

61

Ph

ysic

al F

un

ctio

nin

g0

.07

0.1

60

.46

Ho

t fla

she

s (F

)1

36

1R

ole

Fu

nct

ion

ing

0.0

70

.20

.46

Ho

t fla

she

s (F

)1

36

1E

mo

tion

al F

un

ctio

nin

g0

.15

0.0

06

0.0

7H

ot f

lash

es

(F)

13

61

Co

gn

itive

Fu

nct

ion

ing

0.1

20

.03

0.2

5H

ot f

lash

es

(F)

13

61

So

cia

l Fu

nct

ion

ing

0.1

50

.00

40

.06

Ho

t fla

she

s (F

)1

36

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

80

.14

0.4

6H

ot f

lash

es

(F)

13

59

HR

QO

L S

um

ma

ry S

core

0.1

40

.00

70

.08

Ho

t fla

she

s (F

)2

33

9E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.23

1.1

1-0

.20

.0

.30

.46

Ho

t fla

she

s (F

)2

27

3B

rea

st/P

rost

ate

Ga

stro

inte

stin

al

0.7

11

.10

0.6

5.

<0

.00

1<

0.0

01

Ho

t fla

she

s (F

)2

33

9C

urr

en

tly r

ece

ivin

g h

orm

on

e th

era

py

Oth

er

0.5

71

.08

0.5

3.

<0

.00

10

.00

2H

ot f

lash

es

(F)

23

26

Ph

ysic

al F

un

ctio

nin

g0

.15

0.0

08

0.0

8H

ot f

lash

es

(F)

23

26

Ro

le F

un

ctio

nin

g0

.04

0.4

30

.46

Ho

t fla

she

s (F

)2

32

7E

mo

tion

al F

un

ctio

nin

g0

.22

<0

.00

1<

0.0

01

Ho

t fla

she

s (F

)2

32

7C

og

niti

ve F

un

ctio

nin

g0

.27

<0

.00

1<

0.0

01

Ho

t fla

she

s (F

)2

32

6S

oci

al F

un

ctio

nin

g0

.11

0.0

48

0.3

9H

ot f

lash

es

(F)

23

27

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.10

0.0

70

.46

Ho

t fla

she

s (F

)2

32

1H

RQ

OL

Su

mm

ary

Sco

re0

.22

<0

.00

10

.00

1H

ot f

lash

es

(S)

13

69

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.0

81

.02

-0.0

8.

0.6

40

.64

Ho

t fla

she

s (S

)1

29

2B

rea

st/P

rost

ate

Ga

stro

inte

stin

al

0.4

51

.05

0.4

2.

0.0

05

0.0

49

Ho

t fla

she

s (S

)1

36

9C

urr

en

tly r

ece

ivin

g h

orm

on

e th

era

py

Oth

er

0.4

31

.01

0.4

3.

0.0

01

0.0

2H

ot f

lash

es

(S)

13

61

Ph

ysic

al F

un

ctio

nin

g0

.10

0.0

60

.29

Ho

t fla

she

s (S

)1

36

1R

ole

Fu

nct

ion

ing

0.0

70

.20

.59

Ho

t fla

she

s (S

)1

36

1E

mo

tion

al F

un

ctio

nin

g0

.18

<0

.00

10

.01

Ho

t fla

she

s (S

)1

36

1C

og

niti

ve F

un

ctio

nin

g0

.14

0.0

07

0.0

6H

ot f

lash

es

(S)

13

61

So

cia

l Fu

nct

ion

ing

0.1

9<

0.0

01

0.0

06

Ho

t fla

she

s (S

)1

36

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

20

.03

0.1

5H

ot f

lash

es

(S)

13

59

HR

QO

L S

um

ma

ry S

core

0.1

8<

0.0

01

0.0

1H

ot f

lash

es

(S)

23

39

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.1

50

.99

-0.1

5.

0.4

40

.64

Ho

t fla

she

s (S

)2

27

3B

rea

st/P

rost

ate

Ga

stro

inte

stin

al

0.6

10

.98

0.6

2.

<0

.00

10

.00

2H

ot f

lash

es

(S)

23

39

Cu

rre

ntly

re

ceiv

ing

ho

rmo

ne

the

rap

yO

the

r0

.42

0.9

70

.43

.0

.00

20

.02

Ho

t fla

she

s (S

)2

32

6P

hys

ica

l Fu

nct

ion

ing

0.1

80

.00

10

.02

Ho

t fla

she

s (S

)2

32

6R

ole

Fu

nct

ion

ing

0.0

80

.16

0.5

9H

ot f

lash

es

(S)

23

27

Em

otio

na

l Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1H

ot f

lash

es

(S)

23

27

Co

gn

itive

Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1H

ot f

lash

es

(S)

23

26

So

cia

l Fu

nct

ion

ing

0.1

40

.01

0.0

9H

ot f

lash

es

(S)

23

27

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.13

0.0

20

.11

Ho

t fla

she

s (S

)2

32

1H

RQ

OL

Su

mm

ary

Sco

re0

.26

<0

.00

1<

0.0

01

Incr

ea

sed

pa

ssin

g o

f ga

s (P

)1

33

1E

CO

G P

S 2

-4E

CO

G P

S 0

-1-5

.78

%-0

.12

.0

.40

.52

Incr

ea

sed

pa

ssin

g o

f ga

s (P

)1

22

6G

ast

roin

test

ina

lL

un

g1

7.4

4%

0.3

6.

0.0

20

.21

Incr

ea

sed

pa

ssin

g o

f ga

s (P

)1

32

3P

hys

ica

l Fu

nct

ion

ing

0.1

20

.03

0.2

3In

cre

ase

d p

ass

ing

of g

as

(P)

13

23

Ro

le F

un

ctio

nin

g0

.10

0.0

60

.44

Incr

ea

sed

pa

ssin

g o

f ga

s (P

)1

32

3E

mo

tion

al F

un

ctio

nin

g0

.13

0.0

20

.21

Incr

ea

sed

pa

ssin

g o

f ga

s (P

)1

32

3C

og

niti

ve F

un

ctio

nin

g0

.16

0.0

04

0.0

7In

cre

ase

d p

ass

ing

of g

as

(P)

13

23

So

cia

l Fu

nct

ion

ing

0.1

30

.02

0.2

1In

cre

ase

d p

ass

ing

of g

as

(P)

13

23

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.09

0.1

20

.52

Incr

ea

sed

pa

ssin

g o

f ga

s (P

)1

32

0H

RQ

OL

Su

mm

ary

Sco

re0

.19

<0

.00

10

.00

9In

cre

ase

d p

ass

ing

of g

as

(P)

22

93

EC

OG

PS

2-4

EC

OG

PS

0-1

5.9

4%

0.1

2.

0.4

60

.52

Incr

ea

sed

pa

ssin

g o

f ga

s (P

)2

20

0G

ast

roin

test

ina

lL

un

g5

.22

%0

.11

.0

.52

0.5

2

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 25: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

25

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eIn

cre

ase

d p

ass

ing

of g

as

(P)

22

88

Ph

ysic

al F

un

ctio

nin

g0

.16

0.0

07

0.0

9In

cre

ase

d p

ass

ing

of g

as

(P)

22

88

Ro

le F

un

ctio

nin

g0

.16

0.0

06

0.0

8In

cre

ase

d p

ass

ing

of g

as

(P)

22

86

Em

otio

na

l Fu

nct

ion

ing

0.0

60

.34

0.5

2In

cre

ase

d p

ass

ing

of g

as

(P)

22

86

Co

gn

itive

Fu

nct

ion

ing

0.1

00

.08

0.5

1In

cre

ase

d p

ass

ing

of g

as

(P)

22

86

So

cia

l Fu

nct

ion

ing

0.1

60

.00

70

.09

Incr

ea

sed

pa

ssin

g o

f ga

s (P

)2

28

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

40

.02

0.2

1In

cre

ase

d p

ass

ing

of g

as

(P)

22

85

HR

QO

L S

um

ma

ry S

core

0.1

60

.00

60

.08

Incr

ea

sed

ski

n s

en

sitiv

ity to

su

nlig

ht (

P)

14

09

EC

OG

PS

2-4

EC

OG

PS

0-1

1.2

7%

0.0

4.

0.8

0.8

Incr

ea

sed

ski

n s

en

sitiv

ity to

su

nlig

ht (

P)

13

94

Ph

ysic

al F

un

ctio

nin

g0

.14

0.0

07

0.0

46

Incr

ea

sed

ski

n s

en

sitiv

ity to

su

nlig

ht (

P)

13

94

Ro

le F

un

ctio

nin

g0

.13

0.0

09

0.0

46

Incr

ea

sed

ski

n s

en

sitiv

ity to

su

nlig

ht (

P)

13

94

Em

otio

na

l Fu

nct

ion

ing

0.1

30

.00

80

.04

6In

cre

ase

d s

kin

se

nsi

tivity

to s

un

ligh

t (P

)1

39

4C

og

niti

ve F

un

ctio

nin

g0

.17

<0

.00

10

.00

7In

cre

ase

d s

kin

se

nsi

tivity

to s

un

ligh

t (P

)1

39

4S

oci

al F

un

ctio

nin

g0

.22

<0

.00

1<

0.0

01

Incr

ea

sed

ski

n s

en

sitiv

ity to

su

nlig

ht (

P)

13

94

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.09

0.0

60

.19

Incr

ea

sed

ski

n s

en

sitiv

ity to

su

nlig

ht (

P)

13

91

HR

QO

L S

um

ma

ry S

core

0.1

40

.00

60

.04

6In

cre

ase

d s

kin

se

nsi

tivity

to s

un

ligh

t (P

)2

37

2E

CO

G P

S 2

-4E

CO

G P

S 0

-1-2

.16

%-0

.06

.0

.72

0.8

Incr

ea

sed

ski

n s

en

sitiv

ity to

su

nlig

ht (

P)

23

56

Ph

ysic

al F

un

ctio

nin

g0

.15

0.0

06

0.0

46

Incr

ea

sed

ski

n s

en

sitiv

ity to

su

nlig

ht (

P)

23

56

Ro

le F

un

ctio

nin

g0

.17

0.0

02

0.0

2In

cre

ase

d s

kin

se

nsi

tivity

to s

un

ligh

t (P

)2

35

6E

mo

tion

al F

un

ctio

nin

g0

.26

<0

.00

1<

0.0

01

Incr

ea

sed

ski

n s

en

sitiv

ity to

su

nlig

ht (

P)

23

56

Co

gn

itive

Fu

nct

ion

ing

0.1

40

.00

80

.04

6In

cre

ase

d s

kin

se

nsi

tivity

to s

un

ligh

t (P

)2

35

6S

oci

al F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Incr

ea

sed

ski

n s

en

sitiv

ity to

su

nlig

ht (

P)

23

56

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.13

0.0

10

.04

9In

cre

ase

d s

kin

se

nsi

tivity

to s

un

ligh

t (P

)2

35

2H

RQ

OL

Su

mm

ary

Sco

re0

.20

<0

.00

10

.00

2In

som

nia

(S

)1

85

5E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.34

1.1

20

.30

.<

0.0

01

0.0

05

Inso

mn

ia (

S)

18

55

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.07

1.1

20

.06

.0

.34

0.6

2In

som

nia

(S

)1

85

5S

lee

p a

id in

prio

r w

ee

kO

the

r0

.81

1.0

80

.75

.<

0.0

01

<0

.00

1In

som

nia

(S

)1

85

5S

urg

ery

in p

rior

2 w

ee

ksO

the

r-0

.10

1.1

2-0

.09

.0

.62

0.6

2In

som

nia

(S

)1

83

9P

hys

ica

l Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1In

som

nia

(S

)1

83

9R

ole

Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1In

som

nia

(S

)1

83

6E

mo

tion

al F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Inso

mn

ia (

S)

18

36

Co

gn

itive

Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1In

som

nia

(S

)1

83

6S

oci

al F

un

ctio

nin

g0

.32

<0

.00

1<

0.0

01

Inso

mn

ia (

S)

18

36

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.26

<0

.00

1<

0.0

01

Inso

mn

ia (

S)

18

34

HR

QO

L S

um

ma

ry S

core

0.4

8<

0.0

01

<0

.00

1In

som

nia

(S

)1

83

9In

som

nia

0.7

8<

0.0

01

<0

.00

1In

som

nia

(S

)2

78

5E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.35

1.0

90

.32

.0

.00

10

.00

6In

som

nia

(S

)2

78

5C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

-0.0

71

.10

-0.0

6.

0.3

70

.62

Inso

mn

ia (

S)

27

85

Sle

ep

aid

in p

rior

we

ek

Oth

er

0.6

91

.07

0.6

5.

<0

.00

1<

0.0

01

Inso

mn

ia (

S)

27

85

Su

rge

ry in

prio

r 2

we

eks

Oth

er

0.2

01

.10

0.1

8.

0.4

0.6

2In

som

nia

(S

)2

76

3P

hys

ica

l Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1In

som

nia

(S

)2

76

3R

ole

Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1In

som

nia

(S

)2

76

1E

mo

tion

al F

un

ctio

nin

g0

.37

<0

.00

1<

0.0

01

Inso

mn

ia (

S)

27

61

Co

gn

itive

Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1In

som

nia

(S

)2

76

0S

oci

al F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Inso

mn

ia (

S)

27

61

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.27

<0

.00

1<

0.0

01

Inso

mn

ia (

S)

27

54

HR

QO

L S

um

ma

ry S

core

0.5

0<

0.0

01

<0

.00

1In

som

nia

(S

)2

76

3In

som

nia

0.7

9<

0.0

01

<0

.00

1In

som

nia

(I)

18

53

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

91

.12

0.3

5.

<0

.00

1<

0.0

01

Inso

mn

ia (

I)1

85

3C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

0.0

41

.13

0.0

3.

0.6

30

.82

Inso

mn

ia (

I)1

85

3S

lee

p a

id in

prio

r w

ee

kO

the

r0

.77

1.0

90

.71

.<

0.0

01

<0

.00

1In

som

nia

(I)

18

53

Su

rge

ry in

prio

r 2

we

eks

Oth

er

-0.0

51

.13

-0.0

4.

0.8

20

.82

Inso

mn

ia (

I)1

83

7P

hys

ica

l Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1In

som

nia

(I)

18

37

Ro

le F

un

ctio

nin

g0

.33

<0

.00

1<

0.0

01

Inso

mn

ia (

I)1

83

4E

mo

tion

al F

un

ctio

nin

g0

.43

<0

.00

1<

0.0

01

Inso

mn

ia (

I)1

83

4C

og

niti

ve F

un

ctio

nin

g0

.33

<0

.00

1<

0.0

01

Inso

mn

ia (

I)1

83

4S

oci

al F

un

ctio

nin

g0

.42

<0

.00

1<

0.0

01

Inso

mn

ia (

I)1

83

4G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

9<

0.0

01

<0

.00

1In

som

nia

(I)

18

32

HR

QO

L S

um

ma

ry S

core

0.5

2<

0.0

01

<0

.00

1In

som

nia

(I)

18

37

Inso

mn

ia0

.70

<0

.00

1<

0.0

01

Inso

mn

ia (

I)2

78

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.46

1.0

60

.44

.<

0.0

01

<0

.00

1In

som

nia

(I)

27

84

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r-0

.11

1.0

7-0

.10

.0

.15

0.4

6In

som

nia

(I)

27

84

Sle

ep

aid

in p

rior

we

ek

Oth

er

0.6

81

.04

0.6

6.

<0

.00

1<

0.0

01

Inso

mn

ia (

I)2

78

4S

urg

ery

in p

rior

2 w

ee

ksO

the

r0

.39

1.0

70

.36

.0

.09

0.3

7In

som

nia

(I)

27

62

Ph

ysic

al F

un

ctio

nin

g0

.35

<0

.00

1<

0.0

01

Inso

mn

ia (

I)2

76

2R

ole

Fu

nct

ion

ing

0.3

6<

0.0

01

<0

.00

1In

som

nia

(I)

27

60

Em

otio

na

l Fu

nct

ion

ing

0.4

3<

0.0

01

<0

.00

1In

som

nia

(I)

27

60

Co

gn

itive

Fu

nct

ion

ing

0.3

4<

0.0

01

<0

.00

1In

som

nia

(I)

27

59

So

cia

l Fu

nct

ion

ing

0.4

1<

0.0

01

<0

.00

1In

som

nia

(I)

27

60

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.32

<0

.00

1<

0.0

01

Inso

mn

ia (

I)2

75

3H

RQ

OL

Su

mm

ary

Sco

re0

.56

<0

.00

1<

0.0

01

Inso

mn

ia (

I)2

76

2In

som

nia

0.6

8<

0.0

01

<0

.00

1Ir

reg

ula

r m

en

stru

al p

erio

ds

(P)

17

7E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.00

%0

.00

.1

1Ir

reg

ula

r m

en

stru

al p

erio

ds

(P)

12

9A

ge

<4

0A

ge

>6

03

5.5

1%

0.7

7.

0.1

21

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 26: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

26

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eIr

reg

ula

r m

en

stru

al p

erio

ds

(P)

17

5P

hys

ica

l Fu

nct

ion

ing

0.2

10

.08

1Ir

reg

ula

r m

en

stru

al p

erio

ds

(P)

17

5R

ole

Fu

nct

ion

ing

0.2

50

.03

0.5

4Ir

reg

ula

r m

en

stru

al p

erio

ds

(P)

17

5E

mo

tion

al F

un

ctio

nin

g0

.09

0.4

61

Irre

gu

lar

me

nst

rua

l pe

riod

s (P

)1

75

Co

gn

itive

Fu

nct

ion

ing

0.2

40

.04

0.6

4Ir

reg

ula

r m

en

stru

al p

erio

ds

(P)

17

5S

oci

al F

un

ctio

nin

g0

.19

0.1

1Ir

reg

ula

r m

en

stru

al p

erio

ds

(P)

17

5G

lob

al H

ea

lth S

tatu

s/Q

oL

-0.0

70

.58

1Ir

reg

ula

r m

en

stru

al p

erio

ds

(P)

17

5H

RQ

OL

Su

mm

ary

Sco

re0

.22

0.0

50

.79

Irre

gu

lar

me

nst

rua

l pe

riod

s (P

)2

61

EC

OG

PS

2-4

EC

OG

PS

0-1

7.6

3%

0.1

5.

0.8

31

Irre

gu

lar

me

nst

rua

l pe

riod

s (P

)2

21

Ag

e <

40

Ag

e >

60

47

.37

%1

.52

.0

.21

Irre

gu

lar

me

nst

rua

l pe

riod

s (P

)2

59

Ph

ysic

al F

un

ctio

nin

g-0

.22

0.0

91

Irre

gu

lar

me

nst

rua

l pe

riod

s (P

)2

59

Ro

le F

un

ctio

nin

g-0

.12

0.3

51

Irre

gu

lar

me

nst

rua

l pe

riod

s (P

)2

59

Em

otio

na

l Fu

nct

ion

ing

0.1

40

.29

1Ir

reg

ula

r m

en

stru

al p

erio

ds

(P)

25

9C

og

niti

ve F

un

ctio

nin

g0

.09

0.4

81

Irre

gu

lar

me

nst

rua

l pe

riod

s (P

)2

59

So

cia

l Fu

nct

ion

ing

-0.1

80

.17

1Ir

reg

ula

r m

en

stru

al p

erio

ds

(P)

25

9G

lob

al H

ea

lth S

tatu

s/Q

oL

-0.3

30

.01

**0

.19

Irre

gu

lar

me

nst

rua

l pe

riod

s (P

)2

59

HR

QO

L S

um

ma

ry S

core

-0.1

90

.15

1Itc

hy

skin

(S

)1

41

1E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.05

0.7

9-0

.07

.0

.63

0.8

1Itc

hy

skin

(S

)1

39

6P

hys

ica

l Fu

nct

ion

ing

0.1

10

.03

0.2

5Itc

hy

skin

(S

)1

39

6R

ole

Fu

nct

ion

ing

0.0

90

.08

0.4

Itch

y sk

in (

S)

13

96

Em

otio

na

l Fu

nct

ion

ing

0.0

80

.10

.4Itc

hy

skin

(S

)1

39

6C

og

niti

ve F

un

ctio

nin

g0

.07

0.1

80

.55

Itch

y sk

in (

S)

13

96

So

cia

l Fu

nct

ion

ing

0.1

30

.01

0.1

1Itc

hy

skin

(S

)1

39

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

80

.09

0.4

Itch

y sk

in (

S)

13

93

HR

QO

L S

um

ma

ry S

core

0.1

30

.00

80

.08

Itch

y sk

in (

S)

23

74

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

30

.80

0.0

4.

0.8

10

.81

Itch

y sk

in (

S)

23

59

Ph

ysic

al F

un

ctio

nin

g0

.15

0.0

04

0.0

49

Itch

y sk

in (

S)

23

59

Ro

le F

un

ctio

nin

g0

.15

0.0

04

0.0

49

Itch

y sk

in (

S)

23

59

Em

otio

na

l Fu

nct

ion

ing

0.1

40

.00

80

.08

Itch

y sk

in (

S)

23

59

Co

gn

itive

Fu

nct

ion

ing

0.2

1<

0.0

01

0.0

01

Itch

y sk

in (

S)

23

59

So

cia

l Fu

nct

ion

ing

0.1

9<

0.0

01

0.0

05

Itch

y sk

in (

S)

23

59

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.10

0.0

70

.4Itc

hy

skin

(S

)2

35

5H

RQ

OL

Su

mm

ary

Sco

re0

.22

<0

.00

1<

0.0

01

Lo

ose

sto

ols

(F

)1

81

7E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.24

1.0

40

.23

.0

.01

0.0

2L

oo

se s

too

ls (

F)

18

17

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.24

1.0

40

.23

.0

.00

10

.00

6L

oo

se s

too

ls (

F)

18

17

Dia

rrh

ea

me

d in

prio

r w

ee

kO

the

r1

.51

0.9

71

.56

.<

0.0

01

<0

.00

1L

oo

se s

too

ls (

F)

18

01

Ph

ysic

al F

un

ctio

nin

g0

.18

<0

.00

1<

0.0

01

Lo

ose

sto

ols

(F

)1

80

1R

ole

Fu

nct

ion

ing

0.1

7<

0.0

01

<0

.00

1L

oo

se s

too

ls (

F)

17

98

Em

otio

na

l Fu

nct

ion

ing

0.1

7<

0.0

01

<0

.00

1L

oo

se s

too

ls (

F)

17

98

Co

gn

itive

Fu

nct

ion

ing

0.1

6<

0.0

01

<0

.00

1L

oo

se s

too

ls (

F)

17

98

So

cia

l Fu

nct

ion

ing

0.1

4<

0.0

01

<0

.00

1L

oo

se s

too

ls (

F)

17

98

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.16

<0

.00

1<

0.0

01

Lo

ose

sto

ols

(F

)1

79

6H

RQ

OL

Su

mm

ary

Sco

re0

.28

<0

.00

1<

0.0

01

Lo

ose

sto

ols

(F

)1

80

1D

iarr

he

a0

.71

<0

.00

1<

0.0

01

Lo

ose

sto

ols

(F

)2

75

5E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.24

1.0

40

.23

.0

.02

0.0

2L

oo

se s

too

ls (

F)

27

55

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.18

1.0

40

.18

.0

.02

0.0

2L

oo

se s

too

ls (

F)

27

55

Dia

rrh

ea

me

d in

prio

r w

ee

kO

the

r1

.59

0.9

31

.71

.<

0.0

01

<0

.00

1L

oo

se s

too

ls (

F)

27

33

Ph

ysic

al F

un

ctio

nin

g0

.17

<0

.00

1<

0.0

01

Lo

ose

sto

ols

(F

)2

73

3R

ole

Fu

nct

ion

ing

0.1

4<

0.0

01

0.0

01

Lo

ose

sto

ols

(F

)2

73

1E

mo

tion

al F

un

ctio

nin

g0

.12

0.0

01

0.0

06

Lo

ose

sto

ols

(F

)2

73

1C

og

niti

ve F

un

ctio

nin

g0

.14

<0

.00

1<

0.0

01

Lo

ose

sto

ols

(F

)2

73

0S

oci

al F

un

ctio

nin

g0

.18

<0

.00

1<

0.0

01

Lo

ose

sto

ols

(F

)2

73

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

3<

0.0

01

0.0

02

Lo

ose

sto

ols

(F

)2

72

4H

RQ

OL

Su

mm

ary

Sco

re0

.27

<0

.00

1<

0.0

01

Lo

ose

sto

ols

(F

)2

73

3D

iarr

he

a0

.78

<0

.00

1<

0.0

01

Lo

se a

ny

fing

ern

ails

/toe

na

ils (

P)

14

83

EC

OG

PS

2-4

EC

OG

PS

0-1

-2.1

9%

-0.1

4.

0.3

80

.99

Lo

se a

ny

fing

ern

ails

/toe

na

ils (

P)

14

68

Ph

ysic

al F

un

ctio

nin

g0

.00

0.9

90

.99

Lo

se a

ny

fing

ern

ails

/toe

na

ils (

P)

14

68

Ro

le F

un

ctio

nin

g-0

.03

0.5

60

.99

Lo

se a

ny

fing

ern

ails

/toe

na

ils (

P)

14

68

Em

otio

na

l Fu

nct

ion

ing

-0.0

10

.85

0.9

9L

ose

an

y fin

ge

rna

ils/to

en

ails

(P

)1

46

8C

og

niti

ve F

un

ctio

nin

g0

.10

0.0

30

.4L

ose

an

y fin

ge

rna

ils/to

en

ails

(P

)1

46

8S

oci

al F

un

ctio

nin

g0

.06

0.2

0.9

9L

ose

an

y fin

ge

rna

ils/to

en

ails

(P

)1

46

8G

lob

al H

ea

lth S

tatu

s/Q

oL

-0.0

10

.81

0.9

9L

ose

an

y fin

ge

rna

ils/to

en

ails

(P

)1

46

5H

RQ

OL

Su

mm

ary

Sco

re0

.00

0.9

90

.99

Lo

se a

ny

fing

ern

ails

/toe

na

ils (

P)

24

39

EC

OG

PS

2-4

EC

OG

PS

0-1

-1.9

0%

-0.1

1.

0.5

30

.99

Lo

se a

ny

fing

ern

ails

/toe

na

ils (

P)

24

23

Ph

ysic

al F

un

ctio

nin

g0

.06

0.2

50

.99

Lo

se a

ny

fing

ern

ails

/toe

na

ils (

P)

24

23

Ro

le F

un

ctio

nin

g0

.04

0.3

60

.99

Lo

se a

ny

fing

ern

ails

/toe

na

ils (

P)

24

22

Em

otio

na

l Fu

nct

ion

ing

0.1

00

.04

80

.72

Lo

se a

ny

fing

ern

ails

/toe

na

ils (

P)

24

22

Co

gn

itive

Fu

nct

ion

ing

0.0

60

.23

0.9

9L

ose

an

y fin

ge

rna

ils/to

en

ails

(P

)2

42

1S

oci

al F

un

ctio

nin

g0

.08

0.1

0.9

9L

ose

an

y fin

ge

rna

ils/to

en

ails

(P

)2

42

2G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

60

.25

0.9

9L

ose

an

y fin

ge

rna

ils/to

en

ails

(P

)2

41

5H

RQ

OL

Su

mm

ary

Sco

re0

.09

0.0

80

.99

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

F)

13

47

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

20

.64

0.1

8.

0.2

10

.63

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

F)

12

40

Co

lore

cta

l/Pro

sta

teL

un

g0

.19

0.6

00

.31

.0

.03

0.1

5L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(F

)1

33

9P

hys

ica

l Fu

nct

ion

ing

0.1

80

.00

10

.01

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 27: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

27

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eL

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(F

)1

33

9R

ole

Fu

nct

ion

ing

0.1

8<

0.0

01

0.0

1L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(F

)1

33

9E

mo

tion

al F

un

ctio

nin

g0

.14

0.0

10

.08

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

F)

13

39

Co

gn

itive

Fu

nct

ion

ing

0.1

40

.01

0.0

8L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(F

)1

33

9S

oci

al F

un

ctio

nin

g0

.14

0.0

08

0.0

8L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(F

)1

33

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

70

.00

20

.02

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

F)

13

36

HR

QO

L S

um

ma

ry S

core

0.2

7<

0.0

01

<0

.00

1L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(F

)2

30

4E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.04

0.5

6-0

.07

.0

.68

0.6

8L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(F

)2

20

8C

olo

rect

al/P

rost

ate

Lu

ng

0.0

50

.57

0.0

9.

0.5

20

.68

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

F)

22

98

Ph

ysic

al F

un

ctio

nin

g0

.21

<0

.00

10

.00

3L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(F

)2

29

8R

ole

Fu

nct

ion

ing

0.2

1<

0.0

01

0.0

05

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

F)

22

95

Em

otio

na

l Fu

nct

ion

ing

0.1

20

.04

60

.23

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

F)

22

95

Co

gn

itive

Fu

nct

ion

ing

0.0

80

.15

0.6

1L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(F

)2

29

4S

oci

al F

un

ctio

nin

g0

.15

0.0

10

.08

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

F)

22

95

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.15

0.0

10

.08

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

F)

22

91

HR

QO

L S

um

ma

ry S

core

0.2

6<

0.0

01

<0

.00

1L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(I)

13

48

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

90

.63

0.1

5.

0.3

20

.72

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)1

24

1C

olo

rect

al/P

rost

ate

Lu

ng

0.0

70

.67

0.1

0.

0.4

50

.72

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)1

34

0P

hys

ica

l Fu

nct

ion

ing

0.2

0<

0.0

01

0.0

03

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)1

34

0R

ole

Fu

nct

ion

ing

0.2

1<

0.0

01

0.0

02

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)1

34

0E

mo

tion

al F

un

ctio

nin

g0

.13

0.0

20

.13

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)1

34

0C

og

niti

ve F

un

ctio

nin

g0

.18

0.0

01

0.0

1L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(I)

13

40

So

cia

l Fu

nct

ion

ing

0.1

9<

0.0

01

0.0

06

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)1

34

0G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

10

.04

0.2

8L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(I)

13

37

HR

QO

L S

um

ma

ry S

core

0.2

8<

0.0

01

<0

.00

1L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(I)

23

04

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.0

30

.53

-0.0

6.

0.7

20

.72

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)2

20

8C

olo

rect

al/P

rost

ate

Lu

ng

0.1

10

.55

0.1

9.

0.1

90

.72

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)2

29

8P

hys

ica

l Fu

nct

ion

ing

0.2

0<

0.0

01

0.0

07

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)2

29

8R

ole

Fu

nct

ion

ing

0.2

2<

0.0

01

0.0

02

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)2

29

5E

mo

tion

al F

un

ctio

nin

g0

.10

0.0

90

.44

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)2

29

5C

og

niti

ve F

un

ctio

nin

g0

.10

0.0

80

.44

Lo

ss o

f co

ntr

ol o

f bo

we

l mo

vem

en

ts (

I)2

29

4S

oci

al F

un

ctio

nin

g0

.15

0.0

08

0.0

7L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(I)

22

95

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.19

<0

.00

10

.00

9L

oss

of c

on

tro

l of b

ow

el m

ove

me

nts

(I)

22

91

HR

QO

L S

um

ma

ry S

core

0.2

7<

0.0

01

<0

.00

1L

oss

of c

on

tro

l of u

rine

(F

)1

22

2E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.02

0.9

0-0

.02

.0

.92

0.9

8L

oss

of c

on

tro

l of u

rine

(F

)1

11

2C

olo

rect

al/P

rost

ate

He

ma

tolo

gic

0.5

40

.93

0.5

8.

0.0

05

0.0

9L

oss

of c

on

tro

l of u

rine

(F

)1

22

1P

hys

ica

l Fu

nct

ion

ing

0.0

50

.47

0.9

8L

oss

of c

on

tro

l of u

rine

(F

)1

22

1R

ole

Fu

nct

ion

ing

0.0

00

.98

0.9

8L

oss

of c

on

tro

l of u

rine

(F

)1

22

1E

mo

tion

al F

un

ctio

nin

g-0

.01

0.9

0.9

8L

oss

of c

on

tro

l of u

rine

(F

)1

22

1C

og

niti

ve F

un

ctio

nin

g0

.00

0.9

70

.98

Lo

ss o

f co

ntr

ol o

f urin

e (

F)

12

21

So

cia

l Fu

nct

ion

ing

0.0

50

.49

0.9

8L

oss

of c

on

tro

l of u

rine

(F

)1

22

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

70

.30

.98

Lo

ss o

f co

ntr

ol o

f urin

e (

F)

12

19

HR

QO

L S

um

ma

ry S

core

0.0

70

.31

0.9

8L

oss

of c

on

tro

l of u

rine

(F

)2

19

2E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.04

0.8

9-0

.04

.0

.84

0.9

8L

oss

of c

on

tro

l of u

rine

(F

)2

96

Co

lore

cta

l/Pro

sta

teH

em

ato

log

ic0

.33

0.9

70

.34

.0

.13

0.9

8L

oss

of c

on

tro

l of u

rine

(F

)2

19

0P

hys

ica

l Fu

nct

ion

ing

0.0

80

.25

0.9

8L

oss

of c

on

tro

l of u

rine

(F

)2

19

0R

ole

Fu

nct

ion

ing

0.0

30

.66

0.9

8L

oss

of c

on

tro

l of u

rine

(F

)2

18

9E

mo

tion

al F

un

ctio

nin

g0

.02

0.8

10

.98

Lo

ss o

f co

ntr

ol o

f urin

e (

F)

21

89

Co

gn

itive

Fu

nct

ion

ing

0.0

90

.23

0.9

8L

oss

of c

on

tro

l of u

rine

(F

)2

18

8S

oci

al F

un

ctio

nin

g0

.06

0.3

80

.98

Lo

ss o

f co

ntr

ol o

f urin

e (

F)

21

89

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.09

0.2

30

.98

Lo

ss o

f co

ntr

ol o

f urin

e (

F)

21

86

HR

QO

L S

um

ma

ry S

core

0.0

50

.49

0.9

8L

oss

of c

on

tro

l of u

rine

(I)

12

22

EC

OG

PS

2-4

EC

OG

PS

0-1

00

.78

0.

0.9

90

.99

Lo

ss o

f co

ntr

ol o

f urin

e (

I)1

11

2C

olo

rect

al/P

rost

ate

He

ma

tolo

gic

0.3

20

.76

0.4

2.

0.0

40

.7L

oss

of c

on

tro

l of u

rine

(I)

12

21

Ph

ysic

al F

un

ctio

nin

g0

.10

0.1

20

.99

Lo

ss o

f co

ntr

ol o

f urin

e (

I)1

22

1R

ole

Fu

nct

ion

ing

0.0

60

.36

0.9

9L

oss

of c

on

tro

l of u

rine

(I)

12

21

Em

otio

na

l Fu

nct

ion

ing

0.1

00

.15

0.9

9L

oss

of c

on

tro

l of u

rine

(I)

12

21

Co

gn

itive

Fu

nct

ion

ing

0.0

40

.56

0.9

9L

oss

of c

on

tro

l of u

rine

(I)

12

21

So

cia

l Fu

nct

ion

ing

0.1

20

.07

0.9

9L

oss

of c

on

tro

l of u

rine

(I)

12

21

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.05

0.4

20

.99

Lo

ss o

f co

ntr

ol o

f urin

e (

I)1

21

9H

RQ

OL

Su

mm

ary

Sco

re0

.14

0.0

40

.7L

oss

of c

on

tro

l of u

rine

(I)

21

92

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.1

70

.62

-0.2

7.

0.2

10

.99

Lo

ss o

f co

ntr

ol o

f urin

e (

I)2

96

Co

lore

cta

l/Pro

sta

teH

em

ato

log

ic0

.18

0.6

20

.29

.0

.19

0.9

9L

oss

of c

on

tro

l of u

rine

(I)

21

90

Ph

ysic

al F

un

ctio

nin

g0

.10

0.1

80

.99

Lo

ss o

f co

ntr

ol o

f urin

e (

I)2

19

0R

ole

Fu

nct

ion

ing

0.0

00

.98

0.9

9L

oss

of c

on

tro

l of u

rine

(I)

21

89

Em

otio

na

l Fu

nct

ion

ing

0.0

60

.42

0.9

9L

oss

of c

on

tro

l of u

rine

(I)

21

89

Co

gn

itive

Fu

nct

ion

ing

0.0

40

.60

.99

Lo

ss o

f co

ntr

ol o

f urin

e (

I)2

18

8S

oci

al F

un

ctio

nin

g0

.03

0.6

60

.99

Lo

ss o

f co

ntr

ol o

f urin

e (

I)2

18

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

40

.56

0.9

9L

oss

of c

on

tro

l of u

rine

(I)

21

86

HR

QO

L S

um

ma

ry S

core

0.0

40

.59

0.9

9M

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)1

69

EC

OG

PS

2-4

EC

OG

PS

0-1

-12

.81

%-0

.29

.0

.55

0.9

6M

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)1

27

Ag

e <

40

Ag

e >

60

5.4

3%

0.1

2.

0.8

30

.96

Mis

s a

n e

xpe

cte

d m

en

stru

al p

erio

d (

P)

16

7P

hys

ica

l Fu

nct

ion

ing

0.2

90

.02

0.2

9M

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)1

67

Ro

le F

un

ctio

nin

g0

.26

0.0

30

.43

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 28: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

28

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eM

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)1

67

Em

otio

na

l Fu

nct

ion

ing

-0.0

10

.96

0.9

6M

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)1

67

Co

gn

itive

Fu

nct

ion

ing

0.3

10

.01

0.1

5M

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)1

67

So

cia

l Fu

nct

ion

ing

0.3

20

.00

90

.15

Mis

s a

n e

xpe

cte

d m

en

stru

al p

erio

d (

P)

16

7G

lob

al H

ea

lth S

tatu

s/Q

oL

-0.0

90

.48

0.9

6M

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)1

67

HR

QO

L S

um

ma

ry S

core

0.2

20

.07

0.9

Mis

s a

n e

xpe

cte

d m

en

stru

al p

erio

d (

P)

26

0E

CO

G P

S 2

-4E

CO

G P

S 0

-1-3

9.6

6%

-1.3

6.

0.2

60

.96

Mis

s a

n e

xpe

cte

d m

en

stru

al p

erio

d (

P)

22

0A

ge

<4

0A

ge

>6

04

2.1

1%

1.4

1.

0.4

0.9

6M

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)2

58

Ph

ysic

al F

un

ctio

nin

g-0

.08

0.5

30

.96

Mis

s a

n e

xpe

cte

d m

en

stru

al p

erio

d (

P)

25

8R

ole

Fu

nct

ion

ing

-0.1

00

.44

0.9

6M

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)2

58

Em

otio

na

l Fu

nct

ion

ing

-0.0

50

.71

0.9

6M

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)2

58

Co

gn

itive

Fu

nct

ion

ing

-0.1

00

.46

0.9

6M

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)2

58

So

cia

l Fu

nct

ion

ing

-0.1

30

.33

0.9

6M

iss

an

exp

ect

ed

me

nst

rua

l pe

riod

(P

)2

58

Glo

ba

l He

alth

Sta

tus/

Qo

L-0

.34

0.0

09

**0

.15

Mis

s a

n e

xpe

cte

d m

en

stru

al p

erio

d (

P)

25

8H

RQ

OL

Su

mm

ary

Sco

re-0

.22

0.1

0.9

6M

ou

th o

r th

roa

t so

res

(S)

18

24

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

60

.84

0.3

1.

<0

.00

10

.00

3M

ou

th o

r th

roa

t so

res

(S)

18

24

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.19

0.8

40

.22

.0

.00

10

.00

4M

ou

th o

r th

roa

t so

res

(S)

18

24

He

ad

/Ne

ck w

ith r

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r0

.52

0.8

20

.64

.<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(S)

18

08

Ph

ysic

al F

un

ctio

nin

g0

.17

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (S

)1

80

8R

ole

Fu

nct

ion

ing

0.1

9<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(S)

18

05

Em

otio

na

l Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(S)

18

05

Co

gn

itive

Fu

nct

ion

ing

0.1

6<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(S)

18

05

So

cia

l Fu

nct

ion

ing

0.2

2<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(S)

18

05

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.18

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (S

)1

80

3H

RQ

OL

Su

mm

ary

Sco

re0

.28

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (S

)2

76

1E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.21

0.9

70

.22

.0

.03

0.0

3M

ou

th o

r th

roa

t so

res

(S)

27

61

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.19

0.9

70

.20

.0

.00

70

.01

Mo

uth

or

thro

at s

ore

s (S

)2

76

1H

ea

d/N

eck

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

Oth

er

0.6

40

.94

0.6

8.

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (S

)2

73

9P

hys

ica

l Fu

nct

ion

ing

0.2

2<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(S)

27

39

Ro

le F

un

ctio

nin

g0

.23

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (S

)2

73

7E

mo

tion

al F

un

ctio

nin

g0

.19

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (S

)2

73

7C

og

niti

ve F

un

ctio

nin

g0

.16

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (S

)2

73

6S

oci

al F

un

ctio

nin

g0

.30

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (S

)2

73

7G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

6<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(S)

27

30

HR

QO

L S

um

ma

ry S

core

0.3

4<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(I)

18

22

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

40

.76

0.3

2.

<0

.00

10

.00

2M

ou

th o

r th

roa

t so

res

(I)

18

22

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.14

0.7

70

.19

.0

.00

70

.01

Mo

uth

or

thro

at s

ore

s (I

)1

82

2H

ea

d/N

eck

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

Oth

er

0.4

60

.75

0.6

1.

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (I

)1

80

6P

hys

ica

l Fu

nct

ion

ing

0.1

8<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(I)

18

06

Ro

le F

un

ctio

nin

g0

.24

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (I

)1

80

3E

mo

tion

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (I

)1

80

3C

og

niti

ve F

un

ctio

nin

g0

.12

<0

.00

10

.00

2M

ou

th o

r th

roa

t so

res

(I)

18

03

So

cia

l Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(I)

18

03

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.18

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (I

)1

80

1H

RQ

OL

Su

mm

ary

Sco

re0

.28

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (I

)2

76

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.26

0.9

10

.28

.0

.00

50

.01

Mo

uth

or

thro

at s

ore

s (I

)2

76

2C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

0.1

20

.92

0.1

3.

0.0

70

.07

Mo

uth

or

thro

at s

ore

s (I

)2

76

2H

ea

d/N

eck

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

Oth

er

0.6

10

.89

0.6

8.

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (I

)2

74

0P

hys

ica

l Fu

nct

ion

ing

0.2

1<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(I)

27

40

Ro

le F

un

ctio

nin

g0

.24

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (I

)2

73

8E

mo

tion

al F

un

ctio

nin

g0

.20

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (I

)2

73

8C

og

niti

ve F

un

ctio

nin

g0

.17

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (I

)2

73

7S

oci

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Mo

uth

or

thro

at s

ore

s (I

)2

73

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

3<

0.0

01

<0

.00

1M

ou

th o

r th

roa

t so

res

(I)

27

31

HR

QO

L S

um

ma

ry S

core

0.3

3<

0.0

01

<0

.00

1N

au

sea

(F

)1

83

5E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.39

1.0

60

.36

.<

0.0

01

<0

.00

1N

au

sea

(F

)1

83

5C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

0.4

61

.05

0.4

4.

<0

.00

1<

0.0

01

Na

use

a (

F)

18

35

Cu

rre

ntly

taki

ng

na

use

a m

ed

Oth

er

0.9

80

.96

1.0

2.

<0

.00

1<

0.0

01

Na

use

a (

F)

18

35

Op

ioid

[na

rco

tic] p

ain

me

d in

prio

r w

ee

kO

the

r0

.56

1.0

40

.54

.<

0.0

01

<0

.00

1N

au

sea

(F

)1

81

9P

hys

ica

l Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1N

au

sea

(F

)1

81

9R

ole

Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1N

au

sea

(F

)1

81

6E

mo

tion

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Na

use

a (

F)

18

16

Co

gn

itive

Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1N

au

sea

(F

)1

81

6S

oci

al F

un

ctio

nin

g0

.33

<0

.00

1<

0.0

01

Na

use

a (

F)

18

16

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.28

<0

.00

1<

0.0

01

Na

use

a (

F)

18

14

HR

QO

L S

um

ma

ry S

core

0.4

9<

0.0

01

<0

.00

1N

au

sea

(F

)1

81

9N

au

sea

an

d V

om

itin

g0

.73

<0

.00

1<

0.0

01

Na

use

a (

F)

27

74

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

61

.09

0.3

3.

<0

.00

1<

0.0

01

Na

use

a (

F)

27

74

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.30

1.0

90

.28

.<

0.0

01

<0

.00

1N

au

sea

(F

)2

77

4C

urr

en

tly ta

kin

g n

au

sea

me

dO

the

r0

.96

1.0

00

.95

.<

0.0

01

<0

.00

1N

au

sea

(F

)2

77

4O

pio

id [n

arc

otic

] pa

in m

ed

in p

rior

we

ek

Oth

er

0.6

51

.06

0.6

1.

<0

.00

1<

0.0

01

Na

use

a (

F)

27

52

Ph

ysic

al F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Na

use

a (

F)

27

52

Ro

le F

un

ctio

nin

g0

.30

<0

.00

1<

0.0

01

Na

use

a (

F)

27

50

Em

otio

na

l Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 29: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

29

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eN

au

sea

(F

)2

75

0C

og

niti

ve F

un

ctio

nin

g0

.33

<0

.00

1<

0.0

01

Na

use

a (

F)

27

49

So

cia

l Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1N

au

sea

(F

)2

75

0G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

1<

0.0

01

<0

.00

1N

au

sea

(F

)2

74

3H

RQ

OL

Su

mm

ary

Sco

re0

.50

<0

.00

1<

0.0

01

Na

use

a (

F)

27

52

Na

use

a a

nd

Vo

miti

ng

0.7

5<

0.0

01

<0

.00

1N

au

sea

(S

)1

83

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.36

0.9

70

.37

.<

0.0

01

<0

.00

1N

au

sea

(S

)1

83

4C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

0.3

40

.97

0.3

5.

<0

.00

1<

0.0

01

Na

use

a (

S)

18

34

Cu

rre

ntly

taki

ng

na

use

a m

ed

Oth

er

0.8

80

.88

1.0

0.

<0

.00

1<

0.0

01

Na

use

a (

S)

18

34

Op

ioid

[na

rco

tic] p

ain

me

d in

prio

r w

ee

kO

the

r0

.58

0.9

40

.61

.<

0.0

01

<0

.00

1N

au

sea

(S

)1

81

8P

hys

ica

l Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1N

au

sea

(S

)1

81

8R

ole

Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1N

au

sea

(S

)1

81

5E

mo

tion

al F

un

ctio

nin

g0

.33

<0

.00

1<

0.0

01

Na

use

a (

S)

18

15

Co

gn

itive

Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1N

au

sea

(S

)1

81

5S

oci

al F

un

ctio

nin

g0

.35

<0

.00

1<

0.0

01

Na

use

a (

S)

18

15

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.30

<0

.00

1<

0.0

01

Na

use

a (

S)

18

13

HR

QO

L S

um

ma

ry S

core

0.5

1<

0.0

01

<0

.00

1N

au

sea

(S

)1

81

8N

au

sea

an

d V

om

itin

g0

.73

<0

.00

1<

0.0

01

Na

use

a (

S)

27

75

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

40

.94

0.3

6.

<0

.00

1<

0.0

01

Na

use

a (

S)

27

75

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

.28

0.9

40

.30

.<

0.0

01

<0

.00

1N

au

sea

(S

)2

77

5C

urr

en

tly ta

kin

g n

au

sea

me

dO

the

r0

.79

0.8

80

.90

.<

0.0

01

<0

.00

1N

au

sea

(S

)2

77

5O

pio

id [n

arc

otic

] pa

in m

ed

in p

rior

we

ek

Oth

er

0.5

60

.91

0.6

1.

<0

.00

1<

0.0

01

Na

use

a (

S)

27

53

Ph

ysic

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Na

use

a (

S)

27

53

Ro

le F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Na

use

a (

S)

27

51

Em

otio

na

l Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1N

au

sea

(S

)2

75

1C

og

niti

ve F

un

ctio

nin

g0

.33

<0

.00

1<

0.0

01

Na

use

a (

S)

27

50

So

cia

l Fu

nct

ion

ing

0.3

7<

0.0

01

<0

.00

1N

au

sea

(S

)2

75

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

5<

0.0

01

<0

.00

1N

au

sea

(S

)2

74

4H

RQ

OL

Su

mm

ary

Sco

re0

.53

<0

.00

1<

0.0

01

Na

use

a (

S)

27

53

Na

use

a a

nd

Vo

miti

ng

0.7

6<

0.0

01

<0

.00

1N

ose

ble

ed

s (F

)1

31

5E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.00

0.6

2-0

.01

.0

.96

0.9

9N

ose

ble

ed

s (F

)1

31

5B

eva

cizu

ma

b in

prio

r 2

we

eks

Oth

er

0.0

60

.61

0.1

0.

0.6

20

.99

No

seb

lee

ds

(F)

13

07

Ph

ysic

al F

un

ctio

nin

g-0

.01

0.8

30

.99

No

seb

lee

ds

(F)

13

07

Ro

le F

un

ctio

nin

g0

.00

0.9

90

.99

No

seb

lee

ds

(F)

13

07

Em

otio

na

l Fu

nct

ion

ing

-0.0

90

.12

0.9

9N

ose

ble

ed

s (F

)1

30

7C

og

niti

ve F

un

ctio

nin

g0

.07

0.2

50

.99

No

seb

lee

ds

(F)

13

07

So

cia

l Fu

nct

ion

ing

-0.0

10

.81

0.9

9N

ose

ble

ed

s (F

)1

30

7G

lob

al H

ea

lth S

tatu

s/Q

oL

-0.0

20

.73

0.9

9N

ose

ble

ed

s (F

)1

30

4H

RQ

OL

Su

mm

ary

Sco

re0

.03

0.6

50

.99

No

seb

lee

ds

(F)

22

78

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

40

.50

0.0

8.

0.6

30

.99

No

seb

lee

ds

(F)

22

78

Be

vaci

zum

ab

in p

rior

2 w

ee

ksO

the

r0

.07

0.5

00

.15

.0

.48

0.9

9N

ose

ble

ed

s (F

)2

27

3P

hys

ica

l Fu

nct

ion

ing

0.0

00

.96

0.9

9N

ose

ble

ed

s (F

)2

27

3R

ole

Fu

nct

ion

ing

-0.0

20

.68

0.9

9N

ose

ble

ed

s (F

)2

27

1E

mo

tion

al F

un

ctio

nin

g0

.04

0.5

30

.99

No

seb

lee

ds

(F)

22

71

Co

gn

itive

Fu

nct

ion

ing

0.0

10

.93

0.9

9N

ose

ble

ed

s (F

)2

27

1S

oci

al F

un

ctio

nin

g0

.08

0.1

70

.99

No

seb

lee

ds

(F)

22

71

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.02

0.7

40

.99

No

seb

lee

ds

(F)

22

70

HR

QO

L S

um

ma

ry S

core

0.0

20

.76

0.9

9N

ose

ble

ed

s (S

)1

31

4E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.04

0.5

1-0

.07

.0

.62

0.9

7N

ose

ble

ed

s (S

)1

31

4B

eva

cizu

ma

b in

prio

r 2

we

eks

Oth

er

0.0

20

.51

0.0

5.

0.8

10

.97

No

seb

lee

ds

(S)

13

06

Ph

ysic

al F

un

ctio

nin

g0

.00

0.9

70

.97

No

seb

lee

ds

(S)

13

06

Ro

le F

un

ctio

nin

g0

.02

0.7

60

.97

No

seb

lee

ds

(S)

13

06

Em

otio

na

l Fu

nct

ion

ing

-0.0

60

.30

.97

No

seb

lee

ds

(S)

13

06

Co

gn

itive

Fu

nct

ion

ing

0.0

60

.27

0.9

7N

ose

ble

ed

s (S

)1

30

6S

oci

al F

un

ctio

nin

g0

.02

0.7

40

.97

No

seb

lee

ds

(S)

13

06

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.01

0.9

10

.97

No

seb

lee

ds

(S)

13

03

HR

QO

L S

um

ma

ry S

core

0.0

40

.46

0.9

7N

ose

ble

ed

s (S

)2

27

7E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.01

0.4

7-0

.01

.0

.93

0.9

7N

ose

ble

ed

s (S

)2

27

7B

eva

cizu

ma

b in

prio

r 2

we

eks

Oth

er

0.1

00

.47

0.2

2.

0.3

10

.97

No

seb

lee

ds

(S)

22

72

Ph

ysic

al F

un

ctio

nin

g0

.05

0.4

10

.97

No

seb

lee

ds

(S)

22

72

Ro

le F

un

ctio

nin

g0

.05

0.4

50

.97

No

seb

lee

ds

(S)

22

70

Em

otio

na

l Fu

nct

ion

ing

0.0

80

.21

0.9

7N

ose

ble

ed

s (S

)2

27

0C

og

niti

ve F

un

ctio

nin

g0

.02

0.7

60

.97

No

seb

lee

ds

(S)

22

70

So

cia

l Fu

nct

ion

ing

0.1

10

.08

0.9

7N

ose

ble

ed

s (S

)2

27

0G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

20

.70

.97

No

seb

lee

ds

(S)

22

69

HR

QO

L S

um

ma

ry S

core

0.0

70

.26

0.9

7N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

S)

18

46

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

40

.93

0.2

6.

0.0

04

0.0

2N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

S)

18

46

Ta

xan

e/v

inca

alk

alo

id/p

latin

ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r0

0.9

40

.0

.97

0.9

7N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

S)

18

29

Ph

ysic

al F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (S

)1

82

9R

ole

Fu

nct

ion

ing

0.2

1<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

S)

18

26

Em

otio

na

l Fu

nct

ion

ing

0.2

0<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

S)

18

26

Co

gn

itive

Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

S)

18

26

So

cia

l Fu

nct

ion

ing

0.1

9<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

S)

18

26

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.19

<0

.00

1<

0.0

01

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 30: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

30

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eN

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

S)

18

24

HR

QO

L S

um

ma

ry S

core

0.3

2<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

S)

27

82

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

00

.91

0.1

1.

0.2

60

.77

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (S

)2

78

2T

axa

ne

/vin

ca a

lka

loid

/pla

tin c

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

00

.91

0.

0.9

60

.97

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (S

)2

75

9P

hys

ica

l Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

S)

27

59

Ro

le F

un

ctio

nin

g0

.17

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (S

)2

75

7E

mo

tion

al F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (S

)2

75

7C

og

niti

ve F

un

ctio

nin

g0

.18

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (S

)2

75

6S

oci

al F

un

ctio

nin

g0

.11

0.0

02

0.0

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

S)

27

57

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.20

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (S

)2

75

0H

RQ

OL

Su

mm

ary

Sco

re0

.26

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (I)

18

46

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

80

.88

0.3

2.

<0

.00

10

.00

2N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

I)1

84

6T

axa

ne

/vin

ca a

lka

loid

/pla

tin c

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

0.0

40

.88

0.0

5.

0.5

0.5

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (I)

18

29

Ph

ysic

al F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (I)

18

29

Ro

le F

un

ctio

nin

g0

.20

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (I)

18

26

Em

otio

na

l Fu

nct

ion

ing

0.2

5<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

I)1

82

6C

og

niti

ve F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (I)

18

26

So

cia

l Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

I)1

82

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

0<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

I)1

82

4H

RQ

OL

Su

mm

ary

Sco

re0

.34

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (I)

27

82

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

30

.83

0.1

6.

0.1

10

.33

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (I)

27

82

Ta

xan

e/v

inca

alk

alo

id/p

latin

ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r-0

.05

0.8

3-0

.06

.0

.43

0.5

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (I)

27

59

Ph

ysic

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (I)

27

59

Ro

le F

un

ctio

nin

g0

.23

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (I)

27

57

Em

otio

na

l Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

I)2

75

7C

og

niti

ve F

un

ctio

nin

g0

.22

<0

.00

1<

0.0

01

Nu

mb

ne

ss/ti

ng

ling

in y

ou

r h

an

ds

or

fee

t (I)

27

56

So

cia

l Fu

nct

ion

ing

0.2

0<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

I)2

75

7G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

1<

0.0

01

<0

.00

1N

um

bn

ess

/tin

glin

g in

yo

ur

ha

nd

s o

r fe

et (

I)2

75

0H

RQ

OL

Su

mm

ary

Sco

re0

.33

<0

.00

1<

0.0

01

Pa

in (

F)

18

48

EC

OG

PS

2-4

EC

OG

PS

0-1

0.6

21

.27

0.4

9.

<0

.00

1<

0.0

01

Pa

in (

F)

18

48

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r-0

.07

1.2

9-0

.06

.0

.40

.4P

ain

(F

)1

84

8O

pio

id [n

arc

otic

] pa

in m

ed

in p

rior

we

ek

Oth

er

1.4

11

.11

1.2

7.

<0

.00

1<

0.0

01

Pa

in (

F)

18

48

Su

rge

ry in

prio

r 2

we

eks

Oth

er

0.3

51

.29

0.2

7.

0.1

30

.26

Pa

in (

F)

18

32

Ph

ysic

al F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Pa

in (

F)

18

32

Ro

le F

un

ctio

nin

g0

.41

<0

.00

1<

0.0

01

Pa

in (

F)

18

29

Em

otio

na

l Fu

nct

ion

ing

0.3

8<

0.0

01

<0

.00

1P

ain

(F

)1

82

9C

og

niti

ve F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Pa

in (

F)

18

29

So

cia

l Fu

nct

ion

ing

0.3

6<

0.0

01

<0

.00

1P

ain

(F

)1

82

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.4

1<

0.0

01

<0

.00

1P

ain

(F

)1

82

7H

RQ

OL

Su

mm

ary

Sco

re0

.59

<0

.00

1<

0.0

01

Pa

in (

F)

18

33

Pa

in0

.77

<0

.00

1<

0.0

01

Pa

in (

F)

27

93

EC

OG

PS

2-4

EC

OG

PS

0-1

0.6

21

.29

0.4

8.

<0

.00

1<

0.0

01

Pa

in (

F)

27

93

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r-0

.21

1.3

0-0

.16

.0

.02

**0

.07

Pa

in (

F)

27

93

Op

ioid

[na

rco

tic] p

ain

me

d in

prio

r w

ee

kO

the

r1

.31

1.1

51

.14

.<

0.0

01

<0

.00

1P

ain

(F

)2

79

3S

urg

ery

in p

rior

2 w

ee

ksO

the

r0

.63

1.3

00

.48

.0

.02

0.0

7P

ain

(F

)2

77

1P

hys

ica

l Fu

nct

ion

ing

0.4

1<

0.0

01

<0

.00

1P

ain

(F

)2

77

1R

ole

Fu

nct

ion

ing

0.3

8<

0.0

01

<0

.00

1P

ain

(F

)2

76

9E

mo

tion

al F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Pa

in (

F)

27

69

Co

gn

itive

Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1P

ain

(F

)2

76

8S

oci

al F

un

ctio

nin

g0

.37

<0

.00

1<

0.0

01

Pa

in (

F)

27

69

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.41

<0

.00

1<

0.0

01

Pa

in (

F)

27

62

HR

QO

L S

um

ma

ry S

core

0.5

5<

0.0

01

<0

.00

1P

ain

(F

)2

77

6P

ain

0.7

8<

0.0

01

<0

.00

1P

ain

(S

)1

84

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.66

1.1

60

.57

.<

0.0

01

<0

.00

1P

ain

(S

)1

84

8C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

-0.0

31

.18

-0.0

2.

0.7

30

.73

Pa

in (

S)

18

48

Op

ioid

[na

rco

tic] p

ain

me

d in

prio

r w

ee

kO

the

r1

.31

1.0

11

.31

.<

0.0

01

<0

.00

1P

ain

(S

)1

84

8S

urg

ery

in p

rior

2 w

ee

ksO

the

r0

.40

1.1

80

.34

.0

.06

0.1

8P

ain

(S

)1

83

2P

hys

ica

l Fu

nct

ion

ing

0.4

2<

0.0

01

<0

.00

1P

ain

(S

)1

83

2R

ole

Fu

nct

ion

ing

0.4

3<

0.0

01

<0

.00

1P

ain

(S

)1

82

9E

mo

tion

al F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Pa

in (

S)

18

29

Co

gn

itive

Fu

nct

ion

ing

0.4

0<

0.0

01

<0

.00

1P

ain

(S

)1

82

9S

oci

al F

un

ctio

nin

g0

.37

<0

.00

1<

0.0

01

Pa

in (

S)

18

29

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.42

<0

.00

1<

0.0

01

Pa

in (

S)

18

27

HR

QO

L S

um

ma

ry S

core

0.6

1<

0.0

01

<0

.00

1P

ain

(S

)1

83

3P

ain

0.7

6<

0.0

01

<0

.00

1P

ain

(S

)2

79

3E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.52

1.1

50

.46

.<

0.0

01

<0

.00

1P

ain

(S

)2

79

3C

he

mo

the

rap

y in

prio

r 2

we

eks

Oth

er

-0.1

21

.17

-0.1

0.

0.1

60

.31

Pa

in (

S)

27

93

Op

ioid

[na

rco

tic] p

ain

me

d in

prio

r w

ee

kO

the

r1

.19

1.0

21

.16

.<

0.0

01

<0

.00

1P

ain

(S

)2

79

3S

urg

ery

in p

rior

2 w

ee

ksO

the

r0

.50

1.1

60

.43

.0

.04

0.1

8P

ain

(S

)2

77

1P

hys

ica

l Fu

nct

ion

ing

0.4

4<

0.0

01

<0

.00

1P

ain

(S

)2

77

1R

ole

Fu

nct

ion

ing

0.3

8<

0.0

01

<0

.00

1P

ain

(S

)2

76

9E

mo

tion

al F

un

ctio

nin

g0

.36

<0

.00

1<

0.0

01

Pa

in (

S)

27

69

Co

gn

itive

Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1P

ain

(S

)2

76

8S

oci

al F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 31: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

31

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eP

ain

(S

)2

76

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.4

1<

0.0

01

<0

.00

1P

ain

(S

)2

76

2H

RQ

OL

Su

mm

ary

Sco

re0

.57

<0

.00

1<

0.0

01

Pa

in (

S)

27

76

Pa

in0

.78

<0

.00

1<

0.0

01

Pa

in (

I)1

84

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.83

1.2

30

.67

.<

0.0

01

<0

.00

1P

ain

(I)

18

48

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r-0

.01

1.2

7-0

.01

.0

.90

.9P

ain

(I)

18

48

Op

ioid

[na

rco

tic] p

ain

me

d in

prio

r w

ee

kO

the

r1

.31

1.1

11

.19

.<

0.0

01

<0

.00

1P

ain

(I)

18

48

Su

rge

ry in

prio

r 2

we

eks

Oth

er

0.3

21

.27

0.2

5.

0.1

60

.47

Pa

in (

I)1

83

2P

hys

ica

l Fu

nct

ion

ing

0.4

7<

0.0

01

<0

.00

1P

ain

(I)

18

32

Ro

le F

un

ctio

nin

g0

.48

<0

.00

1<

0.0

01

Pa

in (

I)1

82

9E

mo

tion

al F

un

ctio

nin

g0

.42

<0

.00

1<

0.0

01

Pa

in (

I)1

82

9C

og

niti

ve F

un

ctio

nin

g0

.43

<0

.00

1<

0.0

01

Pa

in (

I)1

82

9S

oci

al F

un

ctio

nin

g0

.46

<0

.00

1<

0.0

01

Pa

in (

I)1

82

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.4

2<

0.0

01

<0

.00

1P

ain

(I)

18

27

HR

QO

L S

um

ma

ry S

core

0.6

5<

0.0

01

<0

.00

1P

ain

(I)

18

33

Pa

in0

.76

<0

.00

1<

0.0

01

Pa

in (

I)2

79

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.65

1.2

30

.53

.<

0.0

01

<0

.00

1P

ain

(I)

27

92

Ch

em

oth

era

py

in p

rior

2 w

ee

ksO

the

r-0

.11

1.2

5-0

.08

.0

.23

0.4

7P

ain

(I)

27

92

Op

ioid

[na

rco

tic] p

ain

me

d in

prio

r w

ee

kO

the

r1

.28

1.0

91

.17

.<

0.0

01

<0

.00

1P

ain

(I)

27

92

Su

rge

ry in

prio

r 2

we

eks

Oth

er

0.7

41

.25

0.5

9.

0.0

05

0.0

2P

ain

(I)

27

70

Ph

ysic

al F

un

ctio

nin

g0

.49

<0

.00

1<

0.0

01

Pa

in (

I)2

77

0R

ole

Fu

nct

ion

ing

0.4

8<

0.0

01

<0

.00

1P

ain

(I)

27

68

Em

otio

na

l Fu

nct

ion

ing

0.4

0<

0.0

01

<0

.00

1P

ain

(I)

27

68

Co

gn

itive

Fu

nct

ion

ing

0.3

6<

0.0

01

<0

.00

1P

ain

(I)

27

67

So

cia

l Fu

nct

ion

ing

0.4

6<

0.0

01

<0

.00

1P

ain

(I)

27

68

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.44

<0

.00

1<

0.0

01

Pa

in (

I)2

76

1H

RQ

OL

Su

mm

ary

Sco

re0

.62

<0

.00

1<

0.0

01

Pa

in (

I)2

77

5P

ain

0.7

8<

0.0

01

<0

.00

1P

ain

du

ring

va

gin

al s

ex

(S)

18

6E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.37

0.7

8-0

.48

.0

.31

Pa

in d

urin

g v

ag

ina

l se

x (S

)1

34

Ag

e <

40

Ag

e >

60

00

.69

0.

11

Pa

in d

urin

g v

ag

ina

l se

x (S

)1

82

Ph

ysic

al F

un

ctio

nin

g-0

.13

0.2

51

Pa

in d

urin

g v

ag

ina

l se

x (S

)1

82

Ro

le F

un

ctio

nin

g0

.15

0.1

71

Pa

in d

urin

g v

ag

ina

l se

x (S

)1

82

Em

otio

na

l Fu

nct

ion

ing

0.1

90

.11

Pa

in d

urin

g v

ag

ina

l se

x (S

)1

82

Co

gn

itive

Fu

nct

ion

ing

0.0

60

.61

1P

ain

du

ring

va

gin

al s

ex

(S)

18

2S

oci

al F

un

ctio

nin

g0

.18

0.1

11

Pa

in d

urin

g v

ag

ina

l se

x (S

)1

82

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.10

0.3

81

Pa

in d

urin

g v

ag

ina

l se

x (S

)1

82

HR

QO

L S

um

ma

ry S

core

0.1

00

.39

1P

ain

du

ring

va

gin

al s

ex

(S)

27

4E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.47

0.8

8-0

.54

.0

.31

Pa

in d

urin

g v

ag

ina

l se

x (S

)2

30

Ag

e <

40

Ag

e >

60

-0.6

60

.93

-0.7

1.

0.0

61

Pa

in d

urin

g v

ag

ina

l se

x (S

)2

70

Ph

ysic

al F

un

ctio

nin

g-0

.01

0.9

11

Pa

in d

urin

g v

ag

ina

l se

x (S

)2

70

Ro

le F

un

ctio

nin

g0

.10

0.3

91

Pa

in d

urin

g v

ag

ina

l se

x (S

)2

70

Em

otio

na

l Fu

nct

ion

ing

0.1

10

.34

1P

ain

du

ring

va

gin

al s

ex

(S)

27

0C

og

niti

ve F

un

ctio

nin

g-0

.01

0.9

41

Pa

in d

urin

g v

ag

ina

l se

x (S

)2

70

So

cia

l Fu

nct

ion

ing

-0.0

70

.55

1P

ain

du

ring

va

gin

al s

ex

(S)

27

0G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

20

.85

1P

ain

du

ring

va

gin

al s

ex

(S)

26

9H

RQ

OL

Su

mm

ary

Sco

re0

.04

0.7

71

Pa

in in

the

ab

do

me

n (

F)

13

31

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

0.8

40

.24

.0

.09

0.1

7P

ain

in th

e a

bd

om

en

(F

)1

22

6G

ast

roin

test

ina

lL

un

g0

.60

.80

0.7

6.

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

F)

13

23

Ph

ysic

al F

un

ctio

nin

g0

.27

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

F)

13

23

Ro

le F

un

ctio

nin

g0

.36

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

F)

13

23

Em

otio

na

l Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(F

)1

32

3C

og

niti

ve F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

F)

13

23

So

cia

l Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(F

)1

32

3G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

8<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(F

)1

32

0H

RQ

OL

Su

mm

ary

Sco

re0

.46

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

F)

22

93

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

30

.88

0.2

6.

0.1

10

.17

Pa

in in

the

ab

do

me

n (

F)

22

00

Ga

stro

inte

stin

al

Lu

ng

0.3

10

.89

0.3

5.

0.0

40

.14

Pa

in in

the

ab

do

me

n (

F)

22

88

Ph

ysic

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

F)

22

88

Ro

le F

un

ctio

nin

g0

.26

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

F)

22

86

Em

otio

na

l Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(F

)2

28

6C

og

niti

ve F

un

ctio

nin

g0

.08

0.1

70

.17

Pa

in in

the

ab

do

me

n (

F)

22

86

So

cia

l Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(F

)2

28

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

4<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(F

)2

28

5H

RQ

OL

Su

mm

ary

Sco

re0

.36

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

S)

13

31

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

30

.81

0.1

6.

0.2

60

.26

Pa

in in

the

ab

do

me

n (

S)

12

26

Ga

stro

inte

stin

al

Lu

ng

0.5

00

.77

0.6

5.

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

S)

13

23

Ph

ysic

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

S)

13

23

Ro

le F

un

ctio

nin

g0

.32

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

S)

13

23

Em

otio

na

l Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(S

)1

32

3C

og

niti

ve F

un

ctio

nin

g0

.24

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

S)

13

23

So

cia

l Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(S

)1

32

3G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

6<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(S

)1

32

0H

RQ

OL

Su

mm

ary

Sco

re0

.43

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

S)

22

93

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

70

.90

0.2

9.

0.0

70

.14

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 32: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

32

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eP

ain

in th

e a

bd

om

en

(S

)2

20

0G

ast

roin

test

ina

lL

un

g0

.31

0.9

20

.34

.0

.04

0.1

2P

ain

in th

e a

bd

om

en

(S

)2

28

8P

hys

ica

l Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(S

)2

28

8R

ole

Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(S

)2

28

6E

mo

tion

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

S)

22

86

Co

gn

itive

Fu

nct

ion

ing

0.1

40

.02

0.0

8P

ain

in th

e a

bd

om

en

(S

)2

28

6S

oci

al F

un

ctio

nin

g0

.26

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

S)

22

86

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.29

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

S)

22

85

HR

QO

L S

um

ma

ry S

core

0.4

2<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(I)

13

31

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

40

.71

0.2

0.

0.1

70

.17

Pa

in in

the

ab

do

me

n (

I)1

22

6G

ast

roin

test

ina

lL

un

g0

.48

0.6

80

.70

.<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(I)

13

23

Ph

ysic

al F

un

ctio

nin

g0

.26

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

I)1

32

3R

ole

Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(I)

13

23

Em

otio

na

l Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(I)

13

23

Co

gn

itive

Fu

nct

ion

ing

0.2

1<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(I)

13

23

So

cia

l Fu

nct

ion

ing

0.3

3<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(I)

13

23

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.23

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

I)1

32

0H

RQ

OL

Su

mm

ary

Sco

re0

.43

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

I)2

29

3E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.30

0.8

30

.36

.0

.03

0.0

6P

ain

in th

e a

bd

om

en

(I)

22

00

Ga

stro

inte

stin

al

Lu

ng

0.3

00

.83

0.3

6.

0.0

30

.06

Pa

in in

the

ab

do

me

n (

I)2

28

8P

hys

ica

l Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(I)

22

88

Ro

le F

un

ctio

nin

g0

.30

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

I)2

28

6E

mo

tion

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

I)2

28

6C

og

niti

ve F

un

ctio

nin

g0

.20

<0

.00

10

.00

3P

ain

in th

e a

bd

om

en

(I)

22

86

So

cia

l Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1P

ain

in th

e a

bd

om

en

(I)

22

86

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.29

<0

.00

1<

0.0

01

Pa

in in

the

ab

do

me

n (

I)2

28

5H

RQ

OL

Su

mm

ary

Sco

re0

.41

<0

.00

1<

0.0

01

Pa

in o

r b

urn

ing

with

urin

atio

n (

S)

12

15

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.1

50

.58

-0.2

6.

0.1

70

.23

Pa

in o

r b

urn

ing

with

urin

atio

n (

S)

15

3P

rost

ate

/Bla

dd

er

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

He

ma

tolo

gic

0.7

90

.66

1.1

9.

<0

.00

10

.00

2P

ain

or

bu

rnin

g w

ith u

rina

tion

(S

)1

21

4P

hys

ica

l Fu

nct

ion

ing

0.1

20

.07

0.2

3P

ain

or

bu

rnin

g w

ith u

rina

tion

(S

)1

21

4R

ole

Fu

nct

ion

ing

0.0

80

.23

0.2

3P

ain

or

bu

rnin

g w

ith u

rina

tion

(S

)1

21

4E

mo

tion

al F

un

ctio

nin

g0

.17

0.0

10

.16

Pa

in o

r b

urn

ing

with

urin

atio

n (

S)

12

14

Co

gn

itive

Fu

nct

ion

ing

0.0

90

.21

0.2

3P

ain

or

bu

rnin

g w

ith u

rina

tion

(S

)1

21

4S

oci

al F

un

ctio

nin

g0

.15

0.0

30

.23

Pa

in o

r b

urn

ing

with

urin

atio

n (

S)

12

14

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.11

0.1

0.2

3P

ain

or

bu

rnin

g w

ith u

rina

tion

(S

)1

21

2H

RQ

OL

Su

mm

ary

Sco

re0

.20

0.0

04

0.0

6P

ain

or

bu

rnin

g w

ith u

rina

tion

(S

)2

19

0E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.15

0.5

2-0

.28

.0

.20

.23

Pa

in o

r b

urn

ing

with

urin

atio

n (

S)

24

8P

rost

ate

/Bla

dd

er

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

He

ma

tolo

gic

0.7

10

.64

1.1

1.

<0

.00

10

.00

9P

ain

or

bu

rnin

g w

ith u

rina

tion

(S

)2

18

8P

hys

ica

l Fu

nct

ion

ing

0.0

90

.23

0.2

3P

ain

or

bu

rnin

g w

ith u

rina

tion

(S

)2

18

8R

ole

Fu

nct

ion

ing

0.1

80

.01

0.1

6P

ain

or

bu

rnin

g w

ith u

rina

tion

(S

)2

18

7E

mo

tion

al F

un

ctio

nin

g0

.19

0.0

09

0.1

3P

ain

or

bu

rnin

g w

ith u

rina

tion

(S

)2

18

7C

og

niti

ve F

un

ctio

nin

g0

.21

0.0

03

0.0

5P

ain

or

bu

rnin

g w

ith u

rina

tion

(S

)2

18

6S

oci

al F

un

ctio

nin

g0

.16

0.0

30

.23

Pa

in o

r b

urn

ing

with

urin

atio

n (

S)

21

87

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.18

0.0

20

.17

Pa

in o

r b

urn

ing

with

urin

atio

n (

S)

21

84

HR

QO

L S

um

ma

ry S

core

0.1

70

.02

0.1

9P

ain

/sw

elli

ng

/re

dn

ess

at I

V (

P)

12

08

EC

OG

PS

2-4

EC

OG

PS

0-1

-4.2

8%

-0.1

4.

0.5

60

.99

Pa

in/s

we

llin

g/r

ed

ne

ss a

t IV

(P

)1

20

8Ir

rita

nt c

he

mo

the

rap

y [fo

otn

ote

3] i

n p

rior

2 w

ee

ksO

the

r2

.52

%0

.08

.0

.59

0.9

9P

ain

/sw

elli

ng

/re

dn

ess

at I

V (

P)

12

03

Ph

ysic

al F

un

ctio

nin

g-0

.05

0.4

80

.99

Pa

in/s

we

llin

g/r

ed

ne

ss a

t IV

(P

)1

20

3R

ole

Fu

nct

ion

ing

-0.0

50

.48

0.9

9P

ain

/sw

elli

ng

/re

dn

ess

at I

V (

P)

12

03

Em

otio

na

l Fu

nct

ion

ing

-0.0

10

.88

0.9

9P

ain

/sw

elli

ng

/re

dn

ess

at I

V (

P)

12

03

Co

gn

itive

Fu

nct

ion

ing

-0.0

10

.85

0.9

9P

ain

/sw

elli

ng

/re

dn

ess

at I

V (

P)

12

03

So

cia

l Fu

nct

ion

ing

0.0

80

.25

0.9

9P

ain

/sw

elli

ng

/re

dn

ess

at I

V (

P)

12

03

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.00

0.9

90

.99

Pa

in/s

we

llin

g/r

ed

ne

ss a

t IV

(P

)1

20

1H

RQ

OL

Su

mm

ary

Sco

re0

.02

0.7

30

.99

Pa

in/s

we

llin

g/r

ed

ne

ss a

t IV

(P

)2

21

0E

CO

G P

S 2

-4E

CO

G P

S 0

-1-5

.90

%-0

.21

.0

.44

0.9

9P

ain

/sw

elli

ng

/re

dn

ess

at I

V (

P)

22

10

Irrit

an

t ch

em

oth

era

py

[foo

tno

te 3

] in

prio

r 2

we

eks

Oth

er

2.1

7%

0.0

7.

0.6

20

.99

Pa

in/s

we

llin

g/r

ed

ne

ss a

t IV

(P

)2

20

1P

hys

ica

l Fu

nct

ion

ing

-0.0

70

.30

.99

Pa

in/s

we

llin

g/r

ed

ne

ss a

t IV

(P

)2

20

1R

ole

Fu

nct

ion

ing

0.0

00

.94

0.9

9P

ain

/sw

elli

ng

/re

dn

ess

at I

V (

P)

22

02

Em

otio

na

l Fu

nct

ion

ing

-0.0

50

.49

0.9

9P

ain

/sw

elli

ng

/re

dn

ess

at I

V (

P)

22

02

Co

gn

itive

Fu

nct

ion

ing

-0.0

30

.66

0.9

9P

ain

/sw

elli

ng

/re

dn

ess

at I

V (

P)

22

02

So

cia

l Fu

nct

ion

ing

-0.0

50

.45

0.9

9P

ain

/sw

elli

ng

/re

dn

ess

at I

V (

P)

22

02

Glo

ba

l He

alth

Sta

tus/

Qo

L-0

.13

0.0

70

.99

Pa

in/s

we

llin

g/r

ed

ne

ss a

t IV

(P

)2

20

0H

RQ

OL

Su

mm

ary

Sco

re-0

.08

0.2

40

.99

Po

un

din

g/r

aci

ng

he

art

be

at (

F)

14

12

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

90

.85

0.2

3.

0.1

10

.2P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (F

)1

39

7P

hys

ica

l Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (F

)1

39

7R

ole

Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (F

)1

39

7E

mo

tion

al F

un

ctio

nin

g0

.21

<0

.00

1<

0.0

01

Po

un

din

g/r

aci

ng

he

art

be

at (

F)

13

97

Co

gn

itive

Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (F

)1

39

7S

oci

al F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Po

un

din

g/r

aci

ng

he

art

be

at (

F)

13

97

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.27

<0

.00

1<

0.0

01

Po

un

din

g/r

aci

ng

he

art

be

at (

F)

13

94

HR

QO

L S

um

ma

ry S

core

0.3

1<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (F

)2

37

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.17

0.8

30

.21

.0

.20

.2P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (F

)2

35

6P

hys

ica

l Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (F

)2

35

6R

ole

Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 33: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

33

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eP

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (F

)2

35

6E

mo

tion

al F

un

ctio

nin

g0

.24

<0

.00

1<

0.0

01

Po

un

din

g/r

aci

ng

he

art

be

at (

F)

23

56

Co

gn

itive

Fu

nct

ion

ing

0.2

0<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (F

)2

35

6S

oci

al F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Po

un

din

g/r

aci

ng

he

art

be

at (

F)

23

56

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.24

<0

.00

1<

0.0

01

Po

un

din

g/r

aci

ng

he

art

be

at (

F)

23

52

HR

QO

L S

um

ma

ry S

core

0.3

4<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (S

)1

41

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.15

0.7

40

.20

.0

.17

0.1

7P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (S

)1

39

7P

hys

ica

l Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (S

)1

39

7R

ole

Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (S

)1

39

7E

mo

tion

al F

un

ctio

nin

g0

.23

<0

.00

1<

0.0

01

Po

un

din

g/r

aci

ng

he

art

be

at (

S)

13

97

Co

gn

itive

Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (S

)1

39

7S

oci

al F

un

ctio

nin

g0

.35

<0

.00

1<

0.0

01

Po

un

din

g/r

aci

ng

he

art

be

at (

S)

13

97

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.31

<0

.00

1<

0.0

01

Po

un

din

g/r

aci

ng

he

art

be

at (

S)

13

94

HR

QO

L S

um

ma

ry S

core

0.3

5<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (S

)2

37

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.16

0.7

10

.22

.0

.17

0.1

7P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (S

)2

35

6P

hys

ica

l Fu

nct

ion

ing

0.2

5<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (S

)2

35

6R

ole

Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (S

)2

35

6E

mo

tion

al F

un

ctio

nin

g0

.22

<0

.00

1<

0.0

01

Po

un

din

g/r

aci

ng

he

art

be

at (

S)

23

56

Co

gn

itive

Fu

nct

ion

ing

0.1

50

.00

40

.01

Po

un

din

g/r

aci

ng

he

art

be

at (

S)

23

56

So

cia

l Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (S

)2

35

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

1<

0.0

01

<0

.00

1P

ou

nd

ing

/ra

cin

g h

ea

rtb

ea

t (S

)2

35

2H

RQ

OL

Su

mm

ary

Sco

re0

.31

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

S)

18

37

EC

OG

PS

2-4

EC

OG

PS

0-1

0.4

80

.88

0.5

4.

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

S)

18

37

Op

ioid

[na

rco

tic] p

ain

me

d in

prio

r w

ee

kO

the

r0

.37

0.8

80

.41

.<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(S

)1

83

7S

lee

p a

id in

prio

r w

ee

kO

the

r0

.22

0.9

00

.24

.0

.00

60

.00

6P

rob

lem

s w

ith c

on

cen

tra

tion

(S

)1

82

1P

hys

ica

l Fu

nct

ion

ing

0.3

9<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(S

)1

82

1R

ole

Fu

nct

ion

ing

0.4

0<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(S

)1

81

8E

mo

tion

al F

un

ctio

nin

g0

.47

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

S)

18

18

Co

gn

itive

Fu

nct

ion

ing

0.7

1<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(S

)1

81

8S

oci

al F

un

ctio

nin

g0

.43

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

S)

18

18

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.34

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

S)

18

16

HR

QO

L S

um

ma

ry S

core

0.5

6<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(S

)2

77

6E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.45

0.9

00

.50

.<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(S

)2

77

6O

pio

id [n

arc

otic

] pa

in m

ed

in p

rior

we

ek

Oth

er

0.4

10

.90

0.4

6.

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

S)

27

76

Sle

ep

aid

in p

rior

we

ek

Oth

er

0.3

30

.91

0.3

7.

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

S)

27

54

Ph

ysic

al F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

S)

27

54

Ro

le F

un

ctio

nin

g0

.37

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

S)

27

52

Em

otio

na

l Fu

nct

ion

ing

0.4

7<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(S

)2

75

2C

og

niti

ve F

un

ctio

nin

g0

.76

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

S)

27

51

So

cia

l Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(S

)2

75

2G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

5<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(S

)2

74

5H

RQ

OL

Su

mm

ary

Sco

re0

.54

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

I)1

83

7E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.46

0.9

00

.51

.<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(I)

18

37

Op

ioid

[na

rco

tic] p

ain

me

d in

prio

r w

ee

kO

the

r0

.32

0.9

00

.36

.<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(I)

18

37

Sle

ep

aid

in p

rior

we

ek

Oth

er

0.1

90

.91

0.2

1.

0.0

20

.02

Pro

ble

ms

with

co

nce

ntr

atio

n (

I)1

82

1P

hys

ica

l Fu

nct

ion

ing

0.3

8<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(I)

18

21

Ro

le F

un

ctio

nin

g0

.40

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

I)1

81

8E

mo

tion

al F

un

ctio

nin

g0

.49

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

I)1

81

8C

og

niti

ve F

un

ctio

nin

g0

.70

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

I)1

81

8S

oci

al F

un

ctio

nin

g0

.49

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

I)1

81

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

4<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(I)

18

16

HR

QO

L S

um

ma

ry S

core

0.5

5<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(I)

27

73

EC

OG

PS

2-4

EC

OG

PS

0-1

0.4

60

.89

0.5

2.

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

I)2

77

3O

pio

id [n

arc

otic

] pa

in m

ed

in p

rior

we

ek

Oth

er

0.3

40

.89

0.3

8.

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

I)2

77

3S

lee

p a

id in

prio

r w

ee

kO

the

r0

.21

0.9

00

.23

.0

.01

0.0

2P

rob

lem

s w

ith c

on

cen

tra

tion

(I)

27

51

Ph

ysic

al F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

I)2

75

1R

ole

Fu

nct

ion

ing

0.3

9<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(I)

27

49

Em

otio

na

l Fu

nct

ion

ing

0.4

6<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(I)

27

49

Co

gn

itive

Fu

nct

ion

ing

0.7

0<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(I)

27

48

So

cia

l Fu

nct

ion

ing

0.3

7<

0.0

01

<0

.00

1P

rob

lem

s w

ith c

on

cen

tra

tion

(I)

27

49

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.34

<0

.00

1<

0.0

01

Pro

ble

ms

with

co

nce

ntr

atio

n (

I)2

74

2H

RQ

OL

Su

mm

ary

Sco

re0

.52

<0

.00

1<

0.0

01

Pro

ble

ms

with

me

mo

ry (

S)

13

68

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

20

.79

0.4

0.

0.0

20

.09

Pro

ble

ms

with

me

mo

ry (

S)

12

91

Bre

ast

/Pro

sta

teG

ast

roin

test

ina

l-0

.17

0.8

2-0

.20

.0

.18

0.3

8P

rob

lem

s w

ith m

em

ory

(S

)1

36

0P

hys

ica

l Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(S

)1

36

0R

ole

Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(S

)1

36

0E

mo

tion

al F

un

ctio

nin

g0

.32

<0

.00

1<

0.0

01

Pro

ble

ms

with

me

mo

ry (

S)

13

60

Co

gn

itive

Fu

nct

ion

ing

0.6

9<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(S

)1

36

0S

oci

al F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Pro

ble

ms

with

me

mo

ry (

S)

13

60

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.22

<0

.00

1<

0.0

01

Pro

ble

ms

with

me

mo

ry (

S)

13

58

HR

QO

L S

um

ma

ry S

core

0.4

5<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(S

)2

33

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.21

0.7

90

.26

.0

.19

0.3

8P

rob

lem

s w

ith m

em

ory

(S

)2

27

2B

rea

st/P

rost

ate

Ga

stro

inte

stin

al

0.0

90

.84

0.1

1.

0.4

90

.49

Pro

ble

ms

with

me

mo

ry (

S)

23

25

Ph

ysic

al F

un

ctio

nin

g0

.26

<0

.00

1<

0.0

01

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 34: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

34

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eP

rob

lem

s w

ith m

em

ory

(S

)2

32

5R

ole

Fu

nct

ion

ing

0.2

1<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(S

)2

32

6E

mo

tion

al F

un

ctio

nin

g0

.30

<0

.00

1<

0.0

01

Pro

ble

ms

with

me

mo

ry (

S)

23

26

Co

gn

itive

Fu

nct

ion

ing

0.7

5<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(S

)2

32

5S

oci

al F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Pro

ble

ms

with

me

mo

ry (

S)

23

26

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.13

0.0

20

.08

Pro

ble

ms

with

me

mo

ry (

S)

23

20

HR

QO

L S

um

ma

ry S

core

0.3

8<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(I)

13

68

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

70

.85

0.4

3.

0.0

10

.05

Pro

ble

ms

with

me

mo

ry (

I)1

29

1B

rea

st/P

rost

ate

Ga

stro

inte

stin

al

-0.0

80

.89

-0.0

9.

0.5

70

.57

Pro

ble

ms

with

me

mo

ry (

I)1

36

0P

hys

ica

l Fu

nct

ion

ing

0.3

1<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(I)

13

60

Ro

le F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Pro

ble

ms

with

me

mo

ry (

I)1

36

0E

mo

tion

al F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Pro

ble

ms

with

me

mo

ry (

I)1

36

0C

og

niti

ve F

un

ctio

nin

g0

.60

<0

.00

1<

0.0

01

Pro

ble

ms

with

me

mo

ry (

I)1

36

0S

oci

al F

un

ctio

nin

g0

.48

<0

.00

1<

0.0

01

Pro

ble

ms

with

me

mo

ry (

I)1

36

0G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

5<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(I)

13

58

HR

QO

L S

um

ma

ry S

core

0.4

5<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(I)

23

38

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

50

.78

0.3

2.

0.1

0.3

1P

rob

lem

s w

ith m

em

ory

(I)

22

72

Bre

ast

/Pro

sta

teG

ast

roin

test

ina

l0

.17

0.8

20

.20

.0

.19

0.3

9P

rob

lem

s w

ith m

em

ory

(I)

23

25

Ph

ysic

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Pro

ble

ms

with

me

mo

ry (

I)2

32

5R

ole

Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(I)

23

26

Em

otio

na

l Fu

nct

ion

ing

0.3

4<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(I)

23

26

Co

gn

itive

Fu

nct

ion

ing

0.6

2<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(I)

23

25

So

cia

l Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1P

rob

lem

s w

ith m

em

ory

(I)

23

26

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.16

0.0

03

0.0

1P

rob

lem

s w

ith m

em

ory

(I)

23

20

HR

QO

L S

um

ma

ry S

core

0.3

7<

0.0

01

<0

.00

1P

rob

lem

s w

ith ta

stin

g fo

od

/drin

k (S

)1

83

9E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.31

1.1

60

.27

.0

.00

30

.00

3P

rob

lem

s w

ith ta

stin

g fo

od

/drin

k (S

)1

82

3P

hys

ica

l Fu

nct

ion

ing

0.2

5<

0.0

01

<0

.00

1P

rob

lem

s w

ith ta

stin

g fo

od

/drin

k (S

)1

82

3R

ole

Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1P

rob

lem

s w

ith ta

stin

g fo

od

/drin

k (S

)1

82

0E

mo

tion

al F

un

ctio

nin

g0

.24

<0

.00

1<

0.0

01

Pro

ble

ms

with

tast

ing

foo

d/d

rink

(S)

18

20

Co

gn

itive

Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1P

rob

lem

s w

ith ta

stin

g fo

od

/drin

k (S

)1

82

0S

oci

al F

un

ctio

nin

g0

.32

<0

.00

1<

0.0

01

Pro

ble

ms

with

tast

ing

foo

d/d

rink

(S)

18

20

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.22

<0

.00

1<

0.0

01

Pro

ble

ms

with

tast

ing

foo

d/d

rink

(S)

18

18

HR

QO

L S

um

ma

ry S

core

0.4

4<

0.0

01

<0

.00

1P

rob

lem

s w

ith ta

stin

g fo

od

/drin

k (S

)2

77

5E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.36

1.2

00

.30

.0

.00

20

.00

3P

rob

lem

s w

ith ta

stin

g fo

od

/drin

k (S

)2

75

3P

hys

ica

l Fu

nct

ion

ing

0.2

5<

0.0

01

<0

.00

1P

rob

lem

s w

ith ta

stin

g fo

od

/drin

k (S

)2

75

3R

ole

Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1P

rob

lem

s w

ith ta

stin

g fo

od

/drin

k (S

)2

75

1E

mo

tion

al F

un

ctio

nin

g0

.18

<0

.00

1<

0.0

01

Pro

ble

ms

with

tast

ing

foo

d/d

rink

(S)

27

51

Co

gn

itive

Fu

nct

ion

ing

0.2

2<

0.0

01

<0

.00

1P

rob

lem

s w

ith ta

stin

g fo

od

/drin

k (S

)2

75

0S

oci

al F

un

ctio

nin

g0

.34

<0

.00

1<

0.0

01

Pro

ble

ms

with

tast

ing

foo

d/d

rink

(S)

27

51

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.29

<0

.00

1<

0.0

01

Pro

ble

ms

with

tast

ing

foo

d/d

rink

(S)

27

44

HR

QO

L S

um

ma

ry S

core

0.4

3<

0.0

01

<0

.00

1R

ash

(P

)1

82

1E

CO

G P

S 2

-4E

CO

G P

S 0

-1-2

.31

%-0

.06

.0

.51

0.9

3R

ash

(P

)1

82

1R

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r2

.73

%0

.07

.0

.30

.93

Ra

sh (

P)

18

05

Ph

ysic

al F

un

ctio

nin

g0

.03

0.4

20

.93

Ra

sh (

P)

18

05

Ro

le F

un

ctio

nin

g0

.03

0.4

20

.93

Ra

sh (

P)

18

02

Em

otio

na

l Fu

nct

ion

ing

0.0

10

.70

.93

Ra

sh (

P)

18

02

Co

gn

itive

Fu

nct

ion

ing

0.0

40

.26

0.9

3R

ash

(P

)1

80

2S

oci

al F

un

ctio

nin

g0

.04

0.2

30

.93

Ra

sh (

P)

18

02

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.02

0.5

10

.93

Ra

sh (

P)

18

00

HR

QO

L S

um

ma

ry S

core

0.0

40

.24

0.9

3R

ash

(P

)2

75

6E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.67

%-0

.02

.0

.87

0.9

3R

ash

(P

)2

75

6R

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r7

.39

%0

.18

.0

.01

0.2

1R

ash

(P

)2

73

5P

hys

ica

l Fu

nct

ion

ing

0.0

50

.21

0.9

3R

ash

(P

)2

73

5R

ole

Fu

nct

ion

ing

0.0

40

.31

0.9

3R

ash

(P

)2

73

3E

mo

tion

al F

un

ctio

nin

g-0

.02

0.5

0.9

3R

ash

(P

)2

73

3C

og

niti

ve F

un

ctio

nin

g0

.03

0.4

70

.93

Ra

sh (

P)

27

32

So

cia

l Fu

nct

ion

ing

0.0

40

.31

0.9

3R

ash

(P

)2

73

3G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

30

.43

0.9

3R

ash

(P

)2

72

6H

RQ

OL

Su

mm

ary

Sco

re0

.00

0.9

30

.93

Rid

ge

s/b

um

ps

on

fin

ge

rna

ils/to

en

ails

(P

)1

48

3E

CO

G P

S 2

-4E

CO

G P

S 0

-1-1

.40

%-0

.04

.0

.78

0.8

9R

idg

es/

bu

mp

s o

n fi

ng

ern

ails

/toe

na

ils (

P)

14

68

Ph

ysic

al F

un

ctio

nin

g0

.06

0.1

70

.89

Rid

ge

s/b

um

ps

on

fin

ge

rna

ils/to

en

ails

(P

)1

46

8R

ole

Fu

nct

ion

ing

-0.0

10

.89

0.8

9R

idg

es/

bu

mp

s o

n fi

ng

ern

ails

/toe

na

ils (

P)

14

68

Em

otio

na

l Fu

nct

ion

ing

-0.0

30

.58

0.8

9R

idg

es/

bu

mp

s o

n fi

ng

ern

ails

/toe

na

ils (

P)

14

68

Co

gn

itive

Fu

nct

ion

ing

0.1

10

.01

0.2

2R

idg

es/

bu

mp

s o

n fi

ng

ern

ails

/toe

na

ils (

P)

14

68

So

cia

l Fu

nct

ion

ing

-0.0

10

.89

0.8

9R

idg

es/

bu

mp

s o

n fi

ng

ern

ails

/toe

na

ils (

P)

14

68

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.01

0.8

60

.89

Rid

ge

s/b

um

ps

on

fin

ge

rna

ils/to

en

ails

(P

)1

46

5H

RQ

OL

Su

mm

ary

Sco

re0

.03

0.4

90

.89

Rid

ge

s/b

um

ps

on

fin

ge

rna

ils/to

en

ails

(P

)2

43

9E

CO

G P

S 2

-4E

CO

G P

S 0

-1-5

.90

%-0

.15

.0

.35

0.8

9R

idg

es/

bu

mp

s o

n fi

ng

ern

ails

/toe

na

ils (

P)

24

23

Ph

ysic

al F

un

ctio

nin

g0

.06

0.2

0.8

9R

idg

es/

bu

mp

s o

n fi

ng

ern

ails

/toe

na

ils (

P)

24

23

Ro

le F

un

ctio

nin

g0

.03

0.4

90

.89

Rid

ge

s/b

um

ps

on

fin

ge

rna

ils/to

en

ails

(P

)2

42

2E

mo

tion

al F

un

ctio

nin

g0

.04

0.4

10

.89

Rid

ge

s/b

um

ps

on

fin

ge

rna

ils/to

en

ails

(P

)2

42

2C

og

niti

ve F

un

ctio

nin

g0

.06

0.2

30

.89

Rid

ge

s/b

um

ps

on

fin

ge

rna

ils/to

en

ails

(P

)2

42

1S

oci

al F

un

ctio

nin

g0

.02

0.6

60

.89

Rid

ge

s/b

um

ps

on

fin

ge

rna

ils/to

en

ails

(P

)2

42

2G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

80

.08

0.8

9

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 35: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

35

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eR

idg

es/

bu

mp

s o

n fi

ng

ern

ails

/toe

na

ils (

P)

24

15

HR

QO

L S

um

ma

ry S

core

0.0

60

.21

0.8

9R

ing

ing

in e

ars

(S

)1

29

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.19

0.7

90

.25

.0

.21

0.6

7R

ing

ing

in e

ars

(S

)1

19

1H

ea

d/N

eck

Pro

sta

te/B

lad

de

r0

.29

0.7

80

.38

.0

.01

0.1

2R

ing

ing

in e

ars

(S

)1

29

1P

hys

ica

l Fu

nct

ion

ing

0.0

60

.33

0.6

7R

ing

ing

in e

ars

(S

)1

29

1R

ole

Fu

nct

ion

ing

0.1

80

.00

20

.03

Rin

gin

g in

ea

rs (

S)

12

88

Em

otio

na

l Fu

nct

ion

ing

0.1

9<

0.0

01

0.0

1R

ing

ing

in e

ars

(S

)1

28

8C

og

niti

ve F

un

ctio

nin

g0

.13

0.0

20

.15

Rin

gin

g in

ea

rs (

S)

12

88

So

cia

l Fu

nct

ion

ing

0.2

0<

0.0

01

0.0

08

Rin

gin

g in

ea

rs (

S)

12

88

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.13

0.0

20

.15

Rin

gin

g in

ea

rs (

S)

12

86

HR

QO

L S

um

ma

ry S

core

0.2

5<

0.0

01

<0

.00

1R

ing

ing

in e

ars

(S

)2

26

2E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.01

0.7

4-0

.02

.0

.94

0.9

4R

ing

ing

in e

ars

(S

)2

17

5H

ea

d/N

eck

Pro

sta

te/B

lad

de

r0

.27

0.7

20

.37

.0

.01

0.1

5R

ing

ing

in e

ars

(S

)2

25

9P

hys

ica

l Fu

nct

ion

ing

0.0

60

.31

0.6

7R

ing

ing

in e

ars

(S

)2

25

9R

ole

Fu

nct

ion

ing

0.1

50

.01

0.1

5R

ing

ing

in e

ars

(S

)2

25

8E

mo

tion

al F

un

ctio

nin

g0

.19

0.0

03

0.0

3R

ing

ing

in e

ars

(S

)2

25

8C

og

niti

ve F

un

ctio

nin

g0

.13

0.0

40

.2R

ing

ing

in e

ars

(S

)2

25

7S

oci

al F

un

ctio

nin

g0

.14

0.0

30

.15

Rin

gin

g in

ea

rs (

S)

22

58

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.14

0.0

20

.15

Rin

gin

g in

ea

rs (

S)

22

55

HR

QO

L S

um

ma

ry S

core

0.2

3<

0.0

01

0.0

03

Sa

d o

r u

nh

ap

py

fee

ling

s (F

)1

84

0E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.28

0.9

80

.28

.0

.00

20

.00

2S

ad

or

un

ha

pp

y fe

elin

gs

(F)

18

40

Cu

rre

ntly

taki

ng

de

pre

ssio

n m

ed

Oth

er

0.5

30

.97

0.5

5.

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (F

)1

82

4P

hys

ica

l Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(F)

18

24

Ro

le F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (F

)1

82

1E

mo

tion

al F

un

ctio

nin

g0

.66

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (F

)1

82

1C

og

niti

ve F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (F

)1

82

1S

oci

al F

un

ctio

nin

g0

.41

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (F

)1

82

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

7<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(F)

18

19

HR

QO

L S

um

ma

ry S

core

0.4

9<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(F)

27

83

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

00

.98

0.3

0.

0.0

02

0.0

02

Sa

d o

r u

nh

ap

py

fee

ling

s (F

)2

78

3C

urr

en

tly ta

kin

g d

ep

ress

ion

me

dO

the

r0

.67

0.9

60

.70

.<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(F)

27

61

Ph

ysic

al F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (F

)2

76

1R

ole

Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(F)

27

59

Em

otio

na

l Fu

nct

ion

ing

0.6

9<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(F)

27

59

Co

gn

itive

Fu

nct

ion

ing

0.4

0<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(F)

27

58

So

cia

l Fu

nct

ion

ing

0.3

5<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(F)

27

59

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.37

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (F

)2

75

2H

RQ

OL

Su

mm

ary

Sco

re0

.47

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (S

)1

84

0E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.31

0.9

00

.34

.<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(S)

18

40

Cu

rre

ntly

taki

ng

de

pre

ssio

n m

ed

Oth

er

0.5

20

.89

0.5

8.

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (S

)1

82

4P

hys

ica

l Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(S)

18

24

Ro

le F

un

ctio

nin

g0

.37

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (S

)1

82

1E

mo

tion

al F

un

ctio

nin

g0

.64

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (S

)1

82

1C

og

niti

ve F

un

ctio

nin

g0

.39

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (S

)1

82

1S

oci

al F

un

ctio

nin

g0

.40

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (S

)1

82

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

7<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(S)

18

19

HR

QO

L S

um

ma

ry S

core

0.5

0<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(S)

27

83

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

90

.87

0.3

4.

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (S

)2

78

3C

urr

en

tly ta

kin

g d

ep

ress

ion

me

dO

the

r0

.68

0.8

40

.81

.<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(S)

27

61

Ph

ysic

al F

un

ctio

nin

g0

.33

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (S

)2

76

1R

ole

Fu

nct

ion

ing

0.3

2<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(S)

27

59

Em

otio

na

l Fu

nct

ion

ing

0.6

6<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(S)

27

59

Co

gn

itive

Fu

nct

ion

ing

0.4

0<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(S)

27

58

So

cia

l Fu

nct

ion

ing

0.3

7<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(S)

27

59

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.38

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (S

)2

75

2H

RQ

OL

Su

mm

ary

Sco

re0

.49

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (I

)1

84

0E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.39

0.9

60

.40

.<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(I)

18

40

Cu

rre

ntly

taki

ng

de

pre

ssio

n m

ed

Oth

er

0.5

70

.95

0.6

0.

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (I

)1

82

4P

hys

ica

l Fu

nct

ion

ing

0.3

4<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(I)

18

24

Ro

le F

un

ctio

nin

g0

.40

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (I

)1

82

1E

mo

tion

al F

un

ctio

nin

g0

.63

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (I

)1

82

1C

og

niti

ve F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (I

)1

82

1S

oci

al F

un

ctio

nin

g0

.49

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (I

)1

82

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

7<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(I)

18

19

HR

QO

L S

um

ma

ry S

core

0.5

0<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(I)

27

82

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

50

.90

0.3

9.

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (I

)2

78

2C

urr

en

tly ta

kin

g d

ep

ress

ion

me

dO

the

r0

.64

0.8

80

.73

.<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(I)

27

60

Ph

ysic

al F

un

ctio

nin

g0

.38

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (I

)2

76

0R

ole

Fu

nct

ion

ing

0.3

8<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(I)

27

58

Em

otio

na

l Fu

nct

ion

ing

0.6

3<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(I)

27

58

Co

gn

itive

Fu

nct

ion

ing

0.4

1<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(I)

27

57

So

cia

l Fu

nct

ion

ing

0.4

3<

0.0

01

<0

.00

1S

ad

or

un

ha

pp

y fe

elin

gs

(I)

27

58

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.36

<0

.00

1<

0.0

01

Sa

d o

r u

nh

ap

py

fee

ling

s (I

)2

75

1H

RQ

OL

Su

mm

ary

Sco

re0

.52

<0

.00

1<

0.0

01

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 36: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

36

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eS

hiv

erin

g o

r sh

aki

ng

ch

ills

(F)

12

00

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

70

.91

0.4

1.

0.0

20

.07

Sh

ive

ring

or

sha

kin

g c

hill

s (F

)1

19

9P

hys

ica

l Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1S

hiv

erin

g o

r sh

aki

ng

ch

ills

(F)

11

99

Ro

le F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Sh

ive

ring

or

sha

kin

g c

hill

s (F

)1

19

9E

mo

tion

al F

un

ctio

nin

g0

.22

0.0

02

0.0

2S

hiv

erin

g o

r sh

aki

ng

ch

ills

(F)

11

99

Co

gn

itive

Fu

nct

ion

ing

0.1

70

.02

0.0

7S

hiv

erin

g o

r sh

aki

ng

ch

ills

(F)

11

99

So

cia

l Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1S

hiv

erin

g o

r sh

aki

ng

ch

ills

(F)

11

99

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.30

<0

.00

1<

0.0

01

Sh

ive

ring

or

sha

kin

g c

hill

s (F

)1

19

7H

RQ

OL

Su

mm

ary

Sco

re0

.37

<0

.00

1<

0.0

01

Sh

ive

ring

or

sha

kin

g c

hill

s (F

)2

17

6E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.29

0.8

40

.34

.0

.09

0.0

9S

hiv

erin

g o

r sh

aki

ng

ch

ills

(F)

21

75

Ph

ysic

al F

un

ctio

nin

g0

.20

0.0

07

0.0

4S

hiv

erin

g o

r sh

aki

ng

ch

ills

(F)

21

75

Ro

le F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Sh

ive

ring

or

sha

kin

g c

hill

s (F

)2

17

5E

mo

tion

al F

un

ctio

nin

g0

.23

0.0

02

0.0

2S

hiv

erin

g o

r sh

aki

ng

ch

ills

(F)

21

75

Co

gn

itive

Fu

nct

ion

ing

0.2

20

.00

40

.02

Sh

ive

ring

or

sha

kin

g c

hill

s (F

)2

17

5S

oci

al F

un

ctio

nin

g0

.15

0.0

49

0.0

9S

hiv

erin

g o

r sh

aki

ng

ch

ills

(F)

21

75

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.18

0.0

20

.07

Sh

ive

ring

or

sha

kin

g c

hill

s (F

)2

17

5H

RQ

OL

Su

mm

ary

Sco

re0

.36

<0

.00

1<

0.0

01

Sh

ive

ring

or

sha

kin

g c

hill

s (S

)1

20

0E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.31

0.8

20

.38

.0

.03

0.1

Sh

ive

ring

or

sha

kin

g c

hill

s (S

)1

19

9P

hys

ica

l Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1S

hiv

erin

g o

r sh

aki

ng

ch

ills

(S)

11

99

Ro

le F

un

ctio

nin

g0

.25

<0

.00

10

.00

4S

hiv

erin

g o

r sh

aki

ng

ch

ills

(S)

11

99

Em

otio

na

l Fu

nct

ion

ing

0.2

30

.00

10

.01

Sh

ive

ring

or

sha

kin

g c

hill

s (S

)1

19

9C

og

niti

ve F

un

ctio

nin

g0

.16

0.0

20

.09

Sh

ive

ring

or

sha

kin

g c

hill

s (S

)1

19

9S

oci

al F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Sh

ive

ring

or

sha

kin

g c

hill

s (S

)1

19

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

4<

0.0

01

<0

.00

1S

hiv

erin

g o

r sh

aki

ng

ch

ills

(S)

11

97

HR

QO

L S

um

ma

ry S

core

0.3

7<

0.0

01

<0

.00

1S

hiv

erin

g o

r sh

aki

ng

ch

ills

(S)

21

76

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

50

.78

0.3

2.

0.1

10

.11

Sh

ive

ring

or

sha

kin

g c

hill

s (S

)2

17

5P

hys

ica

l Fu

nct

ion

ing

0.1

90

.01

0.0

7S

hiv

erin

g o

r sh

aki

ng

ch

ills

(S)

21

75

Ro

le F

un

ctio

nin

g0

.31

<0

.00

1<

0.0

01

Sh

ive

ring

or

sha

kin

g c

hill

s (S

)2

17

5E

mo

tion

al F

un

ctio

nin

g0

.21

0.0

04

0.0

4S

hiv

erin

g o

r sh

aki

ng

ch

ills

(S)

21

75

Co

gn

itive

Fu

nct

ion

ing

0.1

80

.02

0.0

8S

hiv

erin

g o

r sh

aki

ng

ch

ills

(S)

21

75

So

cia

l Fu

nct

ion

ing

0.1

40

.07

0.1

1S

hiv

erin

g o

r sh

aki

ng

ch

ills

(S)

21

75

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.18

0.0

20

.08

Sh

ive

ring

or

sha

kin

g c

hill

s (S

)2

17

5H

RQ

OL

Su

mm

ary

Sco

re0

.36

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(S

)1

83

2E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.66

0.9

00

.74

.<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

18

32

Cu

rre

ntly

usi

ng

an

inh

ale

rO

the

r0

.91

0.8

91

.03

.<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

18

16

Ph

ysic

al F

un

ctio

nin

g0

.47

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(S

)1

81

6R

ole

Fu

nct

ion

ing

0.3

6<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

18

13

Em

otio

na

l Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

18

13

Co

gn

itive

Fu

nct

ion

ing

0.2

5<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

18

13

So

cia

l Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

18

13

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.33

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(S

)1

81

1H

RQ

OL

Su

mm

ary

Sco

re0

.48

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(S

)1

81

6D

ysp

ne

a0

.79

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(S

)2

77

1E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.46

0.9

00

.51

.<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

27

71

Cu

rre

ntly

usi

ng

an

inh

ale

rO

the

r0

.90

0.8

81

.03

.<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

27

49

Ph

ysic

al F

un

ctio

nin

g0

.45

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(S

)2

74

9R

ole

Fu

nct

ion

ing

0.3

4<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

27

47

Em

otio

na

l Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

27

47

Co

gn

itive

Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

27

46

So

cia

l Fu

nct

ion

ing

0.2

6<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

S)

27

47

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.33

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(S

)2

74

0H

RQ

OL

Su

mm

ary

Sco

re0

.46

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(S

)2

74

9D

ysp

ne

a0

.81

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(I)

18

32

EC

OG

PS

2-4

EC

OG

PS

0-1

0.6

00

.97

0.6

2.

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(I)

18

32

Cu

rre

ntly

usi

ng

an

inh

ale

rO

the

r0

.73

0.9

70

.76

.<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

I)1

81

6P

hys

ica

l Fu

nct

ion

ing

0.4

6<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

I)1

81

6R

ole

Fu

nct

ion

ing

0.3

8<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

I)1

81

3E

mo

tion

al F

un

ctio

nin

g0

.26

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(I)

18

13

Co

gn

itive

Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

I)1

81

3S

oci

al F

un

ctio

nin

g0

.34

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(I)

18

13

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.31

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(I)

18

11

HR

QO

L S

um

ma

ry S

core

0.4

7<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

I)1

81

6D

ysp

ne

a0

.69

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(I)

27

70

EC

OG

PS

2-4

EC

OG

PS

0-1

0.4

80

.92

0.5

2.

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(I)

27

70

Cu

rre

ntly

usi

ng

an

inh

ale

rO

the

r0

.74

0.9

10

.81

.<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

I)2

74

8P

hys

ica

l Fu

nct

ion

ing

0.4

6<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

I)2

74

8R

ole

Fu

nct

ion

ing

0.3

8<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

I)2

74

6E

mo

tion

al F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(I)

27

46

Co

gn

itive

Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

I)2

74

5S

oci

al F

un

ctio

nin

g0

.32

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(I)

27

46

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.36

<0

.00

1<

0.0

01

Sh

ort

ne

ss o

f bre

ath

(I)

27

39

HR

QO

L S

um

ma

ry S

core

0.4

8<

0.0

01

<0

.00

1S

ho

rtn

ess

of b

rea

th (

I)2

74

8D

ysp

ne

a0

.73

<0

.00

1<

0.0

01

Ski

n b

urn

s fr

om

ra

dia

tion

(S

)1

35

1E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.09

0.7

1-0

.12

.0

.39

0.7

1

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 37: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

37

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eS

kin

bu

rns

fro

m r

ad

iatio

n (

S)

13

51

Ra

dia

tion

the

rap

y in

prio

r 2

we

eks

Oth

er

0.0

90

.70

0.1

2.

0.2

70

.71

Ski

n b

urn

s fr

om

ra

dia

tion

(S

)1

33

4P

hys

ica

l Fu

nct

ion

ing

0.0

50

.39

0.7

1S

kin

bu

rns

fro

m r

ad

iatio

n (

S)

13

34

Ro

le F

un

ctio

nin

g0

.08

0.1

40

.71

Ski

n b

urn

s fr

om

ra

dia

tion

(S

)1

33

2E

mo

tion

al F

un

ctio

nin

g0

.11

0.0

47

0.5

2S

kin

bu

rns

fro

m r

ad

iatio

n (

S)

13

32

Co

gn

itive

Fu

nct

ion

ing

0.1

9<

0.0

01

0.0

08

Ski

n b

urn

s fr

om

ra

dia

tion

(S

)1

33

2S

oci

al F

un

ctio

nin

g0

.13

0.0

20

.21

Ski

n b

urn

s fr

om

ra

dia

tion

(S

)1

33

2G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

40

.00

90

.13

Ski

n b

urn

s fr

om

ra

dia

tion

(S

)1

33

0H

RQ

OL

Su

mm

ary

Sco

re0

.16

0.0

04

0.0

6S

kin

bu

rns

fro

m r

ad

iatio

n (

S)

23

14

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.2

50

.94

-0.2

6.

0.0

80

.69

Ski

n b

urn

s fr

om

ra

dia

tion

(S

)2

31

4R

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r0

.53

0.9

20

.58

.<

0.0

01

<0

.00

1S

kin

bu

rns

fro

m r

ad

iatio

n (

S)

22

99

Ph

ysic

al F

un

ctio

nin

g0

.02

0.7

10

.71

Ski

n b

urn

s fr

om

ra

dia

tion

(S

)2

29

9R

ole

Fu

nct

ion

ing

0.0

90

.11

0.6

9S

kin

bu

rns

fro

m r

ad

iatio

n (

S)

22

98

Em

otio

na

l Fu

nct

ion

ing

0.2

0<

0.0

01

0.0

07

Ski

n b

urn

s fr

om

ra

dia

tion

(S

)2

29

8C

og

niti

ve F

un

ctio

nin

g0

.09

0.1

10

.69

Ski

n b

urn

s fr

om

ra

dia

tion

(S

)2

29

8S

oci

al F

un

ctio

nin

g0

.10

0.0

90

.69

Ski

n b

urn

s fr

om

ra

dia

tion

(S

)2

29

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

90

.11

0.6

9S

kin

bu

rns

fro

m r

ad

iatio

n (

S)

22

96

HR

QO

L S

um

ma

ry S

core

0.1

50

.01

0.1

6S

kin

cra

ckin

g a

t th

e c

orn

ers

of y

ou

r m

ou

th (

S)

12

52

EC

OG

PS

2-4

EC

OG

PS

0-1

0.1

50

.74

0.2

0.

0.2

60

.79

Ski

n c

rack

ing

at t

he

co

rne

rs o

f yo

ur

mo

uth

(S

)1

13

9H

ea

d/N

eck

He

ma

tolo

gic

-0.0

40

.84

-0.0

4.

0.8

20

.95

Ski

n c

rack

ing

at t

he

co

rne

rs o

f yo

ur

mo

uth

(S

)1

25

2H

ea

d/N

eck

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

Oth

er

0.1

30

.74

0.1

8.

0.1

70

.79

Ski

n c

rack

ing

at t

he

co

rne

rs o

f yo

ur

mo

uth

(S

)1

24

9P

hys

ica

l Fu

nct

ion

ing

0.2

5<

0.0

01

<0

.00

1S

kin

cra

ckin

g a

t th

e c

orn

ers

of y

ou

r m

ou

th (

S)

12

49

Ro

le F

un

ctio

nin

g0

.23

<0

.00

10

.00

4S

kin

cra

ckin

g a

t th

e c

orn

ers

of y

ou

r m

ou

th (

S)

12

46

Em

otio

na

l Fu

nct

ion

ing

0.1

40

.03

0.1

8S

kin

cra

ckin

g a

t th

e c

orn

ers

of y

ou

r m

ou

th (

S)

12

46

Co

gn

itive

Fu

nct

ion

ing

0.2

00

.00

20

.02

Ski

n c

rack

ing

at t

he

co

rne

rs o

f yo

ur

mo

uth

(S

)1

24

6S

oci

al F

un

ctio

nin

g0

.16

0.0

10

.1S

kin

cra

ckin

g a

t th

e c

orn

ers

of y

ou

r m

ou

th (

S)

12

46

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.29

<0

.00

1<

0.0

01

Ski

n c

rack

ing

at t

he

co

rne

rs o

f yo

ur

mo

uth

(S

)1

24

4H

RQ

OL

Su

mm

ary

Sco

re0

.28

<0

.00

1<

0.0

01

Ski

n c

rack

ing

at t

he

co

rne

rs o

f yo

ur

mo

uth

(S

)2

22

0E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.18

0.7

90

.22

.0

.24

0.7

9S

kin

cra

ckin

g a

t th

e c

orn

ers

of y

ou

r m

ou

th (

S)

21

24

He

ad

/Ne

ckH

em

ato

log

ic-0

.01

0.8

7-0

.01

.0

.95

0.9

5S

kin

cra

ckin

g a

t th

e c

orn

ers

of y

ou

r m

ou

th (

S)

22

20

He

ad

/Ne

ck w

ith r

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r0

.16

0.7

90

.20

.0

.15

0.7

9S

kin

cra

ckin

g a

t th

e c

orn

ers

of y

ou

r m

ou

th (

S)

22

18

Ph

ysic

al F

un

ctio

nin

g0

.25

<0

.00

10

.00

3S

kin

cra

ckin

g a

t th

e c

orn

ers

of y

ou

r m

ou

th (

S)

22

18

Ro

le F

un

ctio

nin

g0

.30

<0

.00

1<

0.0

01

Ski

n c

rack

ing

at t

he

co

rne

rs o

f yo

ur

mo

uth

(S

)2

21

8E

mo

tion

al F

un

ctio

nin

g0

.24

<0

.00

10

.00

4S

kin

cra

ckin

g a

t th

e c

orn

ers

of y

ou

r m

ou

th (

S)

22

18

Co

gn

itive

Fu

nct

ion

ing

0.2

20

.00

10

.01

Ski

n c

rack

ing

at t

he

co

rne

rs o

f yo

ur

mo

uth

(S

)2

21

8S

oci

al F

un

ctio

nin

g0

.33

<0

.00

1<

0.0

01

Ski

n c

rack

ing

at t

he

co

rne

rs o

f yo

ur

mo

uth

(S

)2

21

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

20

.00

10

.01

Ski

n c

rack

ing

at t

he

co

rne

rs o

f yo

ur

mo

uth

(S

)2

21

8H

RQ

OL

Su

mm

ary

Sco

re0

.38

<0

.00

1<

0.0

01

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

12

68

EC

OG

PS

2-4

EC

OG

PS

0-1

7.0

9%

0.1

7.

0.3

40

.95

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

12

65

Ph

ysic

al F

un

ctio

nin

g0

.09

0.1

60

.95

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

12

65

Ro

le F

un

ctio

nin

g0

.05

0.4

10

.95

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

12

61

Em

otio

na

l Fu

nct

ion

ing

0.2

00

.00

10

.02

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

12

61

Co

gn

itive

Fu

nct

ion

ing

0.1

50

.02

0.2

2S

po

ts/li

ne

s/flo

ate

rs in

eye

s (P

)1

26

1S

oci

al F

un

ctio

nin

g0

.05

0.4

50

.95

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

12

61

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.11

0.0

90

.95

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

12

59

HR

QO

L S

um

ma

ry S

core

0.1

60

.00

80

.12

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

22

36

EC

OG

PS

2-4

EC

OG

PS

0-1

8.8

1%

0.2

0.

0.2

90

.95

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

22

34

Ph

ysic

al F

un

ctio

nin

g0

.08

0.2

20

.95

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

22

34

Ro

le F

un

ctio

nin

g0

.01

0.8

90

.95

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

22

34

Em

otio

na

l Fu

nct

ion

ing

0.0

50

.45

0.9

5S

po

ts/li

ne

s/flo

ate

rs in

eye

s (P

)2

23

4C

og

niti

ve F

un

ctio

nin

g0

.04

0.5

70

.95

Sp

ots

/lin

es/

floa

ters

in e

yes

(P)

22

34

So

cia

l Fu

nct

ion

ing

-0.0

40

.54

0.9

5S

po

ts/li

ne

s/flo

ate

rs in

eye

s (P

)2

23

4G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

10

.88

0.9

5S

po

ts/li

ne

s/flo

ate

rs in

eye

s (P

)2

23

4H

RQ

OL

Su

mm

ary

Sco

re0

.00

0.9

50

.95

Str

etc

h m

ark

s (P

)1

20

0E

CO

G P

S 2

-4E

CO

G P

S 0

-1-2

.17

%-0

.07

.0

.71

0.9

9S

tre

tch

ma

rks

(P)

12

00

Fe

ma

leM

ale

11

.67

%0

.39

.0

.01

0.2

1S

tre

tch

ma

rks

(P)

11

99

Ph

ysic

al F

un

ctio

nin

g-0

.03

0.7

20

.99

Str

etc

h m

ark

s (P

)1

19

9R

ole

Fu

nct

ion

ing

-0.0

70

.35

0.9

9S

tre

tch

ma

rks

(P)

11

99

Em

otio

na

l Fu

nct

ion

ing

-0.0

20

.74

0.9

9S

tre

tch

ma

rks

(P)

11

99

Co

gn

itive

Fu

nct

ion

ing

0.0

40

.54

0.9

9S

tre

tch

ma

rks

(P)

11

99

So

cia

l Fu

nct

ion

ing

-0.0

10

.85

0.9

9S

tre

tch

ma

rks

(P)

11

99

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.01

0.8

50

.99

Str

etc

h m

ark

s (P

)1

19

7H

RQ

OL

Su

mm

ary

Sco

re0

.00

0.9

90

.99

Str

etc

h m

ark

s (P

)2

17

6E

CO

G P

S 2

-4E

CO

G P

S 0

-16

.94

%0

.19

.0

.31

0.9

9S

tre

tch

ma

rks

(P)

21

76

Fe

ma

leM

ale

13

.15

%0

.42

.0

.01

0.2

1S

tre

tch

ma

rks

(P)

21

75

Ph

ysic

al F

un

ctio

nin

g0

.14

0.0

60

.88

Str

etc

h m

ark

s (P

)2

17

5R

ole

Fu

nct

ion

ing

0.1

10

.13

0.9

9S

tre

tch

ma

rks

(P)

21

75

Em

otio

na

l Fu

nct

ion

ing

0.1

10

.15

0.9

9S

tre

tch

ma

rks

(P)

21

75

Co

gn

itive

Fu

nct

ion

ing

0.0

10

.87

0.9

9S

tre

tch

ma

rks

(P)

21

75

So

cia

l Fu

nct

ion

ing

0.0

50

.52

0.9

9S

tre

tch

ma

rks

(P)

21

75

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.05

0.5

20

.99

Str

etc

h m

ark

s (P

)2

17

5H

RQ

OL

Su

mm

ary

Sco

re0

.20

0.0

08

0.1

5S

ud

de

n u

rge

s to

urin

ate

(F

)1

21

9E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.26

1.0

30

.25

.0

.20

.38

Su

dd

en

urg

es

to u

rina

te (

F)

15

5P

rost

ate

/Bla

dd

er

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

He

ma

tolo

gic

0.9

31

.03

0.9

0.

0.0

02

0.0

3

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 38: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

38

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eS

ud

de

n u

rge

s to

urin

ate

(F

)1

21

8P

hys

ica

l Fu

nct

ion

ing

0.1

60

.02

0.1

5S

ud

de

n u

rge

s to

urin

ate

(F

)1

21

8R

ole

Fu

nct

ion

ing

0.1

40

.04

0.1

6S

ud

de

n u

rge

s to

urin

ate

(F

)1

21

8E

mo

tion

al F

un

ctio

nin

g0

.20

0.0

03

0.0

3S

ud

de

n u

rge

s to

urin

ate

(F

)1

21

8C

og

niti

ve F

un

ctio

nin

g0

.12

0.0

70

.22

Su

dd

en

urg

es

to u

rina

te (

F)

12

18

So

cia

l Fu

nct

ion

ing

0.1

60

.02

0.1

5S

ud

de

n u

rge

s to

urin

ate

(F

)1

21

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

3<

0.0

01

0.0

09

Su

dd

en

urg

es

to u

rina

te (

F)

12

16

HR

QO

L S

um

ma

ry S

core

0.2

5<

0.0

01

0.0

03

Su

dd

en

urg

es

to u

rina

te (

F)

21

93

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

11

.08

0.1

9.

0.3

80

.38

Su

dd

en

urg

es

to u

rina

te (

F)

24

8P

rost

ate

/Bla

dd

er

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

He

ma

tolo

gic

1.6

81

.06

1.5

8.

<0

.00

1<

0.0

01

Su

dd

en

urg

es

to u

rina

te (

F)

21

91

Ph

ysic

al F

un

ctio

nin

g0

.16

0.0

30

.16

Su

dd

en

urg

es

to u

rina

te (

F)

21

91

Ro

le F

un

ctio

nin

g0

.19

0.0

09

0.0

9S

ud

de

n u

rge

s to

urin

ate

(F

)2

19

0E

mo

tion

al F

un

ctio

nin

g0

.15

0.0

30

.16

Su

dd

en

urg

es

to u

rina

te (

F)

21

90

Co

gn

itive

Fu

nct

ion

ing

0.1

90

.00

80

.09

Su

dd

en

urg

es

to u

rina

te (

F)

21

89

So

cia

l Fu

nct

ion

ing

0.1

60

.03

0.1

6S

ud

de

n u

rge

s to

urin

ate

(F

)2

19

0G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

7<

0.0

01

0.0

03

Su

dd

en

urg

es

to u

rina

te (

F)

21

87

HR

QO

L S

um

ma

ry S

core

0.2

4<

0.0

01

0.0

1S

ud

de

n u

rge

s to

urin

ate

(I)

12

19

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

00

.99

0.2

0.

0.3

20

.63

Su

dd

en

urg

es

to u

rina

te (

I)1

55

Pro

sta

te/B

lad

de

r w

ith r

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksH

em

ato

log

ic0

.90

1.1

30

.80

.0

.00

60

.08

Su

dd

en

urg

es

to u

rina

te (

I)1

21

8P

hys

ica

l Fu

nct

ion

ing

0.2

5<

0.0

01

0.0

04

Su

dd

en

urg

es

to u

rina

te (

I)1

21

8R

ole

Fu

nct

ion

ing

0.1

60

.02

0.1

8S

ud

de

n u

rge

s to

urin

ate

(I)

12

18

Em

otio

na

l Fu

nct

ion

ing

0.2

3<

0.0

01

0.0

1S

ud

de

n u

rge

s to

urin

ate

(I)

12

18

Co

gn

itive

Fu

nct

ion

ing

0.0

70

.27

0.6

3S

ud

de

n u

rge

s to

urin

ate

(I)

12

18

So

cia

l Fu

nct

ion

ing

0.2

10

.00

10

.02

Su

dd

en

urg

es

to u

rina

te (

I)1

21

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

10

.00

20

.03

Su

dd

en

urg

es

to u

rina

te (

I)1

21

6H

RQ

OL

Su

mm

ary

Sco

re0

.29

<0

.00

1<

0.0

01

Su

dd

en

urg

es

to u

rina

te (

I)2

19

3E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.05

0.8

60

.06

.0

.79

0.7

9S

ud

de

n u

rge

s to

urin

ate

(I)

24

8P

rost

ate

/Bla

dd

er

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

He

ma

tolo

gic

1.1

40

.88

1.3

0.

<0

.00

10

.00

1S

ud

de

n u

rge

s to

urin

ate

(I)

21

91

Ph

ysic

al F

un

ctio

nin

g0

.12

0.1

10

.57

Su

dd

en

urg

es

to u

rina

te (

I)2

19

1R

ole

Fu

nct

ion

ing

0.1

60

.03

0.1

9S

ud

de

n u

rge

s to

urin

ate

(I)

21

90

Em

otio

na

l Fu

nct

ion

ing

0.1

70

.02

0.1

8S

ud

de

n u

rge

s to

urin

ate

(I)

21

90

Co

gn

itive

Fu

nct

ion

ing

0.1

00

.15

0.6

1S

ud

de

n u

rge

s to

urin

ate

(I)

21

89

So

cia

l Fu

nct

ion

ing

0.1

60

.03

0.1

8S

ud

de

n u

rge

s to

urin

ate

(I)

21

90

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.17

0.0

20

.18

Su

dd

en

urg

es

to u

rina

te (

I)2

18

7H

RQ

OL

Su

mm

ary

Sco

re0

.16

0.0

20

.18

To

ok

too

lon

g to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)1

10

1E

CO

G P

S 2

-4E

CO

G P

S 0

-1-8

.05

%-0

.21

.0

.62

0.6

2T

oo

k to

o lo

ng

to h

ave

an

org

asm

or

clim

ax

(P)

19

7P

hys

ica

l Fu

nct

ion

ing

0.1

80

.08

0.4

7T

oo

k to

o lo

ng

to h

ave

an

org

asm

or

clim

ax

(P)

19

7R

ole

Fu

nct

ion

ing

0.0

70

.51

0.6

2T

oo

k to

o lo

ng

to h

ave

an

org

asm

or

clim

ax

(P)

19

7E

mo

tion

al F

un

ctio

nin

g0

.16

0.1

20

.47

To

ok

too

lon

g to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)1

97

Co

gn

itive

Fu

nct

ion

ing

0.2

30

.02

0.3

1T

oo

k to

o lo

ng

to h

ave

an

org

asm

or

clim

ax

(P)

19

7S

oci

al F

un

ctio

nin

g0

.19

0.0

70

.47

To

ok

too

lon

g to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)1

97

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.18

0.0

70

.47

To

ok

too

lon

g to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)1

97

HR

QO

L S

um

ma

ry S

core

0.2

40

.02

0.2

4T

oo

k to

o lo

ng

to h

ave

an

org

asm

or

clim

ax

(P)

29

2E

CO

G P

S 2

-4E

CO

G P

S 0

-1-2

5.5

8%

-1.0

6.

0.1

60

.47

To

ok

too

lon

g to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)2

88

Ph

ysic

al F

un

ctio

nin

g0

.20

0.0

70

.47

To

ok

too

lon

g to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)2

88

Ro

le F

un

ctio

nin

g0

.28

0.0

07

0.1

1T

oo

k to

o lo

ng

to h

ave

an

org

asm

or

clim

ax

(P)

28

7E

mo

tion

al F

un

ctio

nin

g0

.16

0.1

40

.47

To

ok

too

lon

g to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)2

87

Co

gn

itive

Fu

nct

ion

ing

0.2

40

.03

0.3

2T

oo

k to

o lo

ng

to h

ave

an

org

asm

or

clim

ax

(P)

28

7S

oci

al F

un

ctio

nin

g0

.35

<0

.00

10

.01

To

ok

too

lon

g to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)2

87

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.18

0.1

0.4

7T

oo

k to

o lo

ng

to h

ave

an

org

asm

or

clim

ax

(P)

28

6H

RQ

OL

Su

mm

ary

Sco

re0

.23

0.0

30

.38

Un

ab

le to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)1

11

3E

CO

G P

S 2

-4E

CO

G P

S 0

-1-2

.62

%-0

.06

.0

.87

0.8

7U

na

ble

to h

ave

an

org

asm

or

clim

ax

(P)

11

10

Ph

ysic

al F

un

ctio

nin

g0

.19

0.0

50

.62

Un

ab

le to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)1

11

0R

ole

Fu

nct

ion

ing

0.0

60

.53

0.8

7U

na

ble

to h

ave

an

org

asm

or

clim

ax

(P)

11

10

Em

otio

na

l Fu

nct

ion

ing

0.0

60

.51

0.8

7U

na

ble

to h

ave

an

org

asm

or

clim

ax

(P)

11

10

Co

gn

itive

Fu

nct

ion

ing

0.1

00

.28

0.8

7U

na

ble

to h

ave

an

org

asm

or

clim

ax

(P)

11

10

So

cia

l Fu

nct

ion

ing

0.1

10

.27

0.8

7U

na

ble

to h

ave

an

org

asm

or

clim

ax

(P)

11

10

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.16

0.0

90

.8U

na

ble

to h

ave

an

org

asm

or

clim

ax

(P)

11

10

HR

QO

L S

um

ma

ry S

core

0.1

70

.08

0.8

Un

ab

le to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)2

92

EC

OG

PS

2-4

EC

OG

PS

0-1

-12

.77

%-0

.32

.0

.46

0.8

7U

na

ble

to h

ave

an

org

asm

or

clim

ax

(P)

28

9P

hys

ica

l Fu

nct

ion

ing

0.2

30

.03

0.4

Un

ab

le to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)2

89

Ro

le F

un

ctio

nin

g0

.28

0.0

07

0.1

2U

na

ble

to h

ave

an

org

asm

or

clim

ax

(P)

28

8E

mo

tion

al F

un

ctio

nin

g0

.07

0.5

40

.87

Un

ab

le to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)2

88

Co

gn

itive

Fu

nct

ion

ing

0.1

90

.07

0.7

9U

na

ble

to h

ave

an

org

asm

or

clim

ax

(P)

28

8S

oci

al F

un

ctio

nin

g0

.27

0.0

10

.15

Un

ab

le to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)2

88

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.15

0.1

60

.87

Un

ab

le to

ha

ve a

n o

rga

sm o

r cl

ima

x (P

)2

87

HR

QO

L S

um

ma

ry S

core

0.2

30

.04

0.4

7U

ne

xpe

cte

d d

ecr

ea

se in

sw

ea

ting

(P

)1

40

9E

CO

G P

S 2

-4E

CO

G P

S 0

-1-1

.96

%-0

.10

.0

.53

0.9

8U

ne

xpe

cte

d d

ecr

ea

se in

sw

ea

ting

(P

)1

39

4P

hys

ica

l Fu

nct

ion

ing

0.0

00

.98

0.9

8U

ne

xpe

cte

d d

ecr

ea

se in

sw

ea

ting

(P

)1

39

4R

ole

Fu

nct

ion

ing

0.0

70

.17

0.8

4U

ne

xpe

cte

d d

ecr

ea

se in

sw

ea

ting

(P

)1

39

4E

mo

tion

al F

un

ctio

nin

g0

.11

0.0

30

.27

Un

exp

ect

ed

de

cre

ase

in s

we

atin

g (

P)

13

94

Co

gn

itive

Fu

nct

ion

ing

0.0

50

.34

0.9

8U

ne

xpe

cte

d d

ecr

ea

se in

sw

ea

ting

(P

)1

39

4S

oci

al F

un

ctio

nin

g0

.10

0.0

40

.32

Un

exp

ect

ed

de

cre

ase

in s

we

atin

g (

P)

13

94

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.12

0.0

20

.18

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 39: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

39

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eU

ne

xpe

cte

d d

ecr

ea

se in

sw

ea

ting

(P

)1

39

1H

RQ

OL

Su

mm

ary

Sco

re0

.08

0.1

20

.69

Un

exp

ect

ed

de

cre

ase

in s

we

atin

g (

P)

23

71

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.8

4%

-0.0

4.

0.8

20

.98

Un

exp

ect

ed

de

cre

ase

in s

we

atin

g (

P)

23

56

Ph

ysic

al F

un

ctio

nin

g0

.09

0.0

80

.59

Un

exp

ect

ed

de

cre

ase

in s

we

atin

g (

P)

23

56

Ro

le F

un

ctio

nin

g0

.18

<0

.00

10

.00

6U

ne

xpe

cte

d d

ecr

ea

se in

sw

ea

ting

(P

)2

35

6E

mo

tion

al F

un

ctio

nin

g0

.23

<0

.00

1<

0.0

01

Un

exp

ect

ed

de

cre

ase

in s

we

atin

g (

P)

23

56

Co

gn

itive

Fu

nct

ion

ing

0.2

2<

0.0

01

<0

.00

1U

ne

xpe

cte

d d

ecr

ea

se in

sw

ea

ting

(P

)2

35

6S

oci

al F

un

ctio

nin

g0

.23

<0

.00

1<

0.0

01

Un

exp

ect

ed

de

cre

ase

in s

we

atin

g (

P)

23

56

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.11

0.0

30

.3U

ne

xpe

cte

d d

ecr

ea

se in

sw

ea

ting

(P

)2

35

2H

RQ

OL

Su

mm

ary

Sco

re0

.21

<0

.00

1<

0.0

01

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(F

)1

36

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.21

1.0

00

.21

.0

.22

0.3

5U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

F)

12

91

Bre

ast

/Pro

sta

teG

ast

roin

test

ina

l0

.14

1.0

30

.14

.0

.35

0.3

5U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

F)

13

60

Ph

ysic

al F

un

ctio

nin

g0

.12

0.0

20

.12

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(F

)1

36

0R

ole

Fu

nct

ion

ing

0.1

40

.00

70

.06

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(F

)1

36

0E

mo

tion

al F

un

ctio

nin

g0

.19

<0

.00

10

.00

3U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

F)

13

60

Co

gn

itive

Fu

nct

ion

ing

0.1

10

.03

0.1

2U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

F)

13

60

So

cia

l Fu

nct

ion

ing

0.2

0<

0.0

01

0.0

02

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(F

)1

36

0G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

50

.00

40

.04

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(F

)1

35

8H

RQ

OL

Su

mm

ary

Sco

re0

.22

<0

.00

1<

0.0

01

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(F

)2

33

8E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.20

0.9

3-0

.21

.0

.28

0.3

5U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

F)

22

72

Bre

ast

/Pro

sta

teG

ast

roin

test

ina

l0

.38

0.9

50

.40

.0

.01

0.0

7U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

F)

23

25

Ph

ysic

al F

un

ctio

nin

g0

.19

<0

.00

10

.00

7U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

F)

23

25

Ro

le F

un

ctio

nin

g0

.13

0.0

20

.12

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(F

)2

32

6E

mo

tion

al F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(F

)2

32

6C

og

niti

ve F

un

ctio

nin

g0

.22

<0

.00

1<

0.0

01

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(F

)2

32

5S

oci

al F

un

ctio

nin

g0

.18

<0

.00

10

.00

9U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

F)

23

26

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.16

0.0

03

0.0

3U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

F)

23

20

HR

QO

L S

um

ma

ry S

core

0.2

6<

0.0

01

<0

.00

1U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

S)

13

68

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

20

.88

0.2

5.

0.1

40

.23

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(S

)1

29

1B

rea

st/P

rost

ate

Ga

stro

inte

stin

al

0.1

90

.90

0.2

1.

0.1

70

.23

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(S

)1

36

0P

hys

ica

l Fu

nct

ion

ing

0.1

00

.04

90

.19

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(S

)1

36

0R

ole

Fu

nct

ion

ing

0.1

30

.02

0.0

9U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

S)

13

60

Em

otio

na

l Fu

nct

ion

ing

0.1

9<

0.0

01

0.0

04

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(S

)1

36

0C

og

niti

ve F

un

ctio

nin

g0

.13

0.0

20

.09

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(S

)1

36

0S

oci

al F

un

ctio

nin

g0

.18

<0

.00

10

.00

6U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

S)

13

60

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.15

0.0

04

0.0

4U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

S)

13

58

HR

QO

L S

um

ma

ry S

core

0.2

2<

0.0

01

<0

.00

1U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

S)

23

38

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.2

00

.85

-0.2

4.

0.2

30

.23

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(S

)2

27

2B

rea

st/P

rost

ate

Ga

stro

inte

stin

al

0.3

50

.88

0.4

0.

0.0

10

.09

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(S

)2

32

5P

hys

ica

l Fu

nct

ion

ing

0.1

9<

0.0

01

0.0

06

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(S

)2

32

5R

ole

Fu

nct

ion

ing

0.1

30

.02

0.0

9U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

S)

23

26

Em

otio

na

l Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

S)

23

26

Co

gn

itive

Fu

nct

ion

ing

0.2

3<

0.0

01

<0

.00

1U

ne

xpe

cte

d o

r e

xce

ssiv

e s

we

atin

g (

S)

23

25

So

cia

l Fu

nct

ion

ing

0.2

0<

0.0

01

0.0

04

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(S

)2

32

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

80

.00

10

.01

Un

exp

ect

ed

or

exc

ess

ive

sw

ea

ting

(S

)2

32

0H

RQ

OL

Su

mm

ary

Sco

re0

.28

<0

.00

1<

0.0

01

Un

usu

al d

ark

en

ing

of t

he

ski

n (

P)

15

08

EC

OG

PS

2-4

EC

OG

PS

0-1

-7.4

2%

-0.2

4.

0.1

0.2

Un

usu

al d

ark

en

ing

of t

he

ski

n (

P)

15

08

Ra

dia

tion

the

rap

y in

prio

r 2

we

eks

Oth

er

4.9

0%

0.1

4.

0.1

10

.2U

nu

sua

l da

rke

nin

g o

f th

e s

kin

(P

)1

49

1P

hys

ica

l Fu

nct

ion

ing

0.0

70

.11

0.2

Un

usu

al d

ark

en

ing

of t

he

ski

n (

P)

14

91

Ro

le F

un

ctio

nin

g0

.12

0.0

10

.14

Un

usu

al d

ark

en

ing

of t

he

ski

n (

P)

14

88

Em

otio

na

l Fu

nct

ion

ing

0.1

20

.01

0.1

4U

nu

sua

l da

rke

nin

g o

f th

e s

kin

(P

)1

48

8C

og

niti

ve F

un

ctio

nin

g0

.19

<0

.00

1<

0.0

01

Un

usu

al d

ark

en

ing

of t

he

ski

n (

P)

14

88

So

cia

l Fu

nct

ion

ing

0.1

9<

0.0

01

<0

.00

1U

nu

sua

l da

rke

nin

g o

f th

e s

kin

(P

)1

48

8G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

60

.16

0.2

Un

usu

al d

ark

en

ing

of t

he

ski

n (

P)

14

85

HR

QO

L S

um

ma

ry S

core

0.1

6<

0.0

01

0.0

04

Un

usu

al d

ark

en

ing

of t

he

ski

n (

P)

24

59

EC

OG

PS

2-4

EC

OG

PS

0-1

-9.5

3%

-0.2

8.

0.0

90

.2U

nu

sua

l da

rke

nin

g o

f th

e s

kin

(P

)2

45

9R

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r1

2.5

5%

0.3

3.

<0

.00

10

.00

7U

nu

sua

l da

rke

nin

g o

f th

e s

kin

(P

)2

44

3P

hys

ica

l Fu

nct

ion

ing

0.0

60

.19

0.2

Un

usu

al d

ark

en

ing

of t

he

ski

n (

P)

24

43

Ro

le F

un

ctio

nin

g0

.07

0.1

60

.2U

nu

sua

l da

rke

nin

g o

f th

e s

kin

(P

)2

44

3E

mo

tion

al F

un

ctio

nin

g0

.06

0.2

0.2

Un

usu

al d

ark

en

ing

of t

he

ski

n (

P)

24

43

Co

gn

itive

Fu

nct

ion

ing

0.0

60

.17

0.2

Un

usu

al d

ark

en

ing

of t

he

ski

n (

P)

24

43

So

cia

l Fu

nct

ion

ing

0.0

70

.14

0.2

Un

usu

al d

ark

en

ing

of t

he

ski

n (

P)

24

43

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.09

0.0

50

.2U

nu

sua

l da

rke

nin

g o

f th

e s

kin

(P

)2

43

9H

RQ

OL

Su

mm

ary

Sco

re0

.06

0.2

0.2

Un

usu

al v

ag

ina

l dis

cha

rge

(A

)1

22

4E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.04

0.4

80

.08

.0

.73

0.9

5U

nu

sua

l va

gin

al d

isch

arg

e (

A)

11

00

Ag

e <

40

Ag

e >

60

0.4

70

.57

0.8

3.

<0

.00

10

.00

5U

nu

sua

l va

gin

al d

isch

arg

e (

A)

11

80

Bre

ast

He

ma

tolo

gic

-0.0

90

.43

-0.2

0.

0.3

90

.95

Un

usu

al v

ag

ina

l dis

cha

rge

(A

)1

21

6P

hys

ica

l Fu

nct

ion

ing

0.0

40

.52

0.9

5U

nu

sua

l va

gin

al d

isch

arg

e (

A)

12

16

Ro

le F

un

ctio

nin

g0

.06

0.3

90

.95

Un

usu

al v

ag

ina

l dis

cha

rge

(A

)1

21

6E

mo

tion

al F

un

ctio

nin

g0

.18

0.0

08

0.1

5U

nu

sua

l va

gin

al d

isch

arg

e (

A)

12

16

Co

gn

itive

Fu

nct

ion

ing

0.1

10

.09

0.9

5U

nu

sua

l va

gin

al d

isch

arg

e (

A)

12

16

So

cia

l Fu

nct

ion

ing

0.0

90

.20

.95

Un

usu

al v

ag

ina

l dis

cha

rge

(A

)1

21

6G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

80

.24

0.9

5U

nu

sua

l va

gin

al d

isch

arg

e (

A)

12

15

HR

QO

L S

um

ma

ry S

core

0.1

60

.02

0.3

1

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 40: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

40

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eU

nu

sua

l va

gin

al d

isch

arg

e (

A)

22

09

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

10

.48

0.0

1.

0.9

50

.95

Un

usu

al v

ag

ina

l dis

cha

rge

(A

)2

92

Ag

e <

40

Ag

e >

60

0.5

00

.56

0.9

0.

<0

.00

10

.00

2U

nu

sua

l va

gin

al d

isch

arg

e (

A)

21

71

Bre

ast

He

ma

tolo

gic

0.0

80

.42

0.2

0.

0.4

30

.95

Un

usu

al v

ag

ina

l dis

cha

rge

(A

)2

19

7P

hys

ica

l Fu

nct

ion

ing

0.0

60

.43

0.9

5U

nu

sua

l va

gin

al d

isch

arg

e (

A)

21

97

Ro

le F

un

ctio

nin

g0

.08

0.2

60

.95

Un

usu

al v

ag

ina

l dis

cha

rge

(A

)2

19

9E

mo

tion

al F

un

ctio

nin

g0

.18

0.0

10

.22

Un

usu

al v

ag

ina

l dis

cha

rge

(A

)2

19

9C

og

niti

ve F

un

ctio

nin

g0

.11

0.1

10

.95

Un

usu

al v

ag

ina

l dis

cha

rge

(A

)2

19

9S

oci

al F

un

ctio

nin

g0

.05

0.4

90

.95

Un

usu

al v

ag

ina

l dis

cha

rge

(A

)2

19

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

20

.08

0.9

5U

nu

sua

l va

gin

al d

isch

arg

e (

A)

21

96

HR

QO

L S

um

ma

ry S

core

0.1

60

.03

0.4

3U

rine

co

lor

cha

ng

e (

P)

12

27

EC

OG

PS

2-4

EC

OG

PS

0-1

10

.59

%0

.29

.0

.10

.8U

rine

co

lor

cha

ng

e (

P)

12

27

Da

un

oru

bic

in/d

oxo

rub

icin

/mito

xan

tro

ne

in p

rior

2 w

ee

ksO

the

r5

.68

%0

.16

.0

.58

0.8

7U

rine

co

lor

cha

ng

e (

P)

12

26

Ph

ysic

al F

un

ctio

nin

g0

.11

0.1

0.8

Urin

e c

olo

r ch

an

ge

(P

)1

22

6R

ole

Fu

nct

ion

ing

0.0

90

.16

0.8

7U

rine

co

lor

cha

ng

e (

P)

12

26

Em

otio

na

l Fu

nct

ion

ing

0.1

10

.10

.8U

rine

co

lor

cha

ng

e (

P)

12

26

Co

gn

itive

Fu

nct

ion

ing

0.0

80

.21

0.8

7U

rine

co

lor

cha

ng

e (

P)

12

26

So

cia

l Fu

nct

ion

ing

0.1

70

.01

0.1

7U

rine

co

lor

cha

ng

e (

P)

12

26

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.07

0.2

90

.87

Urin

e c

olo

r ch

an

ge

(P

)1

22

4H

RQ

OL

Su

mm

ary

Sco

re0

.19

0.0

04

0.0

7U

rine

co

lor

cha

ng

e (

P)

22

00

EC

OG

PS

2-4

EC

OG

PS

0-1

-1.1

1%

-0.0

3.

0.8

70

.87

Urin

e c

olo

r ch

an

ge

(P

)2

20

0D

au

no

rub

icin

/do

xoru

bic

in/m

itoxa

ntr

on

e in

prio

r 2

we

eks

Oth

er

55

.84

%1

.24

.<

0.0

01

<0

.00

1U

rine

co

lor

cha

ng

e (

P)

21

98

Ph

ysic

al F

un

ctio

nin

g0

.17

0.0

20

.24

Urin

e c

olo

r ch

an

ge

(P

)2

19

8R

ole

Fu

nct

ion

ing

0.1

60

.03

0.3

1U

rine

co

lor

cha

ng

e (

P)

21

97

Em

otio

na

l Fu

nct

ion

ing

0.1

40

.04

70

.52

Urin

e c

olo

r ch

an

ge

(P

)2

19

7C

og

niti

ve F

un

ctio

nin

g0

.19

0.0

07

0.1

Urin

e c

olo

r ch

an

ge

(P

)2

19

6S

oci

al F

un

ctio

nin

g0

.10

0.1

60

.87

Urin

e c

olo

r ch

an

ge

(P

)2

19

7G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

40

.58

0.8

7U

rine

co

lor

cha

ng

e (

P)

21

94

HR

QO

L S

um

ma

ry S

core

0.1

80

.01

0.1

7V

ag

ina

l dry

ne

ss (

S)

12

24

EC

OG

PS

2-4

EC

OG

PS

0-1

-0.2

40

.93

-0.2

5.

0.2

41

Va

gin

al d

ryn

ess

(S

)1

10

0A

ge

<4

0A

ge

>6

00

.51

0.8

00

.64

.0

.00

40

.09

Va

gin

al d

ryn

ess

(S

)1

18

0B

rea

stH

em

ato

log

ic0

0.9

30

.1

1V

ag

ina

l dry

ne

ss (

S)

12

24

Cu

rre

ntly

re

ceiv

ing

ho

rmo

ne

the

rap

yO

the

r-0

.12

0.9

3-0

.13

.0

.58

1V

ag

ina

l dry

ne

ss (

S)

12

16

Ph

ysic

al F

un

ctio

nin

g-0

.05

0.4

91

Va

gin

al d

ryn

ess

(S

)1

21

6R

ole

Fu

nct

ion

ing

-0.0

10

.85

1V

ag

ina

l dry

ne

ss (

S)

12

16

Em

otio

na

l Fu

nct

ion

ing

0.0

80

.21

1V

ag

ina

l dry

ne

ss (

S)

12

16

Co

gn

itive

Fu

nct

ion

ing

0.1

20

.08

1V

ag

ina

l dry

ne

ss (

S)

12

16

So

cia

l Fu

nct

ion

ing

0.0

30

.65

1V

ag

ina

l dry

ne

ss (

S)

12

16

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.04

0.5

51

Va

gin

al d

ryn

ess

(S

)1

21

5H

RQ

OL

Su

mm

ary

Sco

re0

.13

0.0

51

Va

gin

al d

ryn

ess

(S

)2

20

9E

CO

G P

S 2

-4E

CO

G P

S 0

-1-0

.48

0.7

9-0

.61

.0

.01

**0

.21

Va

gin

al d

ryn

ess

(S

)2

92

Ag

e <

40

Ag

e >

60

-0.0

50

.73

-0.0

7.

0.7

51

Va

gin

al d

ryn

ess

(S

)2

17

1B

rea

stH

em

ato

log

ic0

.21

0.7

90

.27

.0

.29

1V

ag

ina

l dry

ne

ss (

S)

22

09

Cu

rre

ntly

re

ceiv

ing

ho

rmo

ne

the

rap

yO

the

r-0

.03

0.8

0-0

.03

.0

.91

Va

gin

al d

ryn

ess

(S

)2

19

7P

hys

ica

l Fu

nct

ion

ing

-0.0

80

.27

1V

ag

ina

l dry

ne

ss (

S)

21

97

Ro

le F

un

ctio

nin

g0

.01

0.8

61

Va

gin

al d

ryn

ess

(S

)2

19

9E

mo

tion

al F

un

ctio

nin

g0

.03

0.6

61

Va

gin

al d

ryn

ess

(S

)2

19

9C

og

niti

ve F

un

ctio

nin

g0

.08

0.2

71

Va

gin

al d

ryn

ess

(S

)2

19

9S

oci

al F

un

ctio

nin

g0

.07

0.3

61

Va

gin

al d

ryn

ess

(S

)2

19

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.0

70

.34

1V

ag

ina

l dry

ne

ss (

S)

21

96

HR

QO

L S

um

ma

ry S

core

0.0

70

.31

1V

oic

e c

ha

ng

es

(P)

12

52

EC

OG

PS

2-4

EC

OG

PS

0-1

8.0

4%

0.1

8.

0.3

10

.61

Vo

ice

ch

an

ge

s (P

)1

25

2H

ea

d/N

eck

with

ra

dia

tion

the

rap

y in

prio

r 2

we

eks

Oth

er

18

.57

%0

.41

.0

.00

10

.01

Vo

ice

ch

an

ge

s (P

)1

24

9P

hys

ica

l Fu

nct

ion

ing

0.0

80

.21

0.6

1V

oic

e c

ha

ng

es

(P)

12

49

Ro

le F

un

ctio

nin

g0

.14

0.0

20

.12

Vo

ice

ch

an

ge

s (P

)1

24

6E

mo

tion

al F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Vo

ice

ch

an

ge

s (P

)1

24

6C

og

niti

ve F

un

ctio

nin

g0

.24

<0

.00

10

.00

2V

oic

e c

ha

ng

es

(P)

12

46

So

cia

l Fu

nct

ion

ing

0.2

8<

0.0

01

<0

.00

1V

oic

e c

ha

ng

es

(P)

12

46

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.19

0.0

02

0.0

2V

oic

e c

ha

ng

es

(P)

12

44

HR

QO

L S

um

ma

ry S

core

0.2

4<

0.0

01

0.0

02

Vo

ice

ch

an

ge

s (P

)2

22

1E

CO

G P

S 2

-4E

CO

G P

S 0

-11

.05

%0

.02

.0

.90

.9V

oic

e c

ha

ng

es

(P)

22

21

He

ad

/Ne

ck w

ith r

ad

iatio

n th

era

py

in p

rior

2 w

ee

ksO

the

r2

6.6

6%

0.5

8.

<0

.00

1<

0.0

01

Vo

ice

ch

an

ge

s (P

)2

21

9P

hys

ica

l Fu

nct

ion

ing

0.1

90

.00

50

.03

Vo

ice

ch

an

ge

s (P

)2

21

9R

ole

Fu

nct

ion

ing

0.3

0<

0.0

01

<0

.00

1V

oic

e c

ha

ng

es

(P)

22

19

Em

otio

na

l Fu

nct

ion

ing

0.2

2<

0.0

01

0.0

08

Vo

ice

ch

an

ge

s (P

)2

21

9C

og

niti

ve F

un

ctio

nin

g0

.08

0.2

30

.61

Vo

ice

ch

an

ge

s (P

)2

21

9S

oci

al F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Vo

ice

ch

an

ge

s (P

)2

21

9G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

90

.00

40

.03

Vo

ice

ch

an

ge

s (P

)2

21

9H

RQ

OL

Su

mm

ary

Sco

re0

.36

<0

.00

1<

0.0

01

Vo

miti

ng

(F

)1

82

6E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.32

0.7

00

.46

.<

0.0

01

<0

.00

1V

om

itin

g (

F)

18

26

Cu

rre

ntly

taki

ng

na

use

a m

ed

Oth

er

0.4

70

.67

0.6

9.

<0

.00

1<

0.0

01

Vo

miti

ng

(F

)1

81

0P

hys

ica

l Fu

nct

ion

ing

0.2

1<

0.0

01

<0

.00

1V

om

itin

g (

F)

18

10

Ro

le F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Vo

miti

ng

(F

)1

80

7E

mo

tion

al F

un

ctio

nin

g0

.23

<0

.00

1<

0.0

01

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 41: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

41

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eV

om

itin

g (

F)

18

07

Co

gn

itive

Fu

nct

ion

ing

0.1

8<

0.0

01

<0

.00

1V

om

itin

g (

F)

18

07

So

cia

l Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1V

om

itin

g (

F)

18

07

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.21

<0

.00

1<

0.0

01

Vo

miti

ng

(F

)1

80

5H

RQ

OL

Su

mm

ary

Sco

re0

.40

<0

.00

1<

0.0

01

Vo

miti

ng

(F

)1

81

0N

au

sea

an

d V

om

itin

g0

.74

<0

.00

1<

0.0

01

Vo

miti

ng

(F

)2

75

6E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.34

0.6

70

.51

.<

0.0

01

<0

.00

1V

om

itin

g (

F)

27

56

Cu

rre

ntly

taki

ng

na

use

a m

ed

Oth

er

0.3

80

.65

0.5

8.

<0

.00

1<

0.0

01

Vo

miti

ng

(F

)2

73

4P

hys

ica

l Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1V

om

itin

g (

F)

27

34

Ro

le F

un

ctio

nin

g0

.27

<0

.00

1<

0.0

01

Vo

miti

ng

(F

)2

73

2E

mo

tion

al F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Vo

miti

ng

(F

)2

73

2C

og

niti

ve F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Vo

miti

ng

(F

)2

73

1S

oci

al F

un

ctio

nin

g0

.34

<0

.00

1<

0.0

01

Vo

miti

ng

(F

)2

73

2G

lob

al H

ea

lth S

tatu

s/Q

oL

0.3

0<

0.0

01

<0

.00

1V

om

itin

g (

F)

27

25

HR

QO

L S

um

ma

ry S

core

0.4

4<

0.0

01

<0

.00

1V

om

itin

g (

F)

27

34

Na

use

a a

nd

Vo

miti

ng

0.7

0<

0.0

01

<0

.00

1V

om

itin

g (

S)

18

26

EC

OG

PS

2-4

EC

OG

PS

0-1

0.2

80

.71

0.3

9.

<0

.00

1<

0.0

01

Vo

miti

ng

(S

)1

82

6C

urr

en

tly ta

kin

g n

au

sea

me

dO

the

r0

.47

0.6

80

.70

.<

0.0

01

<0

.00

1V

om

itin

g (

S)

18

10

Ph

ysic

al F

un

ctio

nin

g0

.19

<0

.00

1<

0.0

01

Vo

miti

ng

(S

)1

81

0R

ole

Fu

nct

ion

ing

0.2

4<

0.0

01

<0

.00

1V

om

itin

g (

S)

18

07

Em

otio

na

l Fu

nct

ion

ing

0.2

1<

0.0

01

<0

.00

1V

om

itin

g (

S)

18

07

Co

gn

itive

Fu

nct

ion

ing

0.2

0<

0.0

01

<0

.00

1V

om

itin

g (

S)

18

07

So

cia

l Fu

nct

ion

ing

0.2

5<

0.0

01

<0

.00

1V

om

itin

g (

S)

18

07

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.19

<0

.00

1<

0.0

01

Vo

miti

ng

(S

)1

80

5H

RQ

OL

Su

mm

ary

Sco

re0

.39

<0

.00

1<

0.0

01

Vo

miti

ng

(S

)1

81

0N

au

sea

an

d V

om

itin

g0

.70

<0

.00

1<

0.0

01

Vo

miti

ng

(S

)2

75

6E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.36

0.6

70

.54

.<

0.0

01

<0

.00

1V

om

itin

g (

S)

27

56

Cu

rre

ntly

taki

ng

na

use

a m

ed

Oth

er

0.3

90

.66

0.5

9.

<0

.00

1<

0.0

01

Vo

miti

ng

(S

)2

73

4P

hys

ica

l Fu

nct

ion

ing

0.2

9<

0.0

01

<0

.00

1V

om

itin

g (

S)

27

34

Ro

le F

un

ctio

nin

g0

.25

<0

.00

1<

0.0

01

Vo

miti

ng

(S

)2

73

2E

mo

tion

al F

un

ctio

nin

g0

.27

<0

.00

1<

0.0

01

Vo

miti

ng

(S

)2

73

2C

og

niti

ve F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Vo

miti

ng

(S

)2

73

1S

oci

al F

un

ctio

nin

g0

.34

<0

.00

1<

0.0

01

Vo

miti

ng

(S

)2

73

2G

lob

al H

ea

lth S

tatu

s/Q

oL

0.2

8<

0.0

01

<0

.00

1V

om

itin

g (

S)

27

25

HR

QO

L S

um

ma

ry S

core

0.4

4<

0.0

01

<0

.00

1V

om

itin

g (

S)

27

34

Na

use

a a

nd

Vo

miti

ng

0.6

8<

0.0

01

<0

.00

1W

ate

ry e

yes

(S)

12

68

EC

OG

PS

2-4

EC

OG

PS

0-1

0.0

40

.84

0.0

5.

0.7

70

.77

Wa

tery

eye

s (S

)1

26

5P

hys

ica

l Fu

nct

ion

ing

0.2

0<

0.0

01

0.0

1W

ate

ry e

yes

(S)

12

65

Ro

le F

un

ctio

nin

g0

.09

0.1

60

.47

Wa

tery

eye

s (S

)1

26

1E

mo

tion

al F

un

ctio

nin

g0

.13

0.0

30

.21

Wa

tery

eye

s (S

)1

26

1C

og

niti

ve F

un

ctio

nin

g0

.19

0.0

03

0.0

3W

ate

ry e

yes

(S)

12

61

So

cia

l Fu

nct

ion

ing

0.1

00

.10

.41

Wa

tery

eye

s (S

)1

26

1G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

20

.04

0.2

4W

ate

ry e

yes

(S)

12

59

HR

QO

L S

um

ma

ry S

core

0.1

70

.00

60

.06

Wa

tery

eye

s (S

)2

23

6E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.07

0.7

50

.10

.0

.62

0.7

7W

ate

ry e

yes

(S)

22

34

Ph

ysic

al F

un

ctio

nin

g0

.24

<0

.00

10

.00

4W

ate

ry e

yes

(S)

22

34

Ro

le F

un

ctio

nin

g0

.13

0.0

49

0.2

4W

ate

ry e

yes

(S)

22

34

Em

otio

na

l Fu

nct

ion

ing

0.1

70

.00

90

.08

Wa

tery

eye

s (S

)2

23

4C

og

niti

ve F

un

ctio

nin

g0

.20

0.0

02

0.0

3W

ate

ry e

yes

(S)

22

34

So

cia

l Fu

nct

ion

ing

0.1

60

.02

0.1

3W

ate

ry e

yes

(S)

22

34

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.21

0.0

01

0.0

2W

ate

ry e

yes

(S)

22

34

HR

QO

L S

um

ma

ry S

core

0.2

00

.00

20

.02

Wa

tery

eye

s (I

)1

26

8E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.13

0.6

50

.20

.0

.26

0.6

1W

ate

ry e

yes

(I)

12

65

Ph

ysic

al F

un

ctio

nin

g0

.14

0.0

20

.18

Wa

tery

eye

s (I

)1

26

5R

ole

Fu

nct

ion

ing

0.0

40

.48

0.6

1W

ate

ry e

yes

(I)

12

61

Em

otio

na

l Fu

nct

ion

ing

0.1

90

.00

20

.03

Wa

tery

eye

s (I

)1

26

1C

og

niti

ve F

un

ctio

nin

g0

.10

0.1

0.6

1W

ate

ry e

yes

(I)

12

61

So

cia

l Fu

nct

ion

ing

0.1

40

.02

0.1

8W

ate

ry e

yes

(I)

12

61

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.09

0.1

60

.61

Wa

tery

eye

s (I

)1

25

9H

RQ

OL

Su

mm

ary

Sco

re0

.16

0.0

09

0.1

Wa

tery

eye

s (I

)2

23

6E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.07

0.6

90

.10

.0

.61

0.6

1W

ate

ry e

yes

(I)

22

34

Ph

ysic

al F

un

ctio

nin

g0

.12

0.0

60

.4W

ate

ry e

yes

(I)

22

34

Ro

le F

un

ctio

nin

g0

.08

0.2

20

.61

Wa

tery

eye

s (I

)2

23

4E

mo

tion

al F

un

ctio

nin

g0

.19

0.0

03

0.0

47

Wa

tery

eye

s (I

)2

23

4C

og

niti

ve F

un

ctio

nin

g0

.23

<0

.00

10

.00

6W

ate

ry e

yes

(I)

22

34

So

cia

l Fu

nct

ion

ing

0.1

80

.00

60

.08

Wa

tery

eye

s (I

)2

23

4G

lob

al H

ea

lth S

tatu

s/Q

oL

0.1

50

.02

0.1

8W

ate

ry e

yes

(I)

22

34

HR

QO

L S

um

ma

ry S

core

0.1

70

.00

70

.09

Wh

ee

zin

g (

S)

14

55

EC

OG

PS

2-4

EC

OG

PS

0-1

0.3

30

.69

0.4

8.

<0

.00

10

.00

2W

he

ezi

ng

(S

)1

36

5L

un

g/H

ea

d/N

eck

Pro

sta

te/B

lad

de

r0

.17

0.7

10

.24

.0

.05

0.1

Wh

ee

zin

g (

S)

14

45

Ph

ysic

al F

un

ctio

nin

g0

.24

<0

.00

1<

0.0

01

Wh

ee

zin

g (

S)

14

45

Ro

le F

un

ctio

nin

g0

.18

<0

.00

10

.00

1W

he

ezi

ng

(S

)1

44

2E

mo

tion

al F

un

ctio

nin

g0

.27

<0

.00

1<

0.0

01

Wh

ee

zin

g (

S)

14

42

Co

gn

itive

Fu

nct

ion

ing

0.1

9<

0.0

01

<0

.00

1

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 42: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

42

PR

O-C

TC

AE

Ite

mV

isit

NW

ors

e S

ym

pto

m L

ev

el G

rou

pB

ett

er

Sy

mp

tom

Le

ve

l Gro

up

Me

an

or

Pe

rce

nt

Dif

fere

nc

eS

DE

ffe

ct

Siz

e*

EO

RT

C Q

LQ

-C3

0P

ea

rso

n

Co

rre

lati

on

Un

ad

jus

ted

P

-va

lue

Ho

ch

be

rg

P-v

alu

eW

he

ezi

ng

(S

)1

44

2S

oci

al F

un

ctio

nin

g0

.15

0.0

01

0.0

05

Wh

ee

zin

g (

S)

14

42

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.24

<0

.00

1<

0.0

01

Wh

ee

zin

g (

S)

14

39

HR

QO

L S

um

ma

ry S

core

0.3

2<

0.0

01

<0

.00

1W

he

ezi

ng

(S

)2

40

5E

CO

G P

S 2

-4E

CO

G P

S 0

-10

.27

0.6

30

.44

.0

.00

40

.01

Wh

ee

zin

g (

S)

23

27

Lu

ng

/He

ad

/Ne

ckP

rost

ate

/Bla

dd

er

0.0

30

.68

0.0

5.

0.7

10

.71

Wh

ee

zin

g (

S)

23

98

Ph

ysic

al F

un

ctio

nin

g0

.29

<0

.00

1<

0.0

01

Wh

ee

zin

g (

S)

23

98

Ro

le F

un

ctio

nin

g0

.28

<0

.00

1<

0.0

01

Wh

ee

zin

g (

S)

23

95

Em

otio

na

l Fu

nct

ion

ing

0.2

7<

0.0

01

<0

.00

1W

he

ezi

ng

(S

)2

39

5C

og

niti

ve F

un

ctio

nin

g0

.33

<0

.00

1<

0.0

01

Wh

ee

zin

g (

S)

23

94

So

cia

l Fu

nct

ion

ing

0.1

7<

0.0

01

0.0

04

Wh

ee

zin

g (

S)

23

95

Glo

ba

l He

alth

Sta

tus/

Qo

L0

.21

<0

.00

1<

0.0

01

Wh

ee

zin

g (

S)

23

91

HR

QO

L S

um

ma

ry S

core

0.3

7<

0.0

01

<0

.00

1A

bb

rev

iati

on

s:

PR

O-C

TC

AE

, Pa

tien

t-R

ep

ort

ed

Ou

tco

me

s ve

rsio

n o

f th

e C

om

mo

n T

erm

ino

log

y C

rite

ria fo

r A

dve

rse

Eve

nts

; SD

, Sta

nd

ard

de

via

tion

; EO

RT

C Q

LQ

-C3

0, E

uro

pe

an

Org

an

isa

tion

for

Re

sea

rch

an

d T

rea

tme

nt o

f Ca

nce

r C

ore

Qu

alit

y o

f Life

Qu

est

ion

na

ire;

F, F

req

ue

ncy

; S, S

eve

rity;

I, In

terf

ere

nce

with

usu

al o

r d

aily

act

iviti

es;

P, P

rese

nce

/ab

sen

ce; A

, Am

ou

nt;

EC

OG

PS

, Ea

ste

rn C

oo

pe

rativ

e O

nco

log

y G

rou

p P

erf

orm

an

ce S

tatu

s; Q

oL

, Qu

alit

y o

f Life

; HR

QO

L, H

ea

lth-r

ela

ted

qu

alit

y o

f life

* C

oh

en

's d

for

gro

up

diff

ere

nce

s; C

oh

en

's h

for

diff

ere

nce

s in

pro

po

rtio

ns

** N

ot c

on

sid

ere

d a

s e

vid

en

ce o

f va

lidity

be

cau

se d

irect

ion

of e

ffect

is th

e o

pp

osi

te o

f th

at h

ypo

the

size

d1

- H

an

d-f

oo

t syn

dro

me

-ind

uci

ng

ch

em

oth

era

pie

s in

clu

de

ca

pe

cita

bin

e, f

luo

rou

raci

l, su

niti

nib

, an

d s

ora

fen

ib2

- S

kin

-re

act

ion

ch

em

oth

era

pie

s in

clu

de

ep

ide

rma

l gro

wth

fact

or

rece

pto

r in

hib

itors

, do

ceta

xel,

ge

mci

tab

ine

, pa

clita

xel,

an

d p

em

etr

exe

d3

- Ir

rita

nt c

he

mo

the

rap

ies

incl

ud

e b

leo

myc

in, b

ort

ezo

mib

, ca

rbo

pla

tin, c

yclo

ph

osp

ha

mid

e, c

yta

rab

ine

, da

carb

azi

ne

, da

un

oru

bic

in, d

oce

taxe

l, d

oxo

rub

icin

, eto

po

sid

e, f

luo

rou

raci

l, g

em

cita

bin

e, i

fosf

am

ide

, irin

ote

can

, na

b-p

acl

itaxe

l, o

xalip

latin

,p

acl

itaxe

l, to

po

teca

n, a

nd

tra

stu

zum

ab

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020

Page 43: Supplementary Online Content - JAMA Network · Symptomatic AE Term Surveys Based on Cancer Type Survey for all patients after 80% were accrued Breast . Survey Lymphoma/ Myeloma

43

eTable 4. Test-retest Reliability for 49 Preselected PRO-CTCAE Items (N=80)

PRO-CTCAE Symptomatic AE Term Intra-class Correlation Coefficient Frequency Severity Interference Presence Amount

Anxiety 0.78 0.69 0.83 - - Arm/leg swelling 0.86 0.68 0.64 - - Constipation - 0.83 - - - Cough - 0.74 0.53 - - Decreased appetite - 0.80 0.80 - - Dry mouth - 0.74 - - - Fatigue - 0.77 0.79 - - Feelings that nothing could cheer you up 0.70 0.75 0.72 - - Hair loss - - - - 0.96 Headache 0.80 0.78 0.78 - - Hiccups 0.69 0.71 - - - Insomnia - 0.64 0.72 - - Loose stools 0.54 - - - - Mouth or throat sores - 0.82 0.81 - - Nausea 0.80 0.84 - - - Numbness/tingling in your hands or feet - 0.80 0.55 - - Pain 0.83 0.82 0.84 - - Problems with concentration - 0.74 0.70 - - Problems with tasting food/drink - 0.84 - - - Rash - - - 0.86 - Sad or unhappy feelings 0.72 0.61 0.76 - - Shortness of breath - 0.70 0.66 - - Skin burns from radiation - 0.65 - - - Unusual darkening of the skin - - - 0.73 - Vomiting 0.81 0.79 - - - Wheezing 0.65

Abbreviations: PRO-CTCAE, Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events; AE, adverse event

Downloaded From: https://jamanetwork.com/ by a Non-Human Traffic (NHT) User on 07/15/2020